
<html lang="en"     class="pb-page"  data-request-id="c0dfb456-63e4-41b7-ba66-8080de29d169"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-4;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm401509e;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases" /></meta><meta name="dc.Creator" content="Neelu  Kaila" /></meta><meta name="dc.Creator" content="Bruce  Follows" /></meta><meta name="dc.Creator" content="Louis  Leung" /></meta><meta name="dc.Creator" content="Jennifer  Thomason" /></meta><meta name="dc.Creator" content="Adrian  Huang" /></meta><meta name="dc.Creator" content="Alessandro  Moretto" /></meta><meta name="dc.Creator" content="Kristin  Janz" /></meta><meta name="dc.Creator" content="Michael  Lowe" /></meta><meta name="dc.Creator" content="Tarek S.  Mansour" /></meta><meta name="dc.Creator" content="Cedric  Hubeau" /></meta><meta name="dc.Creator" content="Karen  Page" /></meta><meta name="dc.Creator" content="Paul  Morgan" /></meta><meta name="dc.Creator" content="Susan  Fish" /></meta><meta name="dc.Creator" content="Xin  Xu" /></meta><meta name="dc.Creator" content="Cara  Williams" /></meta><meta name="dc.Creator" content="Eddine  Saiah" /></meta><meta name="dc.Description" content="Previously we reported the discovery of CRA-898 (1), a diazine indole acetic acid containing CRTH2 antagonist. This compound had good in vitro and in vivo potency, low rates of metabolism, moderate..." /></meta><meta name="Description" content="Previously we reported the discovery of CRA-898 (1), a diazine indole acetic acid containing CRTH2 antagonist. This compound had good in vitro and in vivo potency, low rates of metabolism, moderate..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 10, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401509e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401509e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401509e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401509e" /></link>
        
    
    

<title>Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401509e" /></meta><meta property="og:title" content="Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0027.jpeg" /></meta><meta property="og:description" content="Previously we reported the discovery of CRA-898 (1), a diazine indole acetic acid containing CRTH2 antagonist. This compound had good in vitro and in vivo potency, low rates of metabolism, moderate permeability, and good oral bioavailability in rodents. However, it showed low oral exposure in nonrodent safety species (dogs and monkeys). In the current paper, we wish to report our efforts to understand and improve the poor PK in nonrodents and development of a new isoquinolinone subseries that led to identification of a new development candidate, CRA-680 (44). This compound was efficacious in both a house dust mouse model of allergic lung inflammation (40 mg/kg qd) as well as a guinea pig allergen challenge model of lung inflammation (20 mg/kg bid)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401509e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401509e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401509e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401509e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401509e&amp;href=/doi/10.1021/jm401509e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1299-1322</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401471v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401948b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neelu++Kaila">Neelu Kaila</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce++Follows">Bruce Follows</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louis++Leung">Louis Leung</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Thomason">Jennifer Thomason</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adrian++Huang">Adrian Huang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Moretto">Alessandro Moretto</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristin++Janz">Kristin Janz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Lowe">Michael Lowe</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tarek+S.++Mansour">Tarek S. Mansour</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cedric++Hubeau">Cedric Hubeau</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Page">Karen Page</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Morgan">Paul Morgan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Fish">Susan Fish</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Xu">Xin Xu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cara++Williams">Cara Williams</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eddine++Saiah">Eddine Saiah</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (617) 665-5626. E-mail: <a href="/cdn-cgi/l/email-protection#cda3a8a8a1b8e3a6aca4a1ac8dbdaba4b7a8bfe3aea2a0"><span class="__cf_email__" data-cfemail="9af4fffff6efb4f1fbf3f6fbdaeafcf3e0ffe8b4f9f5f7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401509e&amp;href=/doi/10.1021%2Fjm401509e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1299–1322</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 10, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 September 2013</li><li><span class="item_label"><b>Published</b> online</span>10 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401509e" title="DOI URL">https://doi.org/10.1021/jm401509e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1299%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNeelu%2BKaila%252C%2BBruce%2BFollows%252C%2BLouis%2BLeung%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D4%26contentID%3Djm401509e%26title%3DDiscovery%2Bof%2BIsoquinolinone%2BIndole%2BAcetic%2BAcids%2Bas%2BAntagonists%2Bof%2BChemoattractant%2BReceptor%2BHomologous%2BMolecule%2BExpressed%2Bon%2BTh2%2BCells%2B%2528CRTH2%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BAllergic%2BInflammatory%2BDiseases%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1322%26publicationDate%3DFebruary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401509e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2206</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401509e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Neelu&quot;,&quot;last_name&quot;:&quot;Kaila&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;Follows&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;Leung&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Thomason&quot;},{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Moretto&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;Janz&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Lowe&quot;},{&quot;first_name&quot;:&quot;Tarek&quot;,&quot;last_name&quot;:&quot;S. Mansour&quot;},{&quot;first_name&quot;:&quot;Cedric&quot;,&quot;last_name&quot;:&quot;Hubeau&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Page&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Morgan&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Fish&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Cara&quot;,&quot;last_name&quot;:&quot;Williams&quot;},{&quot;first_name&quot;:&quot;Eddine&quot;,&quot;last_name&quot;:&quot;Saiah&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1299-1322&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401509e&quot;},&quot;abstract&quot;:&quot;Previously we reported the discovery of CRA-898 (1), a diazine indole acetic acid containing CRTH2 antagonist. This compound had good in vitro and in vivo potency, low rates of metabolism, moderate permeability, and good oral bioavailability in rodents. However, it showed low oral exposure in nonrodent safety species (dogs and monkeys). In the current paper, we wish to report our efforts to understand and improve the poor PK in nonrodents and development of a new isoquinolinone subseries that led to identification of a new development candidate, CRA-680 (44). This compound was efficacious in both a house dust mouse model of allergic lung inflammation (40 mg/kg qd) as well as a guinea pig allergen challenge model of lung inflammation (20 mg/kg bid).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401509e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401509e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401509e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401509e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401509e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401509e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401509e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401509e&amp;href=/doi/10.1021/jm401509e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401509e" /></input><a href="/doi/pdf/10.1021/jm401509e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401509e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401509e%26sid%3Dliteratum%253Aachs%26pmid%3D24512187%26genre%3Darticle%26aulast%3DKaila%26date%3D2014%26atitle%3DDiscovery%2Bof%2BIsoquinolinone%2BIndole%2BAcetic%2BAcids%2Bas%2BAntagonists%2Bof%2BChemoattractant%2BReceptor%2BHomologous%2BMolecule%2BExpressed%2Bon%2BTh2%2BCells%2B%2528CRTH2%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BAllergic%2BInflammatory%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D4%26spage%3D1299%26epage%3D1322%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291864" title="Fluorescence resonance energy transfer">Fluorescence resonance energy transfer</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jmcmar.2014.57.issue-4/production/jmcmar.2014.57.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Previously we reported the discovery of CRA-898 (<b>1</b>), a diazine indole acetic acid containing CRTH2 antagonist. This compound had good in vitro and in vivo potency, low rates of metabolism, moderate permeability, and good oral bioavailability in rodents. However, it showed low oral exposure in nonrodent safety species (dogs and monkeys). In the current paper, we wish to report our efforts to understand and improve the poor PK in nonrodents and development of a new isoquinolinone subseries that led to identification of a new development candidate, CRA-680 (<b>44</b>). This compound was efficacious in both a house dust mouse model of allergic lung inflammation (40 mg/kg qd) as well as a guinea pig allergen challenge model of lung inflammation (20 mg/kg bid).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Arachidonic acid (AA) is released upon catalytic action of cytosolic phospholipase A2 (cPLA2) on membrane phospholipids, which in turn is initiated by activation of mast cells.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Once the AA cascade is triggered, several metabolites are produced. PGD2 is a downstream metabolite and is a major prostanoid; it binds to three different receptors: thromboxane type prostanoid receptor (TP), the PGD2 receptor (DP), and the chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2). CRTH2 is a promiscuous receptor and in addition to PGD2 binds to several of its metabolites.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> It is a seven transmembrane Gi coupled receptor expressed on Th2 cells, eosinophils, basophils, and monocytes. Signaling through CRTH2 results in an inhibition of cAMP, resulting in T cell, eosinophil, basophil, and monocyte chemotaxis as well as stimulation of Th2 T cell cytokine production. Activation of CRTH2 contributes to Th2/eosinophilic type responses associated with allergy and asthma. A comparison of CRTH2 expression with chemotactic behavior of eosinophils in healthy and atopic individuals revealed higher mRNA and protein levels of CRTH2 in eosinophils from atopic subjects compared with those in healthy controls. In agreement with the increased number of CRTH2 receptors in eosinophils from atopic individuals, chemotaxis that is induced by PGD2 was significantly higher in these cells.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> There is also evidence that genetic alterations of CRTH2 are linked to the severity of allergic asthma.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These findings indicate that higher levels of CRTH2 expression and increased responsiveness to its ligand PGD<sub>2</sub> might be the biological basis for its association with asthma.</div><div class="NLM_p">CRTH2 antagonists have been moved to clinical trials for treatment of allergic rhinitis, asthma, and COPD.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Recent clinical data has come from AstraZeneca (AZD1981), Oxagen (OC000459), and Array Biopharma (ARRY-502). Although no beneficial effect was observed with AZD1981 in patients with moderate to severe COPD,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> clinical data from Oxagen looks promising. Their orally active CRTH2 antagonist, OC000459, when dosed at 200 mg twice daily for 16 days, showed a 25% reduction in the late asthmatic response area under the curve as measured by forced expiratory volume in 1 s (FEV1) to inhaled allergen change.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Array BioPharma also observed positive results from a phase 2 trial; their oral CRTH2 antagonist, ARRY-502, improved FEV1 by 3.9% versus placebo in mild to moderate persistent allergic asthma when dosed at 200 mg twice daily for 4 weeks, achieving statistical significance (<i>P</i> = 0.02).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These results have stimulated interest in discovering potent, selective, and orally active CRTH2 antagonists for the treatment of asthma.</div><div class="NLM_p last">Indomethacin was identified as a CRTH2 receptor agonist soon after the discovery of the CRTH2 receptor.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> After indomethacin was discovered, a number of bicyclic indole acetic acids and related analogues were disclosed as potent CRTH2 antagonists. Over the years, aryl acetic acid is a common pharmacophore for a large number of CRTH2 antagonists reported in literature.<a onclick="showRef(event, 'ref6 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref11">(6, 11)</a> We recently reported discovery of a new class of CRTH2 antagonists, the pyridazine linker containing indole acetic acids.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> We had started from an initial phthalazinone indole acetic acid hit, which had good potency but poor permeability, metabolic stability, and PK. Optimization led to CRA-898 (<b>1</b>), a compound with good potency, low rates of metabolism, moderate permeability, and good oral bioavailability in rodents. It was efficacious in mouse models of contact hypersensitivity (1 mg/kg bid) and house dust allergen induced lung inflammation (20 mg/kg qd) when dosed orally. However, compound <b>1</b> showed low oral exposure in nonrodent safety species (dogs and monkeys) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In the current paper, we wish to report our efforts to understand and improve the poor PK in nonrodents and to describe the development of a new isoquinolinone subseries that led to identification of a new development candidate, <b>44</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> <i>N</i>-Benzyl Pyridazine Linker Analogues</h3><div class="NLM_p">The pyridazine linker compounds (<b>4</b>, <b>6</b>, <b>8</b>, <b>10</b>, and <b>12</b>, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) were prepared by reductive alkylation of methyl 2-(5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>1A</b>) with 1-benzyl-6-oxo-1,6-dihydropyridazine-3-carbaldehyde (<b>I</b>-<b>2</b>)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> using triethyl silane/TFA mixture as the reducing agent (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The resulting intermediate <b>I</b>-<b>3</b> was debenzylated using aluminum chloride. In this reaction, the methyl ester was hydrolyzed as well. The resulting pyridazine carboxylic acid (<b>I</b>-<b>4</b>) was alkylated using substituted benzyl bromides to give the dibenzylated intermediates <b>I</b>-<b>5</b>. Base hydrolysis of benzyl esters gave the final products.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyridazine Linker Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> <i>N</i>-Benzyl Pyridone Linker Analogues</h3><div class="NLM_p">To obtain the <i>N</i>-benzylated pyridone linker analogues, reductive alkylation was done either with 1-benzyl-6-oxo-1,6-dihydropyridine-3-carbaldehyde (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) or 6-methoxy pyridine carbaldehyde (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) to give intermediates <b>I</b>-<b>6</b> or <b>I</b>-<b>7</b>, respectively. The <i>N</i>-benzyl pyridone linker analogue <b>3</b> was obtained by hydrolysis of <b>I-6</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). To obtain the substituted <i>N</i>-benzylated pyridone linker analogues (<b>5</b>, <b>7</b>, <b>9</b>, <b>11</b>, <b>13</b>, and <b>14</b>, Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), a procedure by Bowman et al.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> was used, <b>I</b>-<b>7</b> was reacted with benzyl bromides activated by sodium iodide, and the products (<b>I</b>-<b>8</b>) were hydrolyzed with base.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of {3-[(1-Benzyl-6-oxo-1,6-dihydropyridin-3-yl)methyl]-5-fluoro-2-methyl-1<i>H</i>-indol- 1-yl}acetic Acid</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Substituted <i>N</i>-Benzyl Pyridone Linker Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> <i>N</i>-Alkyl Pyridone Linker Analogues</h3><div class="NLM_p">Synthesis of the alkyl pyridone linker analogues was less straightforward (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>); alkylation of <b>I</b>-<b>7</b>, using alkyl halides, was not successful because the alkyl halides were not electrophilic enough to react with the pyridyl nitrogen. Therefore, the methoxy group was cleaved using TMSI, and the intermediate <b>I</b>-<b>9</b> thus obtained was reacted with <b>I</b>-<b>1A</b> to give <b>I</b>-<b>10</b>. Amide <b>I</b>-<b>10</b> was treated with alkyl halide and a base to give <b>I</b>-<b>11</b>. The latter were hydrolyzed to get the <i>N</i>-alkylated pyridone linker analogues (<b>16</b>, <b>18</b>, <b>23</b>). Small amounts of <i>O</i>-alkylated side products were also observed.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>N</i>-Alkyl Pyridone Linker Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> <i>N</i>-Benzyl Pyridones</h3><div class="NLM_p">The direct linked <i>N</i>-benzylated pyridones (<b>19</b>–<b>22</b>, <b>34</b>, <b>35</b>, <b>38</b> Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) were prepared by benzylation of the methoxy pyridine <b>I</b>-<b>14</b> followed by hydrolysis of the methyl ester of intermediate <b>I</b>-<b>15</b>. Intermediates <b>I</b>-<b>14</b> were acquired by palladium mediated coupling of 3-bromo indoles (<b>I</b>-<b>13</b>) with 6-methoxypyridin-3-ylboronic acid. Intermediates <b>I</b>-<b>13</b> were obtained in 2 steps from 5-fluoro-2-methyl indole; first bromination, followed by reaction with methylbromo acetate. A similar Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a> was followed to access <b>32</b> and <b>33</b>, except <i>tert</i>-butyl ester (<b>I</b>-<b>18</b>–<b>I</b>-<b>20</b>) was used as a protecting group instead of methyl ester because better yields were obtained with the former. The 2-methyl propionic acids (<b>43a</b> and <b>43b</b> Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>) were prepared by benzylation of <b>I</b>-<b>22</b> followed by hydrolysis of the methyl ester <b>I</b>-<b>23</b>. <b>I</b>-<b>22</b> were acquired via <b>I</b>-<b>21</b> by following a procedure similar to Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>.</div><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Substituted <i>N</i>-Benzyl Pyridone Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>N</i>-Alkyl Pyridones</h3><div class="NLM_p">To access the <i>N</i>-alkylated pyridones (<b>24</b>–<b>31</b>, and <b>36</b>, Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>), the methyl ether in <b>I</b>-<b>14</b> was removed using acid and the product <b>I</b>-<b>16</b> was alkylated with alkyl bromides using potassium carbonate to give <b>I</b>-<b>17</b>, which was hydrolyzed to give the final products. A minor amount of <i>O</i>-alkylated analogue <b>37</b> was isolated alongside of <i>N</i>-alkylated analogue <b>36</b>. The reaction conditions for synthesis of <b>I</b>-<b>16</b> required some optimization; conventional heating for 48 h gave moderate yield, and heating in the microwave improved the yields.</div><figure id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <i>N</i>-Alkyl Pyridone Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <i>N</i>-Benzyl Isoquinolinone</h3><div class="NLM_p">Initially, the synthesis of the isoquinolinone analogues was tried using the same approach taken for the synthesis of the pyridone analogues shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Following this sequence, 4-bromo-methoxyisoquinoline was converted to the pinocol boronic ester and subsequently coupled to 3-bromoindole in low but acceptable yields (28% and 45%, Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>A). No reaction was observed, however, when the methoxyisoquinoline analogue was subjected to sodium iodide and benzylbromide. The ring system in this example seems to be more stable than the methoxypyridine (<b>I</b>-<b>14</b>) example described above in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. In fact, when the methoxyisoquinoline was subjected to conditions typically used to cleave arylmethoxy groups, such as HBr in acetic acid, no reaction took place. Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>B illustrates another unsuccessful attempt, where isoquinolinone-4-boronic acid (or its <i>N</i>-benzyl derivative) was directly coupled to the indole core. Unfortunately, these couplings were unsuccessful, giving in most cases the reduced form of the indole ring as the major side product.</div><div class="NLM_p">In a third approach to a synthetic route to the benzyl isoquinolinone (<b>48</b>), coupling of 3-boronic ester indole with 4-bromoquinolinone was tried (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>C). This route examined the effect of switching the boronic ester and the aryl halide components of the Suzuki reaction. The literature revealed that most of the Suzuki reactions with 3-boronic acid indoles require an electron withdrawing group at the indole nitrogen such as a sulfonamide. Using a sulfonamide protecting group on the nitrogen atom of the indole (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>C; step 1), the 3-bromoindole was converted to the 3-boronic ester indole, giving a separable mixture of the desired product and the reduced form of the indole as a side product (ratio 2:3). Unfortunately, coupling of the boronic ester with 4-bromo isoquinolinone did not give the desired product. On the basis of the observations above, we suspected that 4-bromoisoquinolinone may be a poor partner in the Suzuki coupling reactions. The coupling described in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a> was different in that the halide coupling partner was aromatic. On the basis of this observation, a benzyl group was used as a protecting group on the oxygen during the Suzuki coupling (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>D). The <i>O</i>-benzyl starting material was prepared via Mitsunobu reaction from 4-bromoisoquinolin-1(2<i>H</i>)-one.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Coupling of the boronic ester with 3-bromoindole using PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> provided the desired product in 56%, a much improved yield in the coupling step. A variety of conditions were tried to cleave benzyl groups, but none were successful. The entire sequence was also run using a PMB protecting group. Cleavage should have occurred easily with either DDQ or TFA, however, neither condition worked. Scheme <a class="ref internalNav" href="#sch10A" aria-label="10">10</a>A illustrates direct coupling of isoquinoline to the indole core, followed by a benzylation/oxidation protocol to convert the isoquinoline to an benzylisoquinolinone as described in literature.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The benzylation step proceeded as expected, however, when the intermediate obtained from the benzylation was treated with the oxidant, K<sub>3</sub>Fe(CN)<sub>6</sub>, overoxidation took place to give unwanted side products. By changing the protecting group to BOC on the indole nitrogen, the oxidation step took place cleanly to afford the desired benzylisoquinolinone product (<b>I</b>-<b>26</b>, Scheme <a class="ref internalNav" href="#sch10A" aria-label="10">10</a>B). In the last three steps of the route, the BOC group was cleaved with TFA and elaborated to the carboxylic side chain to give a 37% overall yield in the 5-step transformation.</div><figure id="sch7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0016.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <i>N</i>-Benzyl 5-Chloro- and 5-<i>H</i> Pyridones</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0017.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of 2-Methyl Propionoc Acid Pyridone Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0018.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of <i>N</i>-Benzyl Isoquinolinone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch10A" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0019.jpeg" id="GRAPHIC-d4618e876-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. (A) Synthesis of <i>N</i>-Benzyl Isoquinolinone, (B) Synthesis of <i>N</i>-Benzyl Isoquinolinone, (C) Synthesis of <i>N</i>-Alkyl Isoquinolinone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch10A"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>N</i>-Alkyl Isoquinolinones</h3><div class="NLM_p last">To access the <i>N</i>-alkyl isoquinolinone analogues (<b>44</b>–<b>47</b> Scheme <a class="ref internalNav" href="#sch10A" aria-label="10">10</a>C), the alkyl isoquinolinone boronic ester (<b>I</b>-<b>29</b>) was coupled with 3-iodo indole (<b>I</b>-<b>30</b>). <b>I</b>-<b>29</b> was prepared in 2 steps from 2-alkylisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>27</b>) via the 4-iodo-2-alkyllisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>28</b>).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Saturated Isoquinolinones</h3><div class="NLM_p">The saturated isoquinolinones (Scheme <a class="ref internalNav" href="#sch11" aria-label="11">11</a>) were synthesized using a similar approach as the alkyl isoquinolinones (Scheme <a class="ref internalNav" href="#sch10A" aria-label="10">10</a>C). The required boronic esters (<b>I</b>-<b>34</b>) were prepared in 3 steps (via <b>I</b>-<b>32</b> and <b>I</b>-<b>33</b>) from the tetrahydroisoquinolin-1(2<i>H</i>)-one <b>I</b>-<b>31</b>. The latter was prepared by platinum oxide reduction of the commercially available isoquinolin-1(2<i>H</i>)-one.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Palladium catalyzed coupling of <b>I</b>-<b>34</b> with indole <b>I</b>-<b>30</b>, followed by hydrolysis, gave final products (<b>49</b>–<b>52</b>).</div><figure id="sch11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0020.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Saturated Isoquinolinone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>1</b>, our first development track candidate, showed good potency in cell based, binding and whole blood assays. This compound exhibited a good PK profile in rodents and was efficacious in mouse models of contact hypersensitivity and house dust allergen induced lung inflammation when dosed orally. However, compound <b>1</b> showed low oral exposure in nonrodent safety species (dogs and monkey). PK properties of <b>1</b> in preclinical animal species are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. A large interspecies variability was observed in plasma clearance (relative to hepatic blood flow) in preclinical animal species (dog > monkey > rat). This was an unexpected result because earlier studies with cyropreserved hepatocytes from each of the species had shown low intrinsic metabolic clearance (<5 μL/min/10<sup>6</sup> cells). Further studies were performed to examine alternative clearance pathways (e.g., renal, biliary) in addition to metabolic clearance.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. PK Properties of Compound <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">iv Cl<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i>1/2<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> h</th><th class="colsep0 rowsep0" align="center" char=".">Vss<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–inf</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (h·kg·ng/mL/mg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">bioavailability (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">5066</td><td class="colsep0 rowsep0" align="char" char=".">772</td><td class="colsep0 rowsep0" align="char" char=".">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">678</td><td class="colsep0 rowsep0" align="char" char=".">716</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">1154</td><td class="colsep0 rowsep0" align="char" char=".">246</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Intravenous dose, 2 mg/kg.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Oral dose, 10 mg/kg.</p></div></div></div><div class="NLM_p">Biliary excretion studies in bile duct cannulated rats showed that following a single iv dose of 5 mg/kg of <b>1</b>, the average plasma clearance was 14 mL/min/kg, with about 27% of the parent drug recovered in bile and none in urine over a period of 24 h. These results suggest that metabolism is the major elimination pathway in rat with biliary excretion of unchanged drug a relatively modest clearance pathway. Nevertheless, a different picture was observed in dogs. A single intravenous dose of 5 mg/kg of <b>1</b> was administered, and quantification of unchanged drug and drug-related products in urine and feces over a 24 h period was assessed by <sup>19</sup>F-NMR and LC/MS. A majority of the administered dose (>90%) was recovered as unchanged drug in feces. These results suggest that in dogs, unlike rats, fecal excretion potentially via biliary excretion represents a major clearance pathway of <b>1</b>.</div><div class="NLM_p">Additional experiments were conducted to further investigate the difference in biliary clearance observed in rats (low) and dogs (high). We reasoned that <b>1</b> may have different hepatobiliary uptake or efflux in different species. Permeability of <b>1</b> was measured in the Caco-2 cell line at reduced pH 6.5. Compound <b>1</b> exhibited reasonable permeability (<i>P</i><sub>app</sub> 7.1 × 10<sup>–6</sup> cm/s) across Caco-2 monolayers, suggesting that the brush-border (microvilli) region of the jejunum segment of the small intestine (where the pH is slightly acidic) may be a predominant site of absorption. Results from initial studies using Caco-2 cell monolayers and selective P-gp (verapamil) or MRP2 (MK-571) inhibitors indicated that MRP2 and to a lesser extent P-gp was involved in the efflux of <b>1</b>.</div><div class="NLM_p">Because MRP2 seemed to be largely responsible for the efflux of <b>1</b> in Caco-2 monolayers, membrane vesicles prepared from Sf9 cells expressing Mrp2/MRP2 from rats, dogs, monkeys, or humans were used to further assess potential species differences in biliary efflux of <b>1</b>. Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> shows the uptake of <b>1</b> into inside-out membrane vesicles. The uptake in dog vesicles was found to be 3–4-fold higher than that in rat, monkey, and human, suggesting species differences in transporter-mediated efflux.</div><figure id="fig1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0002.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Uptake of <b>1</b> into Sf9 cells expressing Mrp2/MRP2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further characterize the hepatobiliary disposition of <b>1</b>, sandwich-cultured hepatocytes from rat and human were used as an in vitro model. Sandwich-cultured hepatocytes form functional bile canalicular networks and maintain the expression and function of key uptake and efflux transporters relative to hepatocytes in vivo. In rat, the in vitro intrinsic biliary clearance was determined to be low (<2.6 μL/min/μg) and seemed to be consistent with the low in vivo biliary clearance (3.8 mL/min/kg). The in vitro intrinsic biliary clearance was also determined to be low (<1 μL/min/μg) in human sandwich-cultured hepatocytes. However, it should be kept in mind that the use of sandwich-cultured hepatocytes to accurately predict biliary clearance in humans remains to be fully established. As a result, despite the low predicted human clearance, the decision was made to identify a different development candidate with improved PK properties in nonrodent species.</div><div class="NLM_p">A cAMP cell based competitive immunoassay (hCRTH2 FRET) using Eu<sup>3+</sup> cryptate-labeled anti-cAMP and <i>d</i><sub>2</sub>-labeled cAMP was used as a primary in vitro screen. Additionally, three secondary assays were used to evaluate compounds: (a) A basophil chemotaxis assay to examine CRTH2 mediated cell migration. This assay was run in a 96-transwell format with human CRTH2+ basophils, derived from IL-3 treated CD34+ progenitor cells, in the presence of 10 nM PGD2. An initial set of compounds were tested in the chemotaxis assay, and a very good correlation was observed between the FRET and chemotaxis assays (Figure <a data-tab="pane-pcw-Figures" href="#fig2A" id="" class=" internalNav">2</a>A). (b) A human CRTH2 competitive binding assay with tritium labeled PGD2. A good correlation was observed between the binding assay and the FRET assay, confirming that the FRET potency was coming from direct binding to hCRTH2 (Figure <a data-tab="pane-pcw-Figures" href="#fig2A" id="" class=" internalNav">2</a>B). Because a good correlation was established between the FRET versus chemotaxis and FRET versus binding assays, only selected compounds were tested in these assays. (c) A human whole blood eosinophil shape change assay (hEOS). Eosinophil shape change is a consequence of cytoskeleton reorganization and is a prerequisite for leukocyte movement, transmigration, and activation, and it can be quantified by flow cytometry through changes in forward light scatter. In this assay, human whole blood was stimulated with PGD2 and analyzed by flow cytometry. Eosinophils were selected based on their autofluorescence in the FL2 channel. Shape change was estimated based on mean forward light scatter values. This assay was used as a secondary assay and could potentially be used as a biomarker in in vivo models and clinical trials. A good correlation was seen between the FRET and hEOS (free) assay (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Potency in the FRET assay (IC<sub>5</sub><sub>0</sub> ≤ 50 nM) and good chemical properties were used as filters to advance compounds to the hEOS assay.</div><figure id="fig2A" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0003.jpeg" id="GRAPHIC-d4618e1240-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Plot of log IC<sub>50</sub> in the FRET and basophil chemotaxis assay. (B) Plot of log IC<sub>50</sub> in the FRET and binding assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig2A"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0004.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of log IC<sub>50</sub> in the FRET and hEOS (free) assay. *Calculated human plasma protein binding used to determine hEOS (free) values</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ligands for the receptors in the prostaglandin family show some degree of cross-reactivity, and there is potential for small molecule inhibitors to do the same. Therefore, selectivity of these compounds against two other prostaglandin receptors (DP1 and TXB2) was investigated using assays described previously.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Representative examples from the series were tested and found to be greater than thousand-fold selective for CRTH2. Early compounds were also tested for affinity to the mouse CRTH2 receptor. A good correlation was seen between the human and murine CRTH2. This result is of importance for the feasibility of in vivo pharmacological studies in mouse models. Compounds were tested in these assays before advancing to in vivo models.</div><div class="NLM_p">Our initial strategy to improve the permeability and oral bioavailability of the diazine class of compounds was to lower the TPSA. One of the nitrogen atoms in the diazine was replaced with carbon giving pyridine indoles. Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> shows comparison of the diazine and pyridine indoles synthesized. In general, the <i>N</i>-benzyl pyridones showed improved IC<sub>50</sub>s but comparable LipE to the diazine indoles. The <i>N</i>-alkyl pyridones showed loss in potency (<b>15</b> versus <b>16</b> and <b>17</b> versus <b>18</b>). Compound <b>14</b> was evaluated in in vivo rat pharmacokinetic studies. The compound had high clearance and poor bioavailability (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In an effort to address the high clearance of these compounds, the metabolically labile methylene group was removed. The direct linked pyridine compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) showed comparable potency to linker pyridines. The SAR of this series was further expanded. Substitution at the 5 position of the indole was studied for the <i>N</i>-alkyl and <i>N</i>-benzyl subseries (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Substituents at the 5-position had an important effect on activity. In both subseries, chloro (<b>26</b>) or fluoro (<b>24</b>) substitution at the 5 position improved potency. Polar groups like methoxy had a detrimental effect on activity (<b>31</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potency in the FRET Assay for Diazine and Pyridone Indoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0021.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">FRET IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2,6-diF</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2,6-diF</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2,5-diF</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2,5-diF</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> (CRA-898)</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2,4-DiF</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2,4-DiF</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">150</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">PK rat (iv 2 mg/kg, PO 10 mpk) Cl = 32 mL/min/kg; <i>F</i> = 4%.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Potency in the FRET Assay for Pyridone Indoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0022.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">n</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">FRET IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">2,4-DiF</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">2,4-DiF</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">2,6-diF</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">2,6-diF</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">i-Pr</td><td class="colsep0 rowsep0" align="char" char=".">137</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">i-Pr</td><td class="colsep0 rowsep0" align="char" char=".">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">84</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">PK rat (iv 2 mg/kg, PO 10 mpk) Cl = 15 mL/min/kg; <i>F</i> < 10%.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">PK rat (iv 2 mg/kg, PO 10 mpk) Cl = 7 mL/min/kg; <i>F</i> 20%.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR at the 5-Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0023.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">FRET IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">i-Pr</td><td class="colsep0 rowsep0" align="char" char=".">195</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">i-Pr</td><td class="colsep0 rowsep0" align="char" char=".">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">i-Pr</td><td class="colsep0 rowsep0" align="char" char=".">556</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">711</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">1120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">2000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">2,6-DiF</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">2,6-DiF</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2,6-DiF</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr></tbody></table></div></div><div class="NLM_p">Transferring the substituent from the nitrogen to the oxygen in the pyridone ring was not tolerated. Greater then 40-fold loss in potency was observed (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Conversion of the acid to amide (<b>39</b>), substituted amide (<b>40</b> and <b>41</b>), and aliphatic sulfonamide (<b>42</b>) all resulted in loss of potency. Likewise, addition of a methyl group at the methylene next to the carboxylic acid reduced potency (<b>43A</b>, <b>43B</b>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of the Pyridone Indoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0024.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0025.gif" alt="" id="fx5" /></img><div></div></div><div class="NLM_p">One of the pyridone analogues, <b>19</b>, was taken forward for rat pharmacokinetic studies. The compound had moderate clearance and poor bioavailability (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). So far, the <i>N</i>-benzyl pyridones had shown poor rat PK properties (<b>14</b>, <b>19</b>), therefore we decided to select an <i>N</i>-alkyl pyridone (<b>16</b>) for evaluation in in vivo rat pharmacokinetic studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). This compound showed low clearance and improved bioavailability. A quick calculation using an in-house model showed that the predicted kinetic solubility at pH 6.5 in PBS buffer for the alkyl pyridone (<b>16</b>, solubility = 240 μg/mL) was higher than the benzyl pyridones (<b>19</b>, solubility = 63 μg/mL; <b>14</b>, solubility = 17 μg/mL), which could result in improved absorption leading to higher bioavailability observed with <b>16</b>. Regrettably, thus far the alkyl pyridones had shown low potency (<b>16</b>, <b>18</b>, <b>23</b>–<b>29</b>). A plot of cLogP and FRET IC<sub>50</sub>s (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) for the pyridones showed that the optimal range for clogP to achieve a potency less than 20 nM in the FRET assay is 3.5 and 5. We decided to pursue the isoqinolinone series to modulate the lipophilicity of the <i>N</i>-alkyl pyridones. The <i>N</i>-alkyl isoquinolinone (<b>44</b>–<b>47</b>) showed 10–20-fold improvement in potency against CRTH2 in the FRET assay with improved or comparable LipE (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The <i>N</i>-benzyl isoqinolinone (<b>48</b>) had similar potency but lower LipE compared to the pyridone. The good potency of the <i>N</i>-alkyl isoquinolinones was confirmed in the human whole blood hEOS assay, and these compounds were then advanced to in vivo studies. Additional ways to modulate the lipophilicity of this scaffold include saturating the ring adjacent to the isoquinoline ring. However, these compounds (<b>49</b>–<b>52</b>) showed loss in potency.</div><figure id="fig4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0005.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of cLogP versus FRET IC<sub>50</sub> (nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SAR of Isoquinolinone Indoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0026.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">FRET IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">LipE</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char=".">FRET IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">LipE</th><th class="colsep0 rowsep0" align="center" char=".">hEOS IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">FRET IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">i-Pr</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">4.01</td><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">i-Pr</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">4.46</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">i-Pr</td><td class="colsep0 rowsep0" align="char" char=".">107</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">3.97</td><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">4.55</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">4.53</td><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4.41</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">123</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>C(CH<sub>3</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">4.04</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">3.52</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">192</td></tr></tbody></table></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">In Vivo Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We utilized an oxazolone induced contact hypersensitivity (CHS) model in the mouse as a primary in vivo screen. In this model, mice were sensitized with oxazolone on their shaved abdomen and then challenged on day 5 by painting their ears with oxazolone. On the day of challenge, the test compound was administered and inhibition of ear swelling was determined as a measure of efficacy. A 40% reduction in ear swelling was observed with CRTH2 knockout mice. Selected compounds were tested in this model at 3 mg/kg po b.i.d. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> shows results for compounds <b>44</b>–<b>47</b>. All compounds showed reduction in ear swelling in the oxazolone CHS model at 3 mg/kg po bid. Compound <b>47</b> was not taken further due to its physicochemical properties. Compounds <b>44</b>, <b>45</b>, and <b>46</b> were progressed into in vivo rat pharmacokinetic studies. To establish pharmacokinetic profiles, compounds were dosed intravenously in rats at 3 mg/kg and orally at 10 mg/kg. Compounds <b>44</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>) and <b>45</b> (Cl = 20 mL/min/kg; <i>F</i> = 35%) showed moderate clearance and oral bioavailability, whereas compound <b>46</b> had moderate clearance (35 mL/min/kg) but poor oral bioavailability (<5%). Compound <b>45</b> had poor oral exposure in guinea pigs, and because our efficacy model was the guinea pig allergen induced pulmonary inflammation model, it would have been very challenging to dose compound <b>45</b>. On the other hand, the po exposure in guinea pigs was acceptable for compound <b>44</b>. Similarly, its PK profile was acceptable in dog and monkey (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Therefore, this compound was selected for evaluation in efficacy models.</div><figure id="fig5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0006.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo efficacy in CHS model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. PK Properties of <b>44</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">iv Cl<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i>1/2<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> h</th><th class="colsep0 rowsep0" align="center" char=".">Vss<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–inf</sub><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (h·kg·ng/mL/mg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">bioavailability (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1676</td><td class="colsep0 rowsep0" align="char" char=".">253</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">9459</td><td class="colsep0 rowsep0" align="char" char=".">2011</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="char" char=".">19675</td><td class="colsep0 rowsep0" align="char" char=".">2967</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Intravenous dose, 2 mg/kg.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Oral dose, 10 mg/kg.</p></div></div></div><div class="NLM_p">First, we sought to evaluate the potential of compound <b>44</b> to modulate house dust mite (HDM)-induced allergic airway disease in mice (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). This model has been previously described<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and uses dexamethasone (Dex) intraperitoneally at 1 mg/kg (qd) as a positive control. Airway inflammation was almost completely abrogated with Dex. Compound <b>44</b> was administered orally at 40 mg/kg (qd), and the eosinophilic component of HDM-induced allergic airway disease was significantly decreased. These anti-inflammatory effects of <b>44</b> treatment on airway neutrophilia were observed along with significantly decreased total BAL cellularity as well as significantly decreased BAL counts of eosinophils and lymphocytes. However, BAL macrophage numbers were unaffected by <b>44</b> treatment. Next, <b>44</b> was tested in a guinea pig allergen challenge model; guinea pig airway allergen challenge models have been used routinely in preclinical development of numerous molecules targeted towards asthma and are recognized to elicit robust allergic pulmonary inflammation that consists primarily of eosinophils. Guinea pigs were sensitized by IP injection with 100 μg of ovalbumin (OVA) emulsified in 100 mg of alum on days 1 and 5. Animals were then challenged via the airways with an aerosol of 0.01% OVA for 60 min on day 15. Compound was dosed at 20 mg/kg bid 1 h prior to challenge and 6 h post challenge on day 15. Animals were sacrificed on day 16 and bronchoalveolar cavities lavaged with 2 × 10 mL of warm PBS. Total BAL cell counts and cell differentials were quantified as described previously.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Compound <b>44</b> significantly attenuated total BAL cellularity, and BAL eosinophil, numbers 24 h post OVA challenge (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). The efficacious doses in the CHS, HDM, and OVA models were different; however, the exposures at these doses were within 2-fold (exposures were predicted based on pharmacokinetic studies).</div><figure id="fig6" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0007.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Modulation of HDM-induced allergic airway disease in BALB/c mice with <b>44</b> and dexamethasone (Dex). Total cellularity and eosinophil, macrophage, lymphocyte, and neutrophil cell numbers in BAL samples collected 72 h post-HDM challenge.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0008.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Modulation of OVA-induced allergic lung inflammation in the guinea pig: total cellularity and eosinophils, in BAL samples collected 24 h post-OVA challenge. Solid bars are OVA sensitized, PBS challenged animals; hatched bars are OVA sensitized OVA challenged animals that received vehicle orally 1 h prior to challenge and 6 h post challenge (1 mL of 0.5 Tween 80 in FlavoRX Cherry blast syrup) <i>N</i> = 15 animals; gray bars are animals that have been treated with dexamethasone orally at 30 mg/kg 1 h prior to challenge. <i>N</i> = 9 animals; open bars are animals that have been treated with compound <b>44</b> orally at 20 mg/kg 1 h prior to challenge and 6 h post challenge. <i>N</i> = 14 animals. <i>P</i> values as determined by student’s unpaired <i>t</i> test compared with vehicle treated animals are provided above the relevant bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To explore efficacy in a nonrodent species and to determine effects on lung function, <b>44</b> was evaluated in a sheep model of <i>Ascaris</i> induced airway bronchoconstriction and AHR (Figure <a data-tab="pane-pcw-Figures" href="#fig8A" id="" class=" internalNav">8</a>A).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Compound <b>44</b>, when dosed at 3 mg/kg iv bid the day prior to challenge and then again 1 h prior to challenge, completely blocked the late phase allergic airway bronchoconstriction (LAR). The animals were also given a fourth dose of <b>44</b>, 8 h post challenge, to evaluate attenuation of airway hyperresponsiveness (AHR) to aerosolized carbachol that was measured the day following allergen challenge. Using this dosing regimen, <b>44</b> (3 mg/kg iv) completely blocked the allergen induced AHR to carbachol. <b>44</b> was also evaluated for efficacy following subchronic administration at 1 mg/kg iv qd for 7 days prior to challenge. Using this dosing regimen, the compound completely blocked the LAR and AHR. Following measurement of AHR, three bronchi from each sheep were lavaged and cell counts determined. <b>44</b> reduced BAL inflammation at this dose (Figure <a data-tab="pane-pcw-Figures" href="#fig8A" id="" class=" internalNav">8</a>B).</div><figure id="fig8A" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0009.jpeg" id="GRAPHIC-d4618e2612-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Administration of compound <b>44</b> at 3 mg/kg iv in a sheep model of allergic airway bronchoconstriction and AHR. (i) While compound <b>44</b> (pink line) did not attenuate EAR as determined by increases in airway resistance above baseline, it completely ablated the <i>Ascaris suum</i> allergen induced LAR compared to untreated historical control values observed after allergen challenge in the same animals. (ii) Compound <b>44</b> blocks AHR to aerosolized carbachol (pink bar) as determined by an increase in PC400 values (the cumulative carbachol breath units that increased specific lung resistance by 400% (PC400) following allergen challenge compared to historical untreated control values in the same animals (blue bar). (B) Compound <b>44</b> attenuates <i>Ascaris</i> induced BAL fluid inflammation at 1 mg/kg iv qd for 7 days in sheep. (C) Reduction in mucocilliary clearance in sheep with <b>44</b> at 3 mpk iv.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig8A"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Preliminary studies also point to a role for CRTH2 in driving impaired airway mucociliary clearance after allergen challenge. Tracheal mucus velocity (TMV), a marker of airway mucociliary clearance, was measured in sheep by a technique described previously.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Administration of <b>44</b> at 3 mg/kg iv resulted in a more rapid return to baseline levels with a TMV of approx 70% of baseline at 4 h and a TMV of 98% of baseline at 8 h compared to an 8 h TMV of 47% of baseline with vehicle treated animals (Figure <a data-tab="pane-pcw-Figures" href="#fig8A" id="" class=" internalNav">8</a>C). Five sheep were used for these studies.</div><div class="NLM_p">Compound <b>44</b> was further profiled in safety and selectivity studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). The potential for clinical metabolic drug–drug interactions was considered low based on in vitro CYP inhibition results (CYP1A2, 2A6, 2B6, 2C19, 2D6, and 3A4 IC<sub>50</sub>s >100 μM, CYP2C9 IC<sub>50</sub> = 55 μM). Compound was clean in the AMES assay. No hERG inhibition was seen at 33 μM. Greater than 800-fold selectivity was seen against DP1 and TP receptors and in the Novascreen and nuclear receptor panel. On the basis of these results and in vivo efficacy, <b>44</b> (CRA-680) was advanced to development track.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Overall Profile of Compound <b>44</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="×" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">hCRTH<sub>2</sub> FRET (IC<sub>50</sub> nM)</th><th class="colsep0 rowsep0" align="center" char=".">hCRTH<sub>2</sub> binding (IC<sub>50</sub> nM)</th><th class="colsep0 rowsep0" align="center" char=".">basophil chemotaxis (IC<sub>50</sub> nM)</th><th class="colsep0 rowsep0" align="center" char=".">hEOS (IC<sub>50</sub> nM)</th><th class="colsep0 rowsep0" align="center" char=".">mCRTH<sub>2</sub> binding (IC<sub>50</sub> nM)</th><th class="colsep0 rowsep0" align="center" char=".">DP<sub>1</sub> FRET (IC<sub>50</sub> nM)</th><th class="colsep0 rowsep0" align="center" char=".">TXA<sub>2</sub> binding (IC<sub>50</sub> nM)</th><th class="colsep0 rowsep0" align="center" char="×">Caco2 permeability at (pH 6) cm/s</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">16000</td><td class="colsep0 rowsep0" align="char" char=".">>1000</td><td class="colsep0 rowsep0" align="char" char="×">2.7 × 10<sup>6</sup></td></tr></tbody></table></div></div><div class="NLM_p last">In summary, we started with <b>1</b>, a compound with good in vitro and in vivo potency, good oral bioavailability in rodents, but low oral exposure in nonrodent species (dogs and monkeys) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Key medicinal chemistry optimization changes included decreasing polar surface area and eliminating metabolically labile methylene group. This led to a new development candidate <b>44</b> with comparable potency to <b>1</b>, moderate bioavailability in rats, and improved PK in dogs and monkeys (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Chemistry</h3><div class="NLM_p last">Reactions were run using commercially available starting materials and solvents without further purification. Proton NMR spectra were recorded at 300 MHz on a Varian Gemini 2000 or at 400 MHz on a Bruker AV-400 spectrometer using TMS (δ 0.0) as a reference. The microwave procedures were carried out with a Biotage microwave. Preparative HPLC was run using a Waters reverse phase prep HPLC with Xterra C18 5 μM, 30 mm × 100 mm column. The flow rate was 40 mL/min and mobile phase A was water, mobile phase B was CH3CN, and triethylamine was used as a modifier. Purity in H<sub>2</sub>O–CH<sub>3</sub>CN was determined using an Agilent 1100 HPLC instrument, and all compounds analyzed were >95% pure.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Biology</h3><div class="NLM_p last">All procedures performed on these animals were in accordance with regulations and established guidelines and were reviewed and approved by an Institutional Animal Care and Use Committee or through an ethical review process.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure A (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>)</h3><div class="NLM_p">Methyl 2-(5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>1A</b>). In a 500 mL 2-necked round-bottomed flask, 5-fluoro-2-methylindole (5.00 g) was taken up with 100 mL anhydrous DMF, under nitrogen. NaH (1.69 g of a 60 wt % suspension in mineral oil, 1.01 g, 42.2 mmol) was added in small aliquots, and the mixture allowed to stir at room temperature for 30 min. Methyl bromoacetate (3.9 mL, 6.5 g, 42 mmol) was added all at once by syringe, and the reaction was allowed to stir overnight. It was then quenched by addition of 20 mL of brine, via syringe, and partitioned between 400 mL each ethyl acetate and brine. The aqueous layer was extracted with additional ethyl acetate (2×), and the combined organic extracts washed with brine (3×), dried over anhydrous magnesium sulfate, filtered, evaporated, and purified by flash chromatography over silica gel (2–20% ethyl acetate in hexanes) to give a white solid that gradually turned pink over several days (5.39 g, 69% yield).</div><div class="NLM_p">Methyl 2-(3-((1-benzyl-6-oxo-1,6-dihydropyridazin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>3</b>). To a 250 mL round-bottom flask under an atmosphere of nitrogen was added <b>I</b>-<b>1A</b> (3.26 g, 14.77 mmol, 1.0 equiv), 1-benzyl-6-oxo-1,6-dihydropyridazine-3-carbaldehyde (<b>I</b>-<b>2</b>) (3.46g, 16.24 mmol, 1.1 equiv), and 100 mL of anhydrous methylene chloride. The resulting solution was cooled to 0 °C in an ice/water bath, and triethylsilane (8.26 mL, 51.69 mmol, 3.5 equiv) and trifluoroacetic acid (3.3 mL, 44.30 mmol, 3.0 equiv) were added dropwise. The mixture was allowed to warm to room temperature and then stirred for 24 h. The mixture was then poured into satd NaHCO<sub>3(aq)</sub> and the aqueous layer extracted with two 50 mL portions of methylene chloride. The combined organic layers were then washed with water and brine and dried over magnesium sulfate. Filtration and removal of solvent in vacuo gave the crude material, which was then purified by silica gel chromatography to give a white solid (2.66g, 43%)</div><div class="NLM_p">2-(5-Fluoro-2-methyl-3-((6-oxo-1,6-dihydropyridazin-3-yl)methyl)-1<i>H</i>-indol-1-yl)acetic acid (<b>I</b>-<b>4</b>). To a 5 mL microwave reaction vessel was added <b>I</b>-<b>3</b> (0.197g, 0.47 mmol, 1.0 equiv), aluminum trichloride (0.375g, 2.84 mmol, 6.0 equiv), and 5 mL of toluene. The vessel was sealed and the mixture heated to 140 °C in a microwave reactor for 1 h. The mixture was then poured into 50 mL of water and extracted with three 50 mL portions of ethyl acetate. The combined organic layers were washed with water and brine then dried over MgSO<sub>4</sub>. Filtration and concentration in vacuo gave the crude product which was taken to the next step.</div><div class="NLM_p">2-(3-((1-Substituted-6-oxo-1,6-dihydropyridazin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)ester <b>I</b>-<b>5</b>. To a 100 mL round-bottom flask under a nitrogen atmosphere was added intermediate <b>I</b>-<b>4</b> (0.069 g, 0.22 mmol, 1.0 equiv), selected bromide (0.67 mmol, 3.0 equiv), potassium carbonate (0.123g, 0.89 mmol, 4.0 equiv), and 40 mL of DMF. The resulting suspension was heated to 85 °C for 16 h. The mixture was then allowed to cool to room temperature and then poured into 200 mL of water. This was extracted with three 50 mL portions of ethyl acetate. The combined organic layers were washed with water and brine and dried over MgSO<sub>4</sub>. Filtration and concentration in vacuo gave a tan solid. The crude material was purified by silica gel chromatography.</div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Pyridazine Linker Analogue</h4><div class="NLM_p last">To a 50 mL round-bottom flask under an atmosphere of nitrogen was added <b>I</b>-<b>5</b> (0.06 mmol, 1.0 equiv) and 20 mL of methanol. To this was added 0.12 mL of 5.0 N NaOH. The resulting mixture was allowed to stir for 16 h at room temperature. Mixture was poured into 100 mL of 1.2 N HCl and extracted with three 50 mL portions of ethyl acetate. The combined organic layers were washed with water and brine and dried over MgSO<sub>4</sub>. Filtration and concentration in vacuo gave crude material which was purified by reverse phase HPLC. The isolated material was then suspended in acetonitrile/water, frozen, and lyophilized to give the desired product (the yields have been reported over three steps).</div></div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (3-{[1-(2-Fluorobenzyl)-6-oxo-1,6-dihydropyridazin-3-yl]methyl}-5-fluoro-2- methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>4</b>)</h4><div class="NLM_p last">General procedure A was followed to make this compound in 33% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.03 (br s, 1H), 7.32–7.40 (m, 2H), 7.11–7.25 (m, 5H), 6.84–6.90 (m, 2H), 5.28 (s, 2H), 4.93 (s, 2H), 3.93 (s, 2H), 2.28 (s, 3H).</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (3-{[1-(3-Fluorobenzyl)-6-oxo-1,6-dihydropyridazin-3-yl]methyl}-5-fluoro-2- methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>6</b>)</h4><div class="NLM_p last">General procedure A was followed to make this compound in 23.1% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.31–7.40 (m, 2H), 7.06–7.19 (m, 5H), 6.82–6.89 (m, 2H), 5.24 (s, 2H), 4.87 (s, 2H), 3.96 (s, 2H), 2.30 (s, 3H).</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (3-{[1-(4-Fluorobenzyl)-6-oxo-1,6-dihydropyridazin-3-yl]methyl}-5-fluoro-2- methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>8</b>)</h4><div class="NLM_p last">General procedure A was followed to make this compound in 21.2% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.23–7.33 (m, 3H), 7.02–7.12 (m, 4H), 6.74–6.84 (m, 2H), 5.14 (s, 2H), 4.85 (s, 2H), 3.88 (s, 2H), 2.23 (s, 3H).</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (3-{[1-(2,6-Difluorobenzyl)-6-oxo-1,6-dihydropyridazin-3-yl]methyl}-5-fluoro-2- methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>10</b>)</h4><div class="NLM_p last">General procedure A was followed to make this compound in 28% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.13 (br s, 1H), 7.52 (tt, <i>J</i> = 6.66, 8.37 Hz, 1H), 7.38 (dd, <i>J</i> = 4.42, 8.97 Hz, 1H), 7.12–7.22 (m, 3H), 7.09 (dd, <i>J</i> = 2.53, 9.85 Hz, 1H), 6.86–6.95 (m, 2H), 5.36 (s, 2H), 4.95 (s, 2H), 3.89 (s, 2H), 2.26 (s, 3H).</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (3-{[1-(2,5-Difluorobenzyl)-6-oxo-1,6-dihydropyridazin-3-yl]methyl}-5-fluoro-2- methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>12</b>)</h4><div class="NLM_p last">General procedure A was followed to make this compound in 22% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.16–7.38 (m, 4H), 7.12 (dd, <i>J</i> = 2.53, 9.85 Hz, 1H), 7.02 (ddd, <i>J</i> = 3.28, 5.62, 8.78 Hz, 1H), 6.83–6.91 (m, 2H), 5.28 (s, 2H), 4.92 (s, 2H), 3.94 (s, 2H), 2.30 (s, 3H).</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> {3-[(1-Benzyl-6-oxo-1,6-dihydropyridin-3-yl)methyl]-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl}acetic Acid (<b>3</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>)</h4><div class="NLM_p last">The procedure described above for <b>I</b>-<b>3</b> was followed, reacting 1-benzyl-6-oxo-1,6-dihydropyridine-3-carbaldehyde<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with <b>I</b>-<b>1A</b> to give methyl 2-(3-((1-benzyl-6-oxo-1,6-dihydropyridin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>6</b>). To a 100 mL round-bottom flask was added intermediate <b>I</b>-<b>6</b> (0.335g, 0.80 mmol, 1.0 equiv) and 20 mL of THF. To this was added a solution of lithium hydroxide (0.096g, 4.0 mmol, 5.0 equiv) in 10 mL of water. To the resulting biphasic mixture was added methanol dropwise until a single layer formed. The resulting solution was stirred for 2 h at room temperature. It was then poured into 1.2 N HCl<sub>(aq)</sub>, and the aqueous layer was extracted with three 50 mL portions of ethyl acetate. The combined organic layers were washed with water and brine and dried over magnesium sulfate. Filtration and removal of solvent in vacuo gave the crude material. This was purified by reverse phase HPLC and the isolated product lyophilized to give a powder (0.161g, 51% yield.). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.74 (d, <i>J</i> = 2.02 Hz, 1H), 7.22–7.37 (m, 6H), 7.19 (td, <i>J</i> = 2.53, 9.35 Hz, 2H), 6.86 (td, <i>J</i> = 2.65, 9.28 Hz, 1H), 6.31 (d, <i>J</i> = 9.35 Hz, 1H), 5.05 (s, 2H), 4.92 (s, 2H), 3.72 (s, 2H), 2.30 (s, 3H).</div></div></div><div id="sec5_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> General Procedure B (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>)</h3><div class="NLM_p">Methyl 2-(5-fluoro-3-((6-methoxypyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>7</b>). <b>I</b>-<b>1A</b> (1.00 g, 4.52 mmol) was reacted with 6-methoxy-3-pyridinecarboxaldehyde (0.620 g, 4.52 mmol) using the procedure for intermediate <b>I</b>-<b>3</b> to give <b>I</b>-<b>7</b> (0.861 g, 56% yield).</div><div class="NLM_p">Methyl 2-(3-((1-substituted benzyl-6-oxo-1,6-dihydropyridin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate <b>I</b>-<b>8</b>. Intermediate <b>I</b>-<b>7</b> (0.954 mmol) and sodium iodide (0.286 g, 1.91 mmol) were taken up in 10 mL of anhydrous acetonitrile, and selected bromide (1.9 mmol) was added. The mixture was refluxed overnight then poured into a mixture of 50 mL each brine and 5% sodium thiosulfate and extracted into ethyl acetate (2×). The combined organic extracts were washed with brine, dried over anhydrous magnesium sulfate, filtered, evaporated, and purified by flash chromatography over silica gel.</div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Pyridone Linker Analogue</h4><div class="NLM_p last">Intermediate <b>I</b>-<b>8</b> (0.513 mmol) was taken up in 15 mL of methanol and 5 mL of tetrahydrofuran. A solution of lithium hydroxide monohydrate (0.430 g, 10.3 mmol) in 5 mL of water was added, and the reaction stirred at room temperature for 55 min until LC-MS analysis showed complete hydrolysis of the ester. The reaction mixture was then acidified with concentrated hydrochloric acid, extracted into ethyl acetate (3×), washed with brine, dried over anhydrous magnesium sulfate, filtered, evaporated, and purified by preparative HPLC (water/acetonitrile with 0.1% formic acid).</div></div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-(5-Fluoro-3-((1-(2-fluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>5</b>)</h4><div class="NLM_p">Methyl 2-(5-fluoro-3-((1-(2-fluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>8</b>–<b>1</b>). General procedure B was followed to make <b>I</b>-<b>8</b>–<b>1</b> from <b>I</b>-<b>7</b> and 2-fluorobenzyl bromide in 66% yield.</div><div class="NLM_p last">General procedure A was followed to make <b>5</b> from <b>I</b>-<b>8</b>–<b>1</b> in 39% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.99 (br s, 1H), 7.67 (d, <i>J</i> = 2.0 Hz, 1H), 7.30–7.38 (m, 2H), 7.16–7.24 (m, 3H), 7.05–7.16 (m, 2H), 6.86 (td, <i>J</i> = 9.1, 2.5 Hz, 1H), 6.32 (d, <i>J</i> = 9.3 Hz, 1H), 5.09 (s, 2H), 4.94 (s, 2H), 3.74 (s, 2H), 2.30 (s, 3H).</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(5-Fluoro-3-((1-(3-fluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid. (<b>7</b>)</h4><div class="NLM_p">Methyl 2-(5-fluoro-3-((1-(3-fluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>8</b>–<b>2</b>). General procedure B was followed to make <b>I</b>-<b>8</b>–<b>2</b> from <b>I</b>-<b>7</b> and 3-fluorobenzyl bromide in 64% yield.</div><div class="NLM_p last">General procedure A was followed to make <b>7</b> from <b>I</b>-<b>8</b>–<b>2</b> in 39% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.76 (d, <i>J</i> = 2.0 Hz, 1H), 7.31–7.40 (m, 2H), 7.19 (dd, <i>J</i> = 9.5, 2.7 Hz, 2H), 7.05–7.14 (m, 3H), 6.86 (td, <i>J</i> = 9.2, 2.5 Hz, 1H), 6.33 (d, <i>J</i> = 9.1 Hz, 1H), 5.06 (s, 2H), 4.94 (s, 2H), 3.73 (s, 2H), 2.31 (s, 3H).</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-(5-Fluoro-3-((1-(4-fluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>9</b>)</h4><div class="NLM_p">Methyl 2-(5-fluoro-3-((1-(4-fluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>8</b>–<b>3</b>). General procedure B was followed to make <b>I</b>-<b>8</b>–<b>3</b> from <b>I</b>-<b>7</b> and 4-fluorobenzyl bromide in 54% yield.</div><div class="NLM_p last">General procedure B was followed to make <b>9</b> from <b>I</b>-<b>8</b>–<b>3</b> in 55% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.97 (br s, 1H), 7.73 (d, <i>J</i> = 2.0 Hz, 1H), 7.30–7.37 (m, 3H), 7.09–7.20 (m, 4H), 6.86 (td, <i>J</i> = 9.1, 2.5 Hz, 1H), 6.31 (d, <i>J</i> = 9.3 Hz, 1H), 5.03 (s, 2H), 4.93 (s, 2H), 3.72 (s, 2H), 2.30 (s, 3H).</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(3-((1-(2,6-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>11</b>)</h4><div class="NLM_p">Methyl 2-(3-((1-(2,6-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>8</b>–<b>4</b>) General procedure B was followed to make <b>I</b>-<b>8</b>–<b>4</b> from <b>I</b>-<b>7</b> and 2,6-difluorobenzyl bromide in 72% yield.</div><div class="NLM_p last">General procedure B was followed to make <b>11</b> from <b>I</b>-<b>8</b>–<b>4</b> in 60% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.98 (br s, 1H), 7.56 (s, 1H), 7.40 (tt, <i>J</i> = 8.3, 6.6 Hz, 1H), 7.34 (dd, <i>J</i> = 8.8, 4.3 Hz, 1H), 7.16 (td, <i>J</i> = 9.3, 2.5 Hz, 2H), 7.01–7.09 (m, 2H), 6.86 (td, <i>J</i> = 9.2, 2.7 Hz, 1H), 6.25 (d, <i>J</i> = 9.3 Hz, 1H), 5.07 (s, 2H), 4.94 (s, 2H), 3.74 (s, 2H), 2.29 (s, 3H).</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(3-((1-(2,5-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>13</b>)</h4><div class="NLM_p">Methyl 2-(3-((1-(2,5-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>8</b>–<b>5</b>). General procedure B was followed to make <b>I</b>-<b>8</b>–<b>5</b> from <b>I</b>-<b>7</b> and 2,5-difluorobenzyl bromide in 68% yield.</div><div class="NLM_p last">General procedure B was followed to make <b>13</b> from <b>I</b>-<b>8</b>–<b>5</b> in 37% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.27 (s, 1H), 7.69 (d, <i>J</i> = 1.8 Hz, 1H), 7.14–7.36 (m, 5H), 6.80–6.91 (m, 2H), 6.33 (d, <i>J</i> = 9.3 Hz, 1H), 5.07 (s, 2H), 4.90 (s, 2H), 3.74 (s, 2H), 2.31 (s, 3H).</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(3-((1-(2,4-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>14</b>)</h4><div class="NLM_p">Intermediate <b>I</b>-<b>8</b>–<b>6</b>. Methyl 2-(3-((1-(2,4-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate. General procedure B was followed to make <b>I</b>-<b>8</b>–<b>6</b> in 56% yield.</div><div class="NLM_p last">General procedure B was followed to make <b>14</b> from <b>I</b>-<b>8</b>–<b>6</b> in 44% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.63 (d, <i>J</i> = 2.5 Hz, 1H), 7.16–7.29 (m, 4H), 7.13 (dd, <i>J</i> = 9.9, 2.5 Hz, 1H), 6.98–7.06 (m, <i>J</i> = 8.5, 8.5, 2.6, 0.9 Hz, 1H), 6.82 (td, <i>J</i> = 9.2, 2.5 Hz, 1H), 6.31 (d, <i>J</i> = 9.3 Hz, 1H), 5.05 (s, 2H), 4.70 (s, 2H), 3.72 (s, 2H), 2.29 (s, 3H).</div></div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> General Procedure C (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>)</h3><div class="NLM_p">6-Oxo-1,6-dihydropyridine-3-carbaldehyde (<b>I</b>-<b>9</b>). In a flame-dried 250 mL 2-necked round-bottomed flask fitted with a condenser, 6-methoxy-3-pyridinecarboxaldehyde (3.43 g, 24.9 mmol) was taken up in 30 mL of anhydrous dichloromethane under nitrogen. Iodotrimethylsilane (5.0 g, 25 mmol) was added by syringe. The mixture was stirred at room temperature for 2.5 h then refluxed for 1.5 h. After cooling to room temperature, 4.1 mL of methanol was added by syringe. The solvent was evaporated, and the residue purified by flash chromatography over silica gel (7–60% acetone in dichloromethane) to give pure product (2.67 g, 87% yield).</div><div class="NLM_p">Methyl 2-(5-fluoro-2-methyl-3-((6-oxo-1,6-dihydropyridin-3-yl)methyl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>10</b>). The procedure described above for <b>I</b>-<b>7</b> was followed, reacting <b>I</b>-<b>1A</b> (2.52 g, 11.4 mmol) with intermediate <b>I</b>-<b>9</b> (1.40 g, 11.4 mmol) in the presence of triethylsilane (5.1 mL, 3.7 g, 32 mmol) and trifluoroacetic acid (1.8 mL, 2.6 g, 23 mmol). Because of the relative insolubility of the product, the workup was modified as follows: the cooled reaction mixture was partitioned between saturated sodium bicarbonate and dichloromethane and the organic layer washed with water and evaporated (product was already starting to precipitate out, so drying over magnesium sulfate and filtering was concluded to be a bad idea). The crude product was purified by recrystallization from acetonitrile, collecting two crops of pure product (2.82 g, 76% yield).</div><div class="NLM_p">Methyl 2-(3-((1-alkyl-6-oxo-1,6-dihydropyridin-3-yl)methyl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>11</b>). In a 100 mL round-bottomed flask under nitrogen, <b>I</b>-<b>10</b> (1.75 mmol) and cesium carbonate or potassium carbonate (8.8 mmol) were taken up in 25 mL of anhydrous DMF and selected alkyl halide (8.8 mmol) was added. The mixture was heated to 55–85 °C until almost complete conversion to product had occurred. The cooled reaction mixture was poured into 250 mL of water and extracted into ethyl acetate; the combined organic extracts were washed with brine, dried over anhydrous magnesium sulfate, filtered, evaporated, and purified by flash chromatography over silica gel to give pure product.</div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Alkyl Pyridone Linker Analogue</h4><div class="NLM_p last">The procedure described above for pyridone linker analogue (in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) was followed, reacting <b>I</b>-<b>11</b> (0.764 mmol) with lithium hydroxide monohydrate (0.642 g, 15.3 mmol). The crude product was purified by recrystallization.</div></div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(5-Fluoro-2-methyl-3-((6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>16</b>)</h4><div class="NLM_p last">Methyl 2-(5-fluoro-2-methyl-3-((6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>11</b>–<b>1</b>). General procedure C was followed reacting <b>I</b>-<b>10</b> with and 1,1,1-trifluoro-2-iodoethane to make <b>I</b>-<b>11</b>–<b>1</b> in 44% yield.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-(5-Fluoro-2-methyl-3-((6-oxo-1-(4,4,4-trifluorobutyl)-1,6-dihydropyridin-3-yl)methyl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>18</b>)</h4><div class="NLM_p">Methyl 2-(5-fluoro-2-methyl-3-((6-oxo-1-(4,4,4-trifluorobutyl)-1,6-dihydropyridin-3-yl)methyl)-1<i>H</i>-indol-1-yl)acetic acid (<b>I</b>-<b>11</b>–<b>2</b>). General procedure C was followed reacting <b>I</b>-<b>10</b> with 4-bromo-1,1,1-trifluorobutane to make <b>I</b>-<b>11</b>–<b>2</b> in 38% yield.</div><div class="NLM_p last">General procedure C was followed to make <b>18</b> from <b>I</b>-<b>11</b>–<b>2</b> in 40% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.00 (br s, 1H), 7.62 (d, <i>J</i> = 2.0 Hz, 1H), 7.35 (dd, <i>J</i> = 9.0, 4.4 Hz, 1H), 7.22 (dd, <i>J</i> = 10.1, 2.5 Hz, 1H), 7.17 (dd, <i>J</i> = 9.3, 2.5 Hz, 1H), 6.86 (td, <i>J</i> = 9.1, 2.5 Hz, 1H), 6.29 (d, <i>J</i> = 9.3 Hz, 1H), 4.95 (s, 2H), 3.90 (t, <i>J</i> = 6.9 Hz, 2H), 3.73 (s, 2H), 2.32 (s, 3H), 2.16–2.31 (m, 2H), 1.84 (quin, <i>J</i> = 7.6 Hz, 2H).</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-(5-Fluoro-2-methyl-3-((6-oxo-1-(4,4,4-trifluorobutyl)-1,6-dihydropyridazin-3-yl)methyl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>15</b>)</h4><div class="NLM_p last">The procedure described in Scheme 5A of ref <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a> was followed to make this compound in 63% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.35 (dd, <i>J</i> = 4.29, 8.84 Hz, 1H), 7.23 (dd, <i>J</i> = 2.53, 9.85 Hz, 1H), 7.14 (d, <i>J</i> = 9.60 Hz, 1H), 6.88 (td, <i>J</i> = 2.40, 9.16 Hz, 1H), 6.81 (d, <i>J</i> = 9.35 Hz, 1H), 4.90 (s, 2H), 3.95 (s, 2H), 3.91 (s, 2H), 2.34 (s, 3H), 0.95 (s, 9H).</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (5-Fluoro-2-methyl-3-{[6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridazin-3- yl]methyl}-1<i>H</i>-indol-1-yl)acetic Acid (<b>17</b>)</h4><div class="NLM_p last">The procedure described in Scheme 5A of ref <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a> was followed to make this compound in 37% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.27 (dd, <i>J</i> = 4.55, 8.84 Hz, 1H), 7.10–7.18 (m, 2H), 6.76–6.87 (m, 2H), 4.77–4.90 (m, 4H), 3.89 (s, 2H), 2.26 (s, 3H).</div></div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> General Procedure D (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>)</h3><div class="NLM_p">3-bromo-5-halo-2-methyl-1<i>H</i>-indole (<b>I</b>-<b>12</b>). To a round-bottom flask containing 5-halo-2-methyl-1<i>H</i>-indole (15.3 mmol) in DMF (50 mL) was added bromine (0.8 mL, 15.3 mmol). The reaction was stirred at room temperature for 30 min and diluted with EtOAc (400 mL). The solution was washed with H<sub>2</sub>O (3 × 250 mL), 0.1 M Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (75 mL), and brine (75 mL). The organic layer was dried (MgSO<sub>4</sub>) and filtered. The solvent was removed under reduced pressure to give the desired product.</div><div class="NLM_p">Methyl 2-(3-bromo-5-halo-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>13</b>). To a round-bottom flask containing <b>I</b>-<b>12</b> (19 mmol), K<sub>2</sub>CO<sub>3</sub> (10.5 g, 76 mmol) in DMF (250 mL) was added methylbromoacetate (3.5 mL, 38 mmol). The reaction was heated to 85 °C for 3 h and cooled to room temperature. The reaction was diluted with EtOAc (500 mL) and washed with H<sub>2</sub>O (3 × 200 mL) and brine (100 mL). The organic layer was dried (MgSO<sub>4</sub>) and filtered. The solvent was removed under reduced pressure to give the product.</div><div class="NLM_p">Methyl 2-(5-halo-3-(6-methoxypyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>14</b>). To a microwave vessel was added <b>I</b>-<b>13</b> (1.3 mmol), 6-methoxypyridin-3-ylboronic acid (0.47 g, 3.1 mmol), PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> (49 mg, 0.07 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (2.0 g, 6.1 mmol) in DME (10.3 mL). The contents were degassed with nitrogen and sealed. The reaction was heated at 150 °C for 20 min in the microwave. The reaction was diluted with EtOAc (250 mL) and washed with H<sub>2</sub>O (3 × 100 mL). The organic layer was dried (MgSO<sub>4</sub>) and filtered. The solvent was removed under reduced pressure, and the crude material was purified by silica gel column chromatography.</div><div class="NLM_p">Methyl 2-(3-(1-substituted benzyl-6-oxo-1,6-dihydropyridin-3-yl)-5-halo-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>15</b>). To a flask containing <b>I</b>-<b>14</b> (1.1 mmol) in CH<sub>3</sub>CN (6 mL) was added sodium iodide (321 mg, 2.1 mmol) and selected bromide (2.1 mmol). The reaction was heated to reflux for 15 h and cooled to room temperature. The contents of the reaction were poured into 0.1 M Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (50 mL) and brine (25 mL) and extracted with EtOAc (3 × 50 mL). The organic layer was dried (MgSO<sub>4</sub>) and filtered. The solvent was removed under reduced pressure, and the crude material was purified by silica gel column chromatography.</div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Pyridone Analogue</h4><div class="NLM_p last">The method described for pyridone linker analogue in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> was used. The crude material was purified by chromatography.</div></div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-(3-(1-Benzyl-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>19</b>)</h4><div class="NLM_p">3-Bromo-5-fluoro-2-methyl-1<i>H</i>-indole (<b>I</b>-<b>12A</b>). General procedure D was followed to give the desired product.</div><div class="NLM_p">Methyl 2-(3-bromo-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>13A</b>). General procedure D was followed to give <b>I</b>-<b>13A</b> from <b>I</b>-<b>12A</b> in 37% yield (2 steps).</div><div class="NLM_p">Methyl 2-(5-fluoro-3-(6-methoxypyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>14A</b>). General procedure D was followed to give <b>I</b>-<b>14A</b> from <b>I</b>-<b>13A</b> in 56% yield.</div><div class="NLM_p">Methyl 2-(3-(1-benzyl-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>15A</b>-<b>1</b>). General procedure D was followed to give <b>I</b>-<b>15A</b>-<b>1</b> from <b>I</b>-<b>14A</b> and benzyl bromide in 95% yield.</div><div class="NLM_p last">General procedure D was followed to make <b>19</b> from <b>I</b>-<b>15A</b>-<b>1</b> in 48% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.10 (br s, 1H), 7.84 (d, <i>J</i> = 2.02 Hz, 1H), 7.56 (dd, <i>J</i> = 2.65, 9.22 Hz, 1H), 7.45 (dd, <i>J</i> = 4.29, 8.84 Hz, 1H), 7.27–7.41 (m, 5H), 7.10 (dd, <i>J</i> = 2.53, 9.85 Hz, 1H), 6.95 (td, <i>J</i> = 2.53, 9.09 Hz, 1H), 6.55 (d, <i>J</i> = 9.09 Hz, 1H), 5.21 (s, 2H), 5.03 (s, 2H), 2.30 (s, 3H).</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-(3-(1-(2,4-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>20</b>)</h4><div class="NLM_p">Methyl 2-(3-(1-(2,4-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>15A</b>-<b>2</b>). General procedure D was followed to make <b>I</b>-<b>15A</b>-<b>2</b> from <b>I</b>-<b>14A</b> and 2,4-difluorobenzyl bromide in 61% yield.</div><div class="NLM_p last">General procedure D was followed to make <b>20</b> from <b>I</b>-<b>15A</b>-<b>2</b> in 76% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.74 (d, 1H), 7.57 (dd, <i>J</i> = 2.65, 9.22 Hz, 1H), 7.23–7.43 (m, 3H), 7.05–7.15 (m, 2H), 6.89 (td, <i>J</i> = 2.53, 9.22 Hz, 1H), 6.53 (d, <i>J</i> = 9.35 Hz, 1H), 5.21 (s, 2H), 4.56 (br s, 2H), 2.30 (s, 3H).</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-(5-Fluoro-3-(1-(4-fluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>21</b>)</h4><div class="NLM_p">Methyl 2-(5-fluoro-3-(1-(4-fluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>15A</b>-<b>3</b>). General procedure D was followed to make <b>I</b>-<b>15A</b>-<b>3</b> from <b>I</b>-<b>14A</b> and 4-fluorobenzyl bromide in 42% yield.</div><div class="NLM_p last">General procedure D was followed to make <b>21</b> from <b>I</b>-<b>15A</b>-<b>3</b> in 76% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (d, <i>J</i> = 2.02 Hz, 1H), 7.56 (dd, <i>J</i> = 2.65, 9.22 Hz, 1H), 7.43–7.50 (m, 3H), 7.17–7.22 (m, 2H), 7.12 (dd, <i>J</i> = 2.27, 9.85 Hz, 1H), 6.97 (td, <i>J</i> = 2.65, 9.16 Hz, 1H), 6.55 (d, 1H), 5.19 (s, 2H), 5.17 (s, 2H), 3.70 (s, 3H), 2.31 (s, 3H).</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-(3-(1-(2,6-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>22</b>)</h4><div class="NLM_p">Methyl 2-(3-(1-(2,6-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>15A</b>-<b>4</b>). General procedure D was followed to make <b>I</b>-<b>15A</b>-<b>4</b> from <b>I</b>-<b>14A</b> and 2,6-difluorobenzyl bromide in 53% yield.</div><div class="NLM_p last">General procedure D was followed to make <b>22</b> from <b>I</b>-<b>15A</b>-<b>4</b> in 78% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.16 (br s, 1H), 7.81 (s, 1H), 7.55 (dd, <i>J</i> = 2.53, 9.35 Hz, 1H), 7.37–7.51 (m, 2H), 7.07–7.19 (m, 3H), 6.97 (td, <i>J</i> = 2.53, 9.09 Hz, 1H), 6.46 (d, <i>J</i> = 9.35 Hz, 1H), 5.24 (s, 2H), 5.03 (s, 2H), 2.33 (s, 3H).</div></div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> General Procedure E (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>)</h3><div class="NLM_p">Methyl 2-(5-halo-2-methyl-3-(6-oxo-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>16</b>). To a microwave vessel was added <b>I</b>-<b>14</b> (2.25 mmol), MeOH (10 mL), and concentrated HCl (0.5 mL, 16.5 mmol). The reaction was heated at 125 °C for 60 min in the microwave. The solvent was removed under reduced pressure, and the crude material was purified by silica gel column chromatography.</div><div class="NLM_p">Methyl 2-(5-halo-3-(1-alkyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate <b>I</b>-<b>17</b>. To a microwave vessel was added <b>I</b>-<b>16</b> (1 mmol), potassium carbonate (0.7 g, 5 mmol), and DMF (12 mL). Then selected bromide (2 mmol) was added and the vessel sealed. The reaction was heated at 65 °C for 20 h on an oil bath. The reaction was diluted with EtOAc (100 mL) and washed with brine (3 × 100 mL). The organic layer was dried (MgSO<sub>4</sub>) and filtered. The solvent was removed under reduced pressure, and the crude material was purified by silica gel column chromatography</div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Alkyl Pyridone Analogue</h4><div class="NLM_p last">The method described for pyridone linker analogue in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> was used. The crude material was purified by HPLC.</div></div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-(5-Fluoro-3-(1-isopropyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>24</b>)</h4><div class="NLM_p">Methyl 2-(5-fluoro-2-methyl-3-(6-oxo-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>16A</b>). General procedure E was followed to make <b>I</b>-<b>16A</b> from <b>I</b>-<b>14A</b> in 75% yield.</div><div class="NLM_p">Methyl 2-(5-fluoro-3-(1-isopropyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>17A</b>-<b>1</b>). General procedure E was followed to make <b>I</b>-<b>17A</b>-<b>1</b> from <b>I</b>-<b>16A</b> and 2-bromo propane in 64% yield.</div><div class="NLM_p last">General procedure E was followed to make <b>24</b> from <b>I</b>-<b>17A</b>-<b>1</b> in 70% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.33 (d, <i>J</i> = 6.3 Hz, 6 H), 2.35 (s, 3 H), 5.05 (s, 2 H), 5.24–5.35 (m, 1 H), 6.85 (d, <i>J</i> = 8.3 Hz, 1 H), 6.97 (td, <i>J</i> = 9.1, 2.5 Hz, 1 H), 7.16 (dd, <i>J</i> = 9.9, 2.5 Hz, 1 H), 7.47 (dd, <i>J</i> = 8.8, 4.5 Hz, 1 H), 7.75 (dd, <i>J</i> = 8.5, 2.4 Hz, 1 H), 8.19 (d, <i>J</i> = 2.5 Hz, 1 H), 13.11 (br s, 1 H).</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-(5-Fluoro-2-methyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>25</b>)</h4><div class="NLM_p">Methyl 2-(5-fluoro-2-methyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>17A</b>-<b>2</b>). General procedure E was followed to make <b>I</b>-<b>17A</b>-<b>2</b> from <b>I</b>-<b>16A</b> in 24% yield.</div><div class="NLM_p last">General procedure E was followed to make <b>24</b> from <b>I</b>-<b>17A</b>-<b>2</b> in 70% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.34 (s, 3 H), 4.97 (q, <i>J</i> = 9.3 Hz, 2 H), 5.05 (s, 2 H), 6.61 (d, <i>J</i> = 9.3 Hz, 1 H), 6.98 (td, <i>J</i> = 9.2, 2.3 Hz, 1 H), 7.18 (dd, <i>J</i> = 9.9, 2.5 Hz, 1 H), 7.47 (dd, <i>J</i> = 9.0, 4.4 Hz, 1 H), 7.64 (dd, <i>J</i> = 9.6, 2.5 Hz, 1 H), 7.75 (d, <i>J</i> = 2.0 Hz, 1 H), 13.12 (s, 1 H).</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-(5-Fluoro-3-(1-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>23</b>)</h4><div class="NLM_p">Methyl 2-(5-fluoro-3-((1-isopropyl-6-oxo-1,6-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>11</b>–<b>3</b>). General procedure C was followed reacting <b>I</b>-<b>10</b> with and 2-bromopropane to make <b>I</b>-<b>11</b>–<b>3</b>. Crude product was taken forward.</div><div class="NLM_p last">General procedure C was followed to make <b>23</b> from <b>I</b>-<b>11</b>–<b>3</b> in 68% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.72 (d, <i>J</i> = 9.60 Hz, 1H), 7.49–7.55 (m, 2H), 7.43–7.48 (m, 2H), 6.97–7.06 (m, 2H), 5.22–5.30 (m, 1H), 5.09 (s, 2H), 1.36 (d, <i>J</i> = 6.57 Hz, 6H).</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-(5-Chloro-3-(1-isopropyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>26</b>)</h4><div class="NLM_p">3-Bromo-5-chloro-2-methyl-1<i>H</i>-indole (<b>I</b>-<b>12B</b>). Intermediate <b>I</b>-<b>12B</b> was prepared according to the method described for <b>I</b>-<b>12</b>-<b>A</b> and the crude product carried forward.</div><div class="NLM_p">Methyl 2-(3-bromo-5-chloro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>13B</b>). Intermediate <b>I</b>-<b>13B</b> was prepared according to the method described for intermediate <b>I</b>-<b>13A</b>. 63% yield (2 steps).</div><div class="NLM_p">Methyl 2-(5-chloro-3-(6-methoxypyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>14B</b>). Intermediate <b>I</b>-<b>14B</b> was prepared according to the method described for intermediate <b>I</b>-<b>14A</b>. 81% yield.</div><div class="NLM_p">Methyl 2-(5-chloro-2-methyl-3-(6-oxo-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>16B</b>). Intermediate <b>I</b>-<b>16B</b> was prepared according to the method described for <b>I</b>-<b>16A</b>. 63% yield.</div><div class="NLM_p">Methyl 2-(5-chloro-3-(1-isopropyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1H-indol-1-yl)acetate (<b>I</b>-<b>17B-1</b>). Intermediate <b>I</b>-<b>17B</b>-<b>1</b> was prepared according to the method described for intermediate <b>I</b>-<b>17A</b>. 62% yield.</div><div class="NLM_p last">The title compound was prepared according to the method described for <b>24</b>. 66% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.34 (d, <i>J</i> = 6.1 Hz, 6 H), 2.36 (s, 3 H), 5.07 (s, 2 H), 5.19–5.36 (m, 1 H), 6.86 (d, <i>J</i> = 8.3 Hz, 1 H), 7.14 (dd, <i>J</i> = 8.6, 2.0 Hz, 1 H), 7.40 (d, <i>J</i> = 2.0 Hz, 1 H), 7.50 (d, <i>J</i> = 8.8 Hz, 1 H), 7.76 (dd, <i>J</i> = 8.3, 2.5 Hz, 1 H), 8.19 (d, <i>J</i> = 2.5 Hz, 1 H), 13.13 (s, 1 H).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-(3-(1-Isopropyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>27</b>)</h4><div class="NLM_p">3-Bromo-2-methyl-1<i>H</i>-indole (<b>I</b>-<b>12C</b>). Intermediate <b>I</b>-<b>12C</b> was prepared according to the method described for intermediate <b>I</b>-<b>12A</b>.</div><div class="NLM_p">Methyl 2-(3-bromo-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>13C</b>). Intermediate <b>I</b>-<b>13</b>-<b>C</b> was prepared according to the method described for intermediate <b>I</b>-<b>13</b>-<b>A</b>. 80% yield. (2 steps).</div><div class="NLM_p">Methyl 2-(3-(6-methoxypyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>14C</b>). Intermediate <b>I</b>-<b>14C</b> was prepared according to the method described for intermediate <b>I</b>-<b>14A</b>. 88% yield.</div><div class="NLM_p">Methyl 2-(2-methyl-3-(6-oxo-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>16C</b>). Intermediate <b>I</b>-<b>16C</b> was prepared according to the method described for intermediate <b>I</b>-<b>16A</b>. 75% yield.</div><div class="NLM_p">Methyl 2-(3-(1-isopropyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>17C</b>-<b>1</b>). Intermediate <b>I</b>-<b>17C</b>-<b>1</b> was prepared according to the method described for intermediate <b>I</b>-<b>17A</b>.</div><div class="NLM_p last">The title compound was prepared from <b>I</b>-<b>17C</b>-<b>1</b> according to the method described for <b>24</b>. 44% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.34 (d, <i>J</i> = 6.3 Hz, 6 H), 2.36 (s, 3 H), 5.04 (s, 2 H), 5.23–5.35 (m, 1 H), 6.86 (d, <i>J</i> = 8.3 Hz, 1 H), 7.05 (t, <i>J</i> = 7.5 Hz, 1 H), 7.13 (td, <i>J</i> = 7.6, 1.1 Hz, 1 H), 7.45 (t, <i>J</i> = 8.0 Hz, 1 H), 7.76 (dd, <i>J</i> = 8.6, 2.5 Hz, 1 H), 8.20 (d, <i>J</i> = 2.5 Hz, 1 H), 13.08 (br s, 1 H).</div></div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-(5-Chloro-2-methyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>28</b>)</h4><div class="NLM_p">Methyl 2-(5-chloro-2-methyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>17</b>-<b>B2</b>). Intermediate <b>I</b>-<b>17B</b>-<b>2</b> was prepared according to the method described for <b>I</b>-<b>17A</b>. 33% yield.</div><div class="NLM_p last">The title compound was prepared according to the method described for <b>24</b>. 58% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.34 (s, 3 H), 4.97 (q, <i>J</i> = 9.2 Hz, 2 H), 5.06 (s, 2 H), 6.61 (d, <i>J</i> = 9.3 Hz, 1 H), 7.14 (dd, <i>J</i> = 8.6, 2.0 Hz, 1 H), 7.43 (d, <i>J</i> = 2.3 Hz, 1 H), 7.50 (d, <i>J</i> = 8.6 Hz, 1 H), 7.64 (dd, <i>J</i> = 9.3, 2.5 Hz, 1 H), 7.77 (d, <i>J</i> = 1.5 Hz, 1 H), 13.14 (s, 1 H).</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-(2-Methyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>29</b>)</h4><div class="NLM_p">Methyl 2-(2-methyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>17C</b>-<b>2</b>). Intermediate <b>I</b>-<b>17C</b>-<b>2</b> was prepared according to the method described for <b>I</b>-<b>17A</b>. 50% yield.</div><div class="NLM_p last">The title compound was prepared from <b>I</b>-<b>17C</b>-<b>2</b> according to the method described for <b>24</b>. 60% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.35 (s, 3 H), 4.97 (q, <i>J</i> = 9.3 Hz, 2 H), 5.04 (s, 2 H), 6.61 (d, <i>J</i> = 9.3 Hz, 1 H), 7.06 (t, <i>J</i> = 7.6 Hz, 1 H), 7.13 (t, <i>J</i> = 8.0 Hz, 1 H), 7.44 (d, <i>J</i> = 8.6 Hz, 2 H), 7.65 (dd, <i>J</i> = 9.5, 2.7 Hz, 1 H), 7.74 (d, <i>J</i> = 2.3 Hz, 1 H), 13.08 (br s, 1 H)</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(2,5-Dimethyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>30</b>)</h4><div class="NLM_p">3-Bromo-2,5-dimethyl-1<i>H</i>-indole (<b>I</b>-<b>12D</b>). Intermediate <b>I</b>-<b>12D</b> was prepared according to the method described for <b>I</b>-<b>12A</b>.</div><div class="NLM_p">Methyl 2-(3-bromo-2,5-dimethyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>12D</b>). Intermediate <b>I</b>-<b>13D</b> was prepared according to the method described for <b>I</b>-<b>13A</b>. Yield 76% (2 steps).</div><div class="NLM_p">Methyl 2-(3-(6-methoxypyridin-3-yl)-2,5-dimethyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>14D</b>). Intermediate <b>I</b>-<b>14D</b> was prepared according to the method described for <b>I</b>-<b>14A</b>. Yield 66%.</div><div class="NLM_p">Methyl 2-(2,5-dimethyl-3-(6-oxo-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>16D</b>). Intermediate <b>I</b>-<b>16D</b> was prepared according to the method described for <b>I</b>-<b>16A</b>. Yield 78%.</div><div class="NLM_p">Methyl 2-(2,5-dimethyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>17D</b>). Intermediate <b>I</b>-<b>17D</b> was prepared according to the method described for intermediate <b>I</b>-<b>17A</b>. Yield 38%.</div><div class="NLM_p last">The title compound was prepared from <b>I</b>-<b>17A</b> according to the method described for <b>24</b>. Yield 72%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.32 (s, 3 H), 2.36 (s, 3 H), 4.87–5.05 (m, 4 H), 6.61 (d, <i>J</i> = 9.3 Hz, 1 H), 6.95 (dd, <i>J</i> = 8.5, 1.4 Hz, 1 H), 7.22 (s, 1 H), 7.31 (d, <i>J</i> = 8.3 Hz, 1 H), 7.64 (dd, <i>J</i> = 9.5, 2.7 Hz, 1 H), 7.71 (d, <i>J</i> = 2.3 Hz, 1 H), 13.02 (br s, 1 H).</div></div><div id="sec5_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-(5-Methoxy-2-methyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>31</b>)</h4><div class="NLM_p">3-Bromo-5-methoxy-2-methyl-1<i>H</i>-indole (<b>I</b>-<b>12E</b>). Intermediate <b>I</b>-<b>12E</b> was prepared according to the method described for <b>I</b>-<b>12A</b>.</div><div class="NLM_p">Methyl 2-(3-bromo-5-methoxy-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>13E</b>). Intermediate <b>I</b>-<b>13E</b> was prepared according to the method described for <b>I</b>-<b>13a</b>. Yield 92% (2 steps).</div><div class="NLM_p">Methyl 2-(5-methoxy-3-(6-methoxypyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>14E</b>). Intermediate <b>I</b>-<b>14E</b> was prepared according to the method described for <b>I</b>-<b>14A</b>. Yield 54%.</div><div class="NLM_p">Methyl 2-(5-methoxy-2-methyl-3-(6-oxo-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>16E</b>). Intermediate <b>I</b>-<b>16E</b> was prepared according to the method described for intermediate <b>I</b>-<b>16D</b>. Yield 46%.</div><div class="NLM_p">Methyl 2-(5-methoxy-2-methyl-3-(6-oxo-1-(2,2,2-trifluoroethyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>17E</b>). Intermediate <b>I</b>-<b>17E</b> was prepared according to the method described for <b>I</b>-<b>17A</b>. The product was carried on to the next step without purification.</div><div class="NLM_p last">The title compound was prepared from <b>I</b>-<b>17E</b> according to the method described for <b>24</b>. Yield 17% for 2 steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.32 (s, 3 H), 3.74 (s, 3 H), 4.89–5.02 (m, 4 H), 6.61 (d, <i>J</i> = 9.3 Hz, 1 H), 6.77 (dd, <i>J</i> = 8.8, 2.3 Hz, 1 H), 6.91 (d, <i>J</i> = 2.3 Hz, 1 H), 7.34 (d, <i>J</i> = 8.6 Hz, 1 H), 7.64 (dd, <i>J</i> = 9.5, 2.7 Hz, 1 H), 7.73 (d, <i>J</i> = 2.5 Hz, 1 H), 13.01 (br s, 1 H)</div></div><div id="sec5_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-(3-(1-Benzyl-6-oxo-1,6-dihydropyridin-3-yl)-5-chloro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>32</b>)</h4><div class="NLM_p"><i>tert</i>-Butyl 2-(3-bromo-5-chloro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>18A</b>). Intermediate <b>I</b>-<b>18A</b> was prepared according to the method described for <b>I</b>-<b>13A</b> reacting <b>I</b>-<b>12B</b> with <i>tert</i>-butyl bromo acetate. Yield 81% (2 steps).</div><div class="NLM_p"><i>tert</i>-Butyl 2-(5-chloro-3-(6-methoxypyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>19A</b>). Intermediate <b>I</b>-<b>19A</b> was prepared according to the method described for <b>I</b>-<b>14A</b>. Yield 42%.</div><div class="NLM_p"><i>tert</i>-Butyl 2-(3-(1-benzyl-6-oxo-1,6-dihydropyridin-3-yl)-5-chloro-2-methyl-1<i>H</i>-indol-1-yl)acetate <b>I</b>-<b>20A</b>-<b>1</b>. Intermediate <b>I</b>-<b>20A</b>-<b>1</b> was prepared according to the method described for <b>I</b>-<b>15A</b>. Yield 52%.</div><div class="NLM_p last">The title compound was prepared according to this method. A round-bottom flask containing <b>I</b>-<b>20A</b>-<b>1</b> (0.7 mmol) was treated with TFA (4 mL) at room temperature for 30 min. The solution was concentrated under reduced pressure, and the crude material was purified by HPLC to give <b>32</b> in 99% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.12 (br s, 1H), 7.86 (d, <i>J</i> = 2.02 Hz, 1H), 7.55 (dd, <i>J</i> = 2.53, 9.35 Hz, 1H), 7.48 (d, <i>J</i> = 8.59 Hz, 1H), 7.27–7.43 (m, 6H), 7.12 (dd, <i>J</i> = 2.15, 8.72 Hz, 1H), 6.55 (d, <i>J</i> = 9.35 Hz, 1H), 5.21 (s, 2H), 5.04 (s, 2H), 2.31 (s, 3H).</div></div><div id="sec5_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-(3-(1-Benzyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>33</b>)</h4><div class="NLM_p"><i>tert</i>-Butyl 2-(3-bromo-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>18B</b>). Intermediate <b>I</b>-<b>18B</b> was prepared according to the method described for <b>I</b>-<b>13A</b> reacting <b>I</b>-<b>12C</b> with <i>tert</i>-butyl bromo acetate. Yield 86% (2 steps).</div><div class="NLM_p"><i>tert</i>-Butyl 2-(3-(6-methoxypyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>19B</b>). Intermediate <b>I</b>-<b>19B</b> was prepared according to the method described for <b>I</b>-<b>14A</b>.</div><div class="NLM_p"><i>tert</i>-Butyl 2-(3-(1-benzyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate(<b>I</b>-<b>20B</b>-<b>1</b>). Intermediate <b>I</b>-<b>20B</b>-<b>1</b> was prepared according to the method described for <b>I</b>-<b>15A</b>. Yield 65%.</div><div class="NLM_p last">The title compound was prepared from <b>I</b>-<b>20B</b>-<b>1</b> according to the method described for <b>32</b> (Yield 56%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.15 (s, 1H), 7.81 (d, <i>J</i> = 2.53 Hz, 1H), 7.57 (dd, <i>J</i> = 2.53, 9.35 Hz, 1H), 7.34–7.44 (m, 6H), 7.31 (dd, <i>J</i> = 3.16, 5.43 Hz, 1H), 7.07–7.15 (m, 1H), 6.97–7.06 (m, 1H), 6.55 (d, <i>J</i> = 9.35 Hz, 1H), 5.21 (s, 2H), 4.96 (s, 2H), 2.31 (s, 3H).</div></div><div id="sec5_8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-(5-Chloro-3-(1-(2,6-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>34</b>)</h4><div class="NLM_p">Methyl 2-(5-chloro-3-(1-(2,6-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>15B</b>-<b>1</b>). General procedure D was followed to make <b>I</b>-<b>15B</b>-<b>1</b> from <b>I</b>-<b>14B</b>, and the product was carried on to the next step without purification.</div><div class="NLM_p last">General procedure D was followed to make <b>34</b> from <b>I</b>-<b>15B</b>-<b>1</b> in 63% yield for 2 steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.33 (s, 3 H), 5.05 (s, 2 H), 5.25 (s, 2 H), 6.47 (d, <i>J</i> = 9.3 Hz, 1 H), 7.07–7.17 (m, 3 H), 7.38 (d, <i>J</i> = 2.0 Hz, 1 H), 7.39–7.48 (m, 1 H), 7.49 (d, <i>J</i> = 8.3 Hz, 1 H), 7.55 (dd, <i>J</i> = 9.3, 2.5 Hz, 1 H), 7.82 (s, 1 H), 13.14 (br s, 1 H)</div></div><div id="sec5_8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 2-(3-(1-(2,6-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>35</b>)</h4><div class="NLM_p">Methyl 2-(3-(1-(2,6-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>15C</b>-<b>1</b>). General procedure D was followed to make <b>I</b>-<b>15C</b>-<b>1</b> from <b>I</b>-<b>15B</b> in 68% yield.</div><div class="NLM_p last">General procedure D was followed to make <b>35</b> from <b>I</b>-<b>15C</b>-<b>1</b> in 76% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.34 (s, 3 H), 5.02 (s, 2 H), 5.24 (s, 2 H), 6.47 (d, <i>J</i> = 9.3 Hz, 1 H), 7.05 (t, <i>J</i> = 7.5 Hz, 1 H), 7.08–7.18 (m, 3 H), 7.35–7.50 (m, 3 H), 7.56 (dd, <i>J</i> = 9.3, 2.5 Hz, 1 H), 7.78 (s, 1 H), 13.07 (br s, 1 H).</div></div><div id="sec5_8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 2-(5-Fluoro-2-methyl-3-(6-oxo-1-(4,4,4-trifluorobutyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>36</b>) and 2-(5-Fluoro-2-methyl-3-(6-(4,4,4-trifluorobutoxy)pyridin-3-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>37</b>)</h4><div class="NLM_p">Methyl 2-(5-fluoro-2-methyl-3-(6-oxo-1-(4,4,4-trifluorobutyl)-1,6-dihydropyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>17A</b>-<b>3</b>) and methyl 2-(5-fluoro-2-methyl-3-(6-(4,4,4-trifluorobutoxy)pyridin-3-yl)-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>17A</b>-<b>3B</b>). General procedure E was followed to make <b>I</b>-<b>17A</b>-<b>3</b> and <b>I</b>-<b>17A</b>-<b>3B</b> from <b>I</b>-<b>16A</b>, and the mixture was carried on to the next step without purification.</div><div class="NLM_p">General procedure E was followed to make <b>36</b> and <b>37</b> from mixture of <b>I</b>-<b>17A</b>-<b>3</b> and <b>I</b>-<b>17A</b>-<b>3B</b>. The mixture was separated by column chromatography.</div><div class="NLM_p"><b>36</b> in 70% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.87–2.01 (m, 2 H), 2.23–2.42 (m, 5 H), 4.05 (t, <i>J</i> = 7.3 Hz, 2 H), 5.02 (s, 2 H), 6.51 (d, <i>J</i> = 9.1 Hz, 1 H), 6.95 (td, <i>J</i> = 9.2, 2.5 Hz, 1 H), 7.18 (dd, <i>J</i> = 9.9, 2.5 Hz, 1 H), 7.44 (dd, <i>J</i> = 8.8, 4.3 Hz, 1 H), 7.54 (dd, <i>J</i> = 9.2, 2.7 Hz, 1 H), 7.75 (d, <i>J</i> = 2.3 Hz, 1 H), 13.24 (br s, 1 H).</div><div class="NLM_p last"><b>37</b> in 70% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (d, <i>J</i> = 1.77 Hz, 1H), 7.79 (dd, <i>J</i> = 2.53, 8.59 Hz, 1H), 7.46 (dd, <i>J</i> = 4.29, 8.84 Hz, 1H), 7.15 (dd, <i>J</i> = 2.53, 9.85 Hz, 1H), 6.92–7.00 (m, 2H), 5.02 (s, 2H), 4.37 (t, <i>J</i> = 6.44 Hz, 2H), 2.38–2.45 (m, 2H), 2.35 (s, 3H), 1.94–2.03 (m, 2H).</div></div><div id="sec5_8_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-(3-(1-(2,3-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>38</b>)</h4><div class="NLM_p">Methyl 2-(3-(1-(2,3-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>15A</b>-<b>5</b>). General procedure D was followed to make <b>I</b>-<b>15A</b>-<b>5</b> from <b>I</b>-<b>14A</b> and 2,3-difluorobenzyl bromide in 78% yield.</div><div class="NLM_p last">General procedure D was followed to make <b>38</b> from <b>I</b>-<b>15A</b>-<b>5</b> in 82% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.32 (s, 3 H), 4.85 (s, 2 H), 5.29 (s, 2 H), 6.54 (d, <i>J</i> = 9.1 Hz, 1 H), 6.92 (td, <i>J</i> = 9.2, 2.5 Hz, 1 H), 7.05 (td, <i>J</i> = 7.1, 1.5 Hz, 1 H), 7.14 (dd, <i>J</i> = 10.0, 2.4 Hz, 1 H), 7.17–7.25 (m, 1 H), 7.33–7.45 (m, 2 H), 7.60 (dd, <i>J</i> = 9.2, 2.7 Hz, 1 H), 7.81 (d, <i>J</i> = 2.5 Hz, 1 H).</div></div><div id="sec5_8_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-(2,3-Difluorobenzyl)-5-(5-fluoro-2-methyl-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)-1<i>H</i>-indol-3-yl)pyridin-2(1<i>H</i>)-one (<b>39</b>)</h4><div class="NLM_p last">To a round-bottom flask containing <b>38</b> (200 mg, 0.469 mmol), BOP (228 mg, 0.52 mmol), and pyrrolidine (43 uL, 0.52 mmol) in DMF (5 mL) was added DIEA (122 μL, 0.7 mmol) to give a orange solution. This was stirred at room temp for 18 h until complete by TLC and LC/MS. Aqueous workup followed by prep HPLC purification and lyophilization afforded the title compound as a white solid. 56% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.76–1.87 (m, 2 H), 1.91–2.03 (m, 2 H), 2.29 (s, 3 H), 3.31–3.36 (m, 2 H), 3.65 (t, <i>J</i> = 6.8 Hz, 2 H), 5.06 (s, 2 H), 5.30 (s, 2 H), 6.55 (d, <i>J</i> = 9.3 Hz, 1 H), 6.93 (td, <i>J</i> = 9.2, 2.7 Hz, 1 H), 7.05 (td, <i>J</i> = 6.3, 1.5 Hz, 1 H), 7.15 (dd, <i>J</i> = 9.9, 2.5 Hz, 1 H), 7.17–7.26 (m, 1 H), 7.32–7.46 (m, 2 H), 7.60 (dd, <i>J</i> = 9.2, 2.7 Hz, 1 H), 7.81 (d, <i>J</i> = 2.5 Hz, 1 H).</div></div><div id="sec5_8_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 2-(3-(1-(2,3-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)-<i>N</i>,<i>N</i>-dimethylacetamide (<b>40</b>)</h4><div class="NLM_p last">The title compound was prepared according to the method described for <b>39</b>. 60% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.27 (s, 3 H), 2.86 (s, 3 H), 3.16 (s, 3 H), 5.15 (s, 2 H), 5.30 (s, 2 H), 6.55 (d, <i>J</i> = 9.3 Hz, 1 H), 6.92 (td, <i>J</i> = 9.2, 2.5 Hz, 1 H), 7.05 (td, <i>J</i> = 6.3, 1.5 Hz, 1 H), 7.14 (dd, <i>J</i> = 10.0, 2.4 Hz, 1 H), 7.17–7.26 (m, 1 H), 7.32–7.44 (m, 2 H), 7.60 (dd, <i>J</i> = 9.2, 2.7 Hz, 1 H), 7.80 (d, <i>J</i> = 2.5 Hz, 1 H).</div></div><div id="sec5_8_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-(3-(1-(2,3-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetamide (<b>41</b>)</h4><div class="NLM_p last">The title compound was prepared according to the method described for <b>39</b>. 75% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.34 (s, 3 H), 4.81 (s, 2 H), 5.30 (s, 2 H), 6.55 (d, <i>J</i> = 9.3 Hz, 1 H), 6.96 (td, <i>J</i> = 9.2, 2.5 Hz, 1 H), 7.02–7.09 (m, 1 H), 7.15 (dd, <i>J</i> = 10.0, 2.4 Hz, 1 H), 7.18–7.25 (m, <i>J</i> = 8.1, 8.1, 5.1, 1.5 Hz, 1 H), 7.28 (s, 1 H), 7.34–7.43 (m, 2 H), 7.60 (dd, <i>J</i> = 9.3, 2.5 Hz, 2 H), 7.80 (d, <i>J</i> = 2.5 Hz, 1 H).</div></div><div id="sec5_8_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-(3-(1-(2,3-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)-<i>N</i>-(methylsulfonyl)acetamide (<b>42</b>)</h4><div class="NLM_p last">The title compound was prepared according to the method described for <b>39</b>. 58% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.33 (s, 3 H), 3.27 (s, 3 H), 5.05 (s, 2 H), 5.30 (s, 2 H), 6.55 (d, <i>J</i> = 9.3 Hz, 1 H), 6.92–7.09 (m, 2 H), 7.11–7.27 (m, 2 H), 7.33–7.49 (m, 2 H), 7.60 (dd, <i>J</i> = 9.3, 2.5 Hz, 1 H), 7.83 (d, <i>J</i> = 2.3 Hz, 1 H).</div></div><div id="sec5_8_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (<i>R</i>)-2-(3-(1-(2,3-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)propanoic Acid (<b>43a</b>) and (<i>S</i>)-2-(3-(1-(2,3-Difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)propanoic Acid (<b>43b</b>)</h4><div class="NLM_p">Methyl 2-(3-bromo-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)propanoate (<b>I</b>-<b>21</b>). Intermediate <b>I</b>-<b>21</b> was prepared according to the method described for <b>I</b>-<b>13</b>. 36% yield.</div><div class="NLM_p">Methyl 2-(5-fluoro-3-(6-methoxypyridin-3-yl)-2-methyl-1<i>H</i>-indol-1-yl)propanoate (<b>I</b>-<b>22</b>). Intermediate <b>I</b>-<b>22</b> was prepared according to the method described for <b>I</b>-<b>14</b>. 41% yield.</div><div class="NLM_p">Methyl 2-(3-(1-(2,3-difluorobenzyl)-6-oxo-1,6-dihydropyridin-3-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)propanoate (<b>I</b>-<b>23</b>). Intermediate <b>23</b> was prepared according to the method described for <b>I</b>-<b>15</b>. Purification by flash chromatography afforded the product in a 75% yield.</div><div class="NLM_p last">The title compound was prepared from <b>I</b>-<b>23</b> according to the method described for pyridine analogue Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. 15% yield for <b>43a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.62 (d, <i>J</i> = 7.1 Hz, 3 H), 2.38 (s, 3 H), 5.29 (s, 2 H), 5.44 (q, <i>J</i> = 6.3 Hz, 1 H), 6.54 (d, <i>J</i> = 9.3 Hz, 1 H), 6.95 (td, <i>J</i> = 9.0, 2.3 Hz, 1 H), 7.05 (t, <i>J</i> = 6.9 Hz, 1 H), 7.14 (dd, <i>J</i> = 9.9, 2.3 Hz, 1 H), 7.17–7.27 (m, 1 H), 7.29–7.46 (m, 2 H), 7.60 (dd, <i>J</i> = 9.3, 2.3 Hz, 1 H), 7.84 (d, <i>J</i> = 1.8 Hz, 1 H), 13.20 (br s, 1 H). 15% yield for <b>43b</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.62 (d, <i>J</i> = 7.3 Hz, 3 H), 2.38 (s, 3 H), 5.28 (s, 2 H), 5.46 (q, <i>J</i> = 7.2 Hz, 1 H), 6.54 (d, <i>J</i> = 9.1 Hz, 1 H), 6.96 (td, <i>J</i> = 9.2, 2.7 Hz, 1 H), 7.02–7.09 (m, 1 H), 7.14 (dd, <i>J</i> = 9.9, 2.5 Hz, 1 H), 7.21 (qd, <i>J</i> = 8.1, 5.1, 1.5 Hz, 1 H), 7.30–7.44 (m, 2 H), 7.60 (dd, <i>J</i> = 9.2, 2.7 Hz, 1 H), 7.83 (d, <i>J</i> = 2.5 Hz, 1 H), 13.13 (br s, 1 H).</div></div><div id="sec5_8_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 2-(3-(2-Benzyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>48</b>) (Scheme <a class="ref internalNav" href="#sch10A" aria-label="10">10</a>B)</h4><div class="NLM_p"><i>tert</i>-Butyl 3-bromo-5-fluoro-2-methyl-1<i>H</i>-indole-1-carboxylate (<b>I</b>-<b>24</b>). To a 1000 mL round-bottom flask containing 5-fluoro-2-methyl-1<i>H</i>-indole (5.66 g, 38 mmol) and DMF (127 mL) was added bromine (2.0 mL, 38 mmol). After 15 min, the reaction was diluted with EtOAc (800 mL) and washed with water (500 mL) and brine (500 mL) and dried (MgSO<sub>4</sub>). The suspension was filtered and concentrated. The residue was dissolved in THF (381 mL) and treated with BOC<sub>2</sub> (8.3 g, 38 mmol) and DMAP (232 mg, 1.9 mmol). After 3 h, the reaction was concentrated to remove the THF. The residue was diluted with EtOAc (500 mL) and washed with water (250 mL) and brine (250 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude material was purified by Biotage to give a beige solid (12.45 g, 75% yield).</div><div class="NLM_p"><i>tert</i>-Butyl 5-fluoro-3-(isoquinolin-4-yl)-2-methyl-1<i>H</i>-indole-1-carboxylate (<b>I</b>-<b>25</b>). To a microwave vial containing <b>I</b>-<b>24</b> (1.03 g, 3.1 mmol), isoquinolin-4-ylboronic acid (1.02 g, 3.1 mmol), Na<sub>2</sub>CO<sub>3</sub> (640 mg, 6.1 mmol), and THF–H<sub>2</sub>O (20 mL, 1:1) was added Pd(PPh<sub>3</sub>)<sub>4</sub> (200 mg, 0.15 mmol). The vessel was sealed and heated at 150 °C for 15 min. The reaction was filtered through filter paper and diluted with EtOAc (200 mL) and water (100 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude material was purified by silica gel chromatography, eluting with an EtOAc/hexane gradient to give a red solid (1.18g, 30% yield).</div><div class="NLM_p last"><i>tert</i>-Butyl 3-(2-benzyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-5-fluoro-2-methyl-1<i>H</i>-indole-1-carboxylate (<b>I</b>-<b>26</b>). To a flask containing <b>I</b>-<b>25</b> (159 mg, 0.42 mmol) in CH<sub>3</sub>CN (4.5 mL) was added benzyl iodide (100 mg, 0.46 mmol). The reaction was heated at reflux for 3 h. The solution was cooled and diluted with EtOAc (100 mL). The organic layer was washed with water (50 mL) and brine (50 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated to give an amber oil. To the amber oil was added hexane (∼5–10 mL), and the suspension was agitated and stirred until a powdery light-brown solid appeared. The hexane was decanted, and the solid was dried in the vacuum oven. To the material was added water (2 mL) and THF (2 mL). An aqueous solution of KOH (1.8 M, 1.68 mmol, 0.93 mL) was added immediately, followed by addition of a solution of K<sub>3</sub>Fe(CN)<sub>6</sub> (415 mg, 1.26 mmol) in water (0.5 M, 2.5 mL). DMF was slowly added to the mixture until the reaction appeared to be homogeneous. The reaction was diluted with EtOAc (50 mL) and washed with water (50 mL). The eluent was concentrated, and the product was taken into the next step without further purification (91 mg, 45% yield).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Compound <b>48</b></h4><div class="NLM_p last">To a flask containing <b>I</b>-<b>26</b> (202 mg, 0.42 mmol) was added TFA (2 mL). The reaction was stirred for 20 min and then concentrated. The residue was dissolved in EtOAc (50 mL) and washed with H<sub>2</sub>O (25 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude material was dissolved in DMF (4 mL) and treated with methylbromoacetate (116 μL, 1.3 mmol) and potassium carbonate (232 mg, 1.7 mmol). The reaction was heated to 90 °C for 4 h and cooled to room temperature. The solution was diluted with EtOAc (75 mL) and washed with water (3 × 50 mL). The organic layer was concentrated to remove the EtOAc. The residue was dissolved in THF–MeOH–H<sub>2</sub>O (15 mL, 1:1:1) and treated with 1 M NaOH (2 mL). The reaction was stirred for 2–3 h and then concentrated to remove the volatile solvent. The aqueous layer was made acidic by addition of 1 M HCl. The product was extracted with EtOAc (3 × 15 mL) and purified by reverse phase HPLC to give a beige solid, yield 25%. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.47 (dd, 1H), 7.52–7.68 (m, 2H), 7.25–7.44 (m, 8H), 6.90 (td, <i>J</i> = 2.65, 9.16 Hz, 1H), 6.71 (dd, <i>J</i> = 2.53, 9.60 Hz, 1H), 5.20–5.45 (m, 2H), 4.96 (s, 2H), 2.21 (s, 3H).</div></div></div><div id="sec5_9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> General Procedure F (Scheme <a class="ref internalNav" href="#sch10A" aria-label="10">10</a>C)</h3><div class="NLM_p">2-Alkylisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>27</b>). In a 1000 mL round-bottom flask was isoquinolin-1(2<i>H</i>)-one (14.27 g, 98 mmol), selected alkylhalide (98 mmol), and cesium carbonate (32.0 g, 98 mmol) in DMF (328 mL) to give a pale-yellow suspension. The reaction was heated to 50 °C in an oil bath for 3 h. The reaction mixture was diluted with ethyl acetate (600 mL). The organic layer was washed with water (4 × 250 mL) and dried (MgSO<sub>4</sub>). The suspension was filtered, and the solvent was removed under reduced pressure. A solution of the material in CH<sub>2</sub>Cl<sub>2</sub> and MeOH was added to a Biotage samplet. The samplet was then put in a chamber and evacuated to remove the excess solvent. Purification using a Biotage column yielded 2-alkylisoquinolin-1(2<i>H</i>)-one.</div><div class="NLM_p">4-Iodo-2-alkylisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>28</b>). To a cooled 500 mL round-bottomed flask of Et<sub>2</sub>O (103 mL) containing a suspension of silver trifluoromethanesulfonate (13.19 g, 51.3 mmol), potassium hydroxide (2.88 g, 51.3 mmol), and <b>I</b>-<b>27</b> (51.3 mmol) was added iodine (13.03 g, 51.3 mmol) at 0 °C to give a cloudy suspension. After 2 h, the suspension was diluted with diethylether (200 mL) and filtered to remove the silver. The organic layer was washed with 0.1 M sodium thiosulfate (200 mL) and brine (200 mL) and dried (MgSO<sub>4</sub>). The solution was filtered and concentrated. The residue was purified via Biotage.</div><div class="NLM_p">2-Alkyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>29</b>). In a 500 mL round-bottomed flask was bis(pinacolato)diboron (5.68 g, 22.35 mmol) and <b>I</b>-<b>28</b> (22.35 mmol), acetic acid, and potassium acetate (6.58 g, 67.1 mmol) in DMSO (112 mL) to give a dark-orange solution. The reaction was purged with nitrogen gas, and then PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (1.095 g, 1.341 mmol) was added. The reaction was heated at 80 °C for 18 h and then cooled to room temperature. The reaction mixture was diluted with EtOAc (800 mL) and washed with water (3 × 300 mL) and saturated NaCl (1 × 300 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered and concentrated. The residue was purified via Biotage.</div><div class="NLM_p">Methyl 2-(5-fluoro-3-iodo-2-methyl-1<i>H</i>-indol-1-yl)acetate (<b>I</b>-<b>30</b>). To a 500 mL round-bottomed flask under an atmosphere of nitrogen was added 5-fluoro-3-iodo-2-methyl-1<i>H</i>-indole (8.3 g, 30.2 mmol), methyl 2-bromoacetate (11.10 mL, 121 mmol), and potassium carbonate (20.85 g, 151 mmol) in 150 mL of DMF to give a brown suspension. This was heated to 90 °C and allowed to stir for 16 h. The mixture was cooled to room temperature and poured into 800 mL of water. This was extracted with three 250 mL portions of ethyl acetate. The combined organic layers were washed with water and brine then dried over MgSO<sub>4</sub>. Filtration and concentration in vacuo gave the crude material which was purified by silica gel chromatography (6–50% EtOAc/Hex; 340 g SNAP column) to give a tan solid (8.08 g, 77% yield).</div><div class="NLM_p">To a 500 mL round-bottomed flask under an atmosphere of nitrogen was added 5-fluoro-3-iodo-2-methyl-1<i>H</i>-indole (8.3 g, 30.2 mmol), methyl 2-bromoacetate (11.10 mL, 121 mmol), and potassium carbonate (20.85 g, 151 mmol) in 150 mL of DMF to give a brown suspension. This was heated to 90 °C and allowed to stir for 16 h. The mixture was cooled to room temperature and poured into 800 mL of water. This was extracted with three 250 mL portions of ethyl acetate. The combined organic layers were washed with water and brine then dried over MgSO<sub>4</sub>. Filtration and concentration in vacuo gave the crude material which was purified by silica gel chromatography to give <b>I</b>-<b>30</b> as a tan solid (8.08 g, 77% yield).</div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Alkyl Isoquinolinone</h4><div class="NLM_p last">To a 75 mL sealed vessel was added <b>I</b>-<b>29</b> (18.65 mmol), methyl 2-(5-fluoro-3-iodo-2-methyl-1<i>H</i>-indol-1-yl)acetate (9.71 g, 28.0 mmol, <b>I</b>-<b>30</b>), potassium phosphate tribasic monohydrate (7.92 g, 37.3 mmol), and 2-dicyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl (0.765 g, 1.865 mmol) in butan-1-ol (133 mL) and water (53.3 mL) to give a suspension. The reaction was purged with nitrogen. The catalyst, palladium(II) acetate (0.209 g, 0.932 mmol), was added, and the vessel was sealed. The tube was heated at 100 °C in an oil bath for 18 h. To the aqueous layer was added 1 N HCl until the solution was acidic by litmus test. The solution was stirred rigorously for 5 min and allowed to partition into two layers. The aqueous layer was decanted using a pipet. The organic layer was filtered through filter paper to remove the catalyst and then concentrated under reduced pressure to remove the nBuOH. The material was dissolved in MeOH (80 mL) and THF (80 mL) and treated with 50 mL of 1N aqueous NaOH. After stirring for 20 min, the organic layer was removed under reduced pressure and the aqueous layer was rendered acidic by addition of 1N HCl (50 mL). The product was extracted with EtOAc (3 × 200 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated to give the crude material. The crude material was purified to give the final product.</div></div><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 2-(5-Fluoro-3-(2-isopropyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>44</b>)</h4><div class="NLM_p">2-Isopropylisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>27</b>–<b>1</b>). General procedure F was followed to give <b>I</b>-<b>27</b>–<b>1</b> from isoquinolin-1(2<i>H</i>)-one and 2-iodopropane in 26% yield.</div><div class="NLM_p">4-Iodo-2-isopropylisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>28</b>–<b>1</b>). General procedure F was followed to give <b>I</b>-<b>28</b>–<b>1</b> from <b>I</b>-<b>27</b>–<b>1</b> in 44% yield.</div><div class="NLM_p">2-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>29</b>–<b>1</b>). General procedure F was followed to give <b>I</b>-<b>29</b>–<b>1</b> from <b>I</b>-<b>28</b>–<b>1</b> in 83% yield.</div><div class="NLM_p last">General procedure F was followed to convert <b>I</b>-<b>29</b>–<b>1</b> to <b>44</b> in 74% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.11 (s, 1H), 8.32–8.40 (m, 1H), 7.63 (td, <i>J</i> = 1.39, 7.64 Hz, 1H), 7.48–7.56 (m, 2H), 7.42 (s, 1H), 7.22 (s, 1H), 6.97 (td, <i>J</i> = 2.65, 9.16 Hz, 1H), 6.81 (dd, <i>J</i> = 2.53, 9.85 Hz, 1H), 5.22–5.36 (m, 1H), 5.10 (d, <i>J</i> = 2.53 Hz, 2H), 2.22 (s, 3H), 1.39 (dd, <i>J</i> = 3.79, 6.82 Hz, 6H).</div></div><div id="sec5_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 2-(5-Fluoro-2-methyl-3-(2-neopentyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>45</b>)</h4><div class="NLM_p">2-(2,2,2-Trifluoroethyl)isoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>27</b>–<b>2</b>). General procedure F was followed to give <b>I</b>-<b>27</b>–<b>2</b> from isoquinolin-1(2<i>H</i>)-one and 1,1,1-trifluoro-2-iodoethane, 97% yield.</div><div class="NLM_p">4-Iodo-2-(2,2,2-trifluoroethyl)isoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>28</b>–<b>2</b>). Bis(pyridine)iodonium tetrafluoroborate (5.67 g, 15.25 mmol) was dissolved in dry dichloromethane (69.3 mL) and added slowly to <b>I</b>-<b>27</b>–<b>2</b> (3.15 g, 13.87 mmol) and trifluoromethanesulfonic acid (2.71 mL, 30.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub>. After completion of the reaction by TLC, the reaction was quenched by the addition of 0.1 M sodium thiosulfate (∼100 mL) and washed with saturated NaCl (250 mL). The organic layer was isolated, dried (MgSO<sub>4</sub>), filtered, and concentrated to give a dark-orange solid. The solid was purified to give an orange solid (3.9 g; 80% yield).</div><div class="NLM_p">4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethyl)isoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>29</b>–<b>2</b>). General procedure F was followed to give <b>I</b>-<b>29</b>–<b>2</b> from <b>I</b>-<b>28</b>–<b>2</b>, 69% yield.</div><div class="NLM_p last">General procedure F was followed to convert <b>I</b>-<b>29</b>–<b>2</b> to <b>45</b>, yield 34%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.13 (s, 1H), 8.34–8.41 (m, 1H), 7.71 (ddd, <i>J</i> = 1.52, 7.14, 8.27 Hz, 1H), 7.60 (ddd, <i>J</i> = 1.26, 7.07, 8.08 Hz, 1H), 7.53 (dd, <i>J</i> = 4.29, 9.09 Hz, 1H), 7.48 (s, 1H), 7.26 (d, <i>J</i> = 7.33 Hz, 1H), 6.98 (td, <i>J</i> = 2.53, 9.22 Hz, 1H), 6.83 (dd, <i>J</i> = 2.40, 9.73 Hz, 1H), 5.12 (s, 2H), 4.93–5.09 (m, 2H), 2.23 (s, 3H).</div></div><div id="sec5_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 2-(5-Fluoro-3-(1-oxo-2-(4,4,4-trifluorobutyl)-1,2-dihydroisoquinolin-4-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>46</b>)</h4><div class="NLM_p">2-(4,4,4-Trifluorobutyl)isoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>27</b>–<b>3</b>). General procedure F was followed to give <b>I</b>-<b>27</b>–<b>3</b> from isoquinolin-1(2<i>H</i>)-one and 4-bromo-1,1,1-trifluorobutane, 93% yield.</div><div class="NLM_p">4-Iodo-2-(4,4,4-trifluorobutyl)isoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>28</b>–<b>3</b>). General procedure F was followed to give <b>I</b>-<b>28</b>–<b>3</b> from <b>I</b>-<b>27</b>–<b>3</b> in 58% yield.</div><div class="NLM_p">4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(4,4,4-trifluorobutyl)isoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>29</b>–<b>3</b>). General procedure F was followed to give <b>I</b>-<b>29</b>–<b>3</b> from <b>I</b>-<b>28</b>–<b>3</b>, 71% yield.</div><div class="NLM_p last">General procedure F was followed to convert <b>I</b>-<b>29</b>–<b>3</b> to <b>46</b>, yield 64%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.09 (br s, 1H), 8.31–8.39 (m, 1H), 7.61–7.68 (m, 1H), 7.50–7.58 (m, 2H), 7.50 (s, 1H), 7.21 (d, <i>J</i> = 7.58 Hz, 1H), 6.96 (td, <i>J</i> = 2.53, 9.22 Hz, 1H), 6.86 (dd, <i>J</i> = 2.53, 9.60 Hz, 1H), 5.10 (s, 2H), 4.07–4.18 (m, 2H), 2.35 (d, <i>J</i> = 11.37 Hz, 2H), 2.22 (s, 3H), 1.98 (d, <i>J</i> = 7.07 Hz, 2H).</div></div><div id="sec5_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 2-(5-Fluoro-3-(2-neopentyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>47</b>)</h4><div class="NLM_p">2-Neopentylisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>27</b>–<b>4</b>). General procedure F was followed to give <b>I</b>-<b>27</b>–<b>3</b> from isoquinolin-1(2<i>H</i>)-one and 1-bromo-2,2-dimethylpropane, yield 57%.</div><div class="NLM_p">4-Iodo-2-neopentylisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>28</b>–<b>4</b>). Intermediate <b>I</b>-<b>28</b>–<b>4</b> was prepared according to the method described for intermediate <b>I</b>-<b>28</b>–<b>3</b>, 73% yield.</div><div class="NLM_p">2-Neopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>29</b>–<b>4</b>). General procedure F was followed to give <b>I</b>-<b>29</b>–<b>4</b> from <b>I</b>-<b>28</b>–<b>4</b>, 50% yield.</div><div class="NLM_p last">General procedure F was followed to convert <b>I</b>-<b>29</b>–<b>4</b> to <b>47</b>, yield 47%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.11 (br s, 1H), 8.35 (dd, <i>J</i> = 1.01, 8.08 Hz, 1H), 7.63 (td, <i>J</i> = 1.52, 7.58 Hz, 1H), 7.47–7.56 (m, 2H), 7.35 (s, 1H), 7.19 (d, <i>J</i> = 7.58 Hz, 1H), 6.96 (td, <i>J</i> = 2.65, 9.16 Hz, 1H), 6.80 (dd, <i>J</i> = 2.53, 9.60 Hz, 1H), 5.10 (s, 2H), 3.85–4.07 (m, 2H), 2.22 (s, 3H), 0.99 (s, 9H).</div></div></div><div id="sec5_10_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> General Procedure G</h3><div class="NLM_p">5,6,7,8-Tetrahydroisoquinolin-1(2<i>H</i>)-one (intermediate <b>I</b>-<b>31</b>). To a 100 mL round-bottomed flask under an atmosphere of nitrogen was added isoquinolin-1(2<i>H</i>)-one (0.5 g, 3.44 mmol) in 20 mL of acetic acid to give a colorless solution. Platinum(IV) oxide (0.235 g, 1.033 mmol) was added. Hydrogen gas was sparged through the solution via a needle attached to a balloon for 10 min. The reaction was then allowed to stir for 16 h under one atmosphere of nitrogen. The catalyst was filtered off and the acetic acid removed by azeotroping with hexane. The residue was purified by silica gel chromatography to give the desired product as a white solid (0.100g, 20% yield).</div><div class="NLM_p">2-Substituted-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>32</b>). To a 20 mL microwave vial was added intermediate <b>I</b>-<b>31</b> (1.01 g, 6.77 mmol) and cesium carbonate (4.41 g, 13.54 mmol) in 10 mL of DMF to give a white suspension. Selected halide (20.31 mmol) was added. The vial was sealed and the mixture heated to 50 °C. The reaction was allowed to stir 16 h. The mixture was then poured into water and extracted with 3 × 100 mL portions of ethyl acetate. The combined organic layers were washed with water and brine and then dried over MgSO<sub>4</sub> and filtered. The resulting solution was concentrated, and the residue was purified by silica gel chromatography to give the desired product.</div><div class="NLM_p">4-Iodo-2-substituted-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>33</b>). To a 50 mL round-bottomed flask under an atmosphere of nitrogen was added intermediate <b>I</b>-<b>32</b> (1.694 mmol) and trifluoromethanesulfonic acid (0.331 mL, 3.73 mmol) in 20 mL of dichloromethane to give a tan solution. Dipyridinium-1-yliodate(I), BF<sub>4</sub><sup>–</sup> (0.693 g, 1.863 mmol) was added slowly as a solution in 5 mL of dichloromethane, and the resulting solution was allowed to stir 1 h. The reaction was then quenched with 100 mL of 0.1 M sodium thiosulfate. The organic layer was washed with brine and dried over MgSO<sub>4</sub> and then filtered and concentrated in vacuo to give an orange solid. The residue was purified by silica gel chromatography to give the desired product.</div><div class="NLM_p">2-Substituted-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>34</b>). To a 50 mL round-bottomed flask under an atmosphere of nitrogen was added 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (0.401 g, 1.578 mmol), intermediate <b>I</b>-<b>33</b> (1.435 mmol), and potassium acetate (0.422 g, 4.30 mmol) in 25 mL of DMSO to give an orange solution. PdCl2(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (0.070 g, 0.086 mmol) was added. The reaction was heated to 80 °C and allowed to stir for 16 h. The mixture was then poured into 100 mL of water and extracted with three 50 mL portions of ethyl acetate. The combined organic layers were washed with water and brine, dried over magnesium sulfate, filtered, and concentrated. The residue was purified by silica gel to give the desired product.</div><div id="sec5_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Saturated Isoquinolinone</h4><div class="NLM_p last">To a 5 mL microwave vessel was added intermediate <b>I</b>-<b>30</b> (0.571 g, 1.645 mmol), intermediate <b>I</b>-<b>34</b> (0.823 mmol), and potassium phosphate tribasic monohydrate (0.349 g, 1.645 mmol) in 4 mL of butan-1-ol and 1.6 mL water to give a tan suspension. 2-Dicyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl (0.034 g, 0.082 mmol) was added. The vial was purged with nitrogen, and palladium(II) acetate (9.24 mg, 0.041 mmol) was added. The vessel was sealed and heated to 100 °C in an oil bath and allowed to stir for 16 h. The reaction mixture was then poured into 50 mL of water extracted with three 25 mL portions of ethyl acetate. The combined organic layers were washed with water and brine. The organic was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was redissolved into 10 mL of THF. To this was added lithium hydroxide (0.073 g, 3.06 mmol) dissolved into 5 mL of water. Methanol was added until solution was monophasic. The mixture was stirred for 30 min and was then poured into 100 mL of 1.2 N HCl. The aqueous layer was extracted with three 50 mL portions of ethyl acetate. The combined organic layers were washed with water and brine. The organic was dried MgSO<sub>4</sub>, filtered, and concentrated. The crude material was then purified.</div></div><div id="sec5_10_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 2-(5-Fluoro-3-(2-isopropyl-1-oxo-1,2,5,6,7,8-hexahydroisoquinolin-4-yl)-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>49</b>)</h4><div class="NLM_p">2-Isopropyl-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>32</b>–<b>1</b>). General procedure G was followed to give <b>I</b>-<b>32</b>–<b>1</b> from <b>I</b>-<b>31</b> and 2-iodopropane, yield 25%.</div><div class="NLM_p">4-Iodo-2-isopropyl-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>33</b>–<b>1</b>). General procedure G was followed to give <b>I</b>-<b>33</b>–<b>1</b> from <b>I</b>-<b>32</b>–<b>1</b>, yield 85%.</div><div class="NLM_p">2-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>34</b>–<b>1</b>). General procedure G was followed to give <b>I</b>-<b>34</b>–<b>1</b> from <b>I</b>-<b>33</b><b>–1</b>, 57% yield.</div><div class="NLM_p last">General procedure G was followed to convert <b>I</b>-<b>34</b>–<b>1</b> to <b>49</b> yield 23%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.30 (d, 6 H) 1.41–1.61 (m, 2 H) 1.68 (quin, <i>J</i> = 5.9 Hz, 2 H) 2.01–2.25 (m, 5 H) 2.44 (d, <i>J</i> = 5.6 Hz, 2 H) 5.02 (d, <i>J</i> = 1.0 Hz, 2 H) 5.14 (quin, <i>J</i> = 6.8 Hz, 1 H) 6.84–6.97 (m, 2 H) 7.29 (s, 1 H) 7.43 (dd, <i>J</i> = 9.0, 4.4 Hz, 1 H) 13.07 (br s, 1 H).</div></div><div id="sec5_10_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 2-(5-Fluoro-2-methyl-3-(1-oxo-2-(2,2,2-trifluoroethyl)-1,2,5,6,7,8-hexahydroisoquinolin-4-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>50</b>)</h4><div class="NLM_p">2-(2,2,2-Trifluoroethyl)-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>32</b>–<b>2</b>). General procedure G was followed to give <b>I</b>-<b>32</b>–<b>2</b> from <b>I</b>-<b>31</b> and 1,1,1-trifluoro-2-iodoethane, 66% yield.</div><div class="NLM_p">4-Iodo-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>33</b>–<b>2</b>). General procedure G was followed to give <b>I</b>-<b>33</b>–<b>2</b> from <b>I</b>-<b>32</b>–<b>2</b>, 19% yield.</div><div class="NLM_p">4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I-34–2</b>). General procedure G was followed to give <b>I</b>-<b>34</b>–<b>2</b> from <b>I</b>-<b>33</b>–<b>2</b>, 61% yield.</div><div class="NLM_p last">General procedure G was followed to convert <b>I</b>-<b>34</b>–<b>2</b> to <b>50</b>, 25% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.45–1.63 (m, 2 H) 1.64–1.75 (m, 2 H) 2.04–2.28 (m, 5 H) 2.39–2.53 (m, 2 H) 4.78–4.98 (m, 2 H) 5.03 (d, <i>J</i> = 1.5 Hz, 2 H) 6.85–6.97 (m, 2 H) 7.37 (s, 1 H) 7.45 (dd, <i>J</i> = 8.8, 4.3 Hz, 1 H) 13.09 (br s, 1 H).</div></div><div id="sec5_10_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 2-(5-Fluoro-2-methyl-3-(1-oxo-2-(4,4,4-trifluorobutyl)-1,2,5,6,7,8-hexahydroisoquinolin-4-yl)-1<i>H</i>-indol-1-yl)acetic Acid (<b>51</b>)</h4><div class="NLM_p">2-(4,4,4-Trifluorobutyl)-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>32</b>–<b>3</b>). General procedure G was followed to give <b>I</b>-<b>32</b>–<b>3</b> from <b>I</b>-<b>31</b> and 4-bromo-1,1,1-trifluorobutane, 53% yield.</div><div class="NLM_p">4-Iodo-2-(4,4,4-trifluorobutyl)-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>33</b>–<b>3</b>). General procedure G was followed to give <b>I</b>-<b>33</b>–<b>2</b> from <b>I</b>-<b>32</b>–<b>2</b> in 21% yield.</div><div class="NLM_p">4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(4,4,4-trifluorobutyl)-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>34</b>–<b>3</b>). General procedure G was followed to give <b>I</b>-<b>34</b>–<b>3</b> from <b>I</b><b>-33</b>–<b>3</b>, 61% yield.</div><div class="NLM_p last">General procedure G was followed to convert <b>I</b>-<b>34</b>–<b>3</b> to <b>51</b>, 33% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.42–1.60 (m, 2 H) 1.61–1.74 (m, 2 H) 1.90 (quin, <i>J</i> = 7.6 Hz, 2 H) 2.04–2.23 (m, 5 H) 2.23–2.36 (m, 2 H) 2.40–2.45 (m, 2 H) 3.89–4.03 (m, 2 H) 5.02 (d, <i>J</i> = 1.3 Hz, 2 H) 6.84–6.97 (m, 2 H) 7.38 (s, 1 H) 7.43 (dd, <i>J</i> = 8.7, 4.4 Hz, 1 H) 13.08 (br s, 1 H).</div></div><div id="sec5_10_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 2-(3-(2-Benzyl-1-oxo-1,2,5,6,7,8-hexahydroisoquinolin-4-yl)-5-fluoro-2-methyl-1<i>H</i>-indol-1-yl)acetic Acid (<b>52</b>)</h4><div class="NLM_p">2-Benzyl-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>32</b>–<b>4</b>). General procedure G was followed to give <b>I</b>-<b>32</b>–<b>4</b> from <b>I</b>-<b>31</b> and benzyl bromide, 73% yield.</div><div class="NLM_p">2-Benzyl-4-iodo-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>33</b>–<b>4</b>). General procedure G was followed to give <b>I</b>-<b>33</b>–<b>4</b> from <b>I</b>-<b>32</b>–<b>4</b>, 53% yield.</div><div class="NLM_p">2-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6,7,8-tetrahydroisoquinolin-1(2<i>H</i>)-one (<b>I</b>-<b>34</b>–<b>4</b>). General procedure G was followed to give <b>I</b>-<b>34</b>–<b>4</b> from <b>I</b>-<b>33</b><b>–4</b>, 71% yield.</div><div class="NLM_p last">General procedure G was followed to convert <b>I</b>-<b>34</b>–<b>4</b> to <b>52</b>, 33% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.47–1.66 (m, 2 H) 1.68–1.80 (m, 2 H) 2.05–2.31 (m, 5 H) 2.42–2.68 (m, 2 H) 5.07 (s, 2 H) 5.20 (d, <i>J</i> = 4.8 Hz, 2 H) 6.90 (dd, <i>J</i> = 9.6, 2.3 Hz, 1 H) 6.98 (td, <i>J</i> = 9.1, 2.5 Hz, 1 H) 7.29–7.37 (m, 1 H) 7.37–7.44 (m, 4 H) 7.49 (dd, <i>J</i> = 8.7, 4.4 Hz, 1 H) 7.54 (s, 1 H).</div></div></div><div id="sec5_10_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Membrane Vesicles and Sandwich-Cultured Hepatocytes Studies</h3><div class="NLM_p last">Membrane vesicles prepared from Mrp2/MRP2 expressing Sf9 insect cells were purchased from Invitrogen (Carlsbad, CA). Incubations were performed according to the vendor’s recommended procedures using a substrate concentration of 10 μM, 50 μg protein/incubation, and an incubation time of 5 min at 37 °C in the presence or absence of ATP and an ATP generating system. MK571 (250 μM), a Mrp2/MRP2 inhibitor, was included in separate incubations. Net uptake activity was obtained by subtracting activity in the presence of ATP from that in the presence of AMP. Rat and human sandwich-cultured hepatocytes were purchased from Qualyst (Durham, NC), and incubations were performed according to the vendor’s recommended procedures using substrate concentrations of 1–50 μM (rat) or 1–10 μM (human). The amount of substrate excreted into the bile canalicular network was calculated as the difference between the amount of substrate accumulated in the hepatocytes when incubations were conducted in the presence or absence of Ca<sup>2+</sup>. In vitro intrinsic biliary clearance was calculated by the amount of substrate excreted in the bile divided by the concentration of substrate present with time.</div></div><div id="sec5_10_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> hCRTH2 FRET Assay</h3><div class="NLM_p last">The cAMP TR-FRET assay was performed by incubating a dilution series of compound concentrations with 30000 cells per assay well of CHO-K1 cells expressing the recombinant human CRTH2 receptor (Euroscreen, Belgium). Incubations were performed at room temperature for 30 min in the presence of 10 uM forskolin and 10 nM PGD2. The assay buffer used contained 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4, 124 mM sodium chloride, 5 mM potassium chloride, 1.45 mM calcium chloride, 1.25 mM magnesium chloride, 1.25 mM potassium dihydrogen phosphate, 13.3 mM glucose, and 0.5 g/L BSA. Following the 30 min incubation at room temperature, <i>d</i><sub>2</sub>-cAMP and europium-labeled antibody supplied with the Hi-Range Assay Reagent kit (Cisbio, Bedford, MA) were separately diluted into the supplier-provided cell lysis buffer, and each was added to the assay plate, as per manufacturer’s directions. Data was collected on the Envision plate reader (Perkin-Elmer, Waltham, MA) using λex, 340 nm, and λem, 615/665. Samples containing cells and DMSO alone were included as a control in order to measure the maximal signal.</div></div><div id="sec5_10_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Human Eosinophil Shape Change Assay (hEOS)</h3><div class="NLM_p last">Peripheral blood from healthy human donors, prescreened for having greater than 3% eosinophils, was collected into sodium heparin tubes. Blood was incubated with compound for 10 min at room temperature and then activated with 50 nM PGD2 for 10 min at 37 °C. The reaction was stopped by transferring the plates to ice and adding 1% paraformaldehyde fixative. The samples were then transferred to ammonium chloride lysis solution, mixed gently, and incubated on ice for 40 min. Eosinophil shape change was analyzed by flow cytometry using a FACSCalibur outfitted with a 96-well autosampler. Individual cell populations were separated based on their forward and side scatter properties. Gross cellular toxicity was noted as a reduced or abnormal forward/side scatter pattern compared to untreated or placebo treated blood cell populations. Granulocytes were gated and assessed for autofluorescence in the FL1 and FL2 channels. Eosinophils were isolated based on their higher autofluorescence in both channels. Finally, shape change was measured by alterations in the mean forward scatter of the eosinophils in response to PGD2.</div></div><div id="sec5_10_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> Contact Hypersensitivity Mouse Ear Model (CHS)</h3><div class="NLM_p last">Inflammation was measured in the ear skin of mice. One week prior to challenge, mice were sensitized on the shaved abdomen by applying 100 μL of 2% oxazolone made in 100% ethanol. Five days later, baseline ear thickness measurements were taken on the left and right ears using a Mitutoyo micrometer. Compound was given orally prior to challenge. One hour after treatment, the left ears of the mice were challenged topically with 10 μL of 2% oxazolone on the left ear, and as a negative control 10 μL of 100% ethanol on the right ear. Mice received another dose of compound orally 7 h post challenge. The following day (24 h) ear swelling was measured again with the micrometer, and the swelling was expressed postchallenge–prechallenge thickness (Δ) (Student’s unpaired <i>t</i> test used for statistical analysis).</div></div><div id="sec5_10_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> House Dust Mite Model</h3><div class="NLM_p last">Mouse model of house dust mite-induced allergic airway disease: Age-matched 6–12 week old female BALB/c mice were obtained from Taconic Farms (Hudson, NY). All in vivo experiments were performed in accordance with animal use protocols approved by Pfizer’s Institutional Animal Care and Use Committee. On day 0, 7, and 14 of the protocol, mice were anesthetized with isoflurane and received house dust mite extract from <i>Dermatophagoides pteronyssinus</i> (HDM, Greer Laboratories, Lenoir, NC). Briefly, 100 μg HDM extract in 40 μL of saline were instilled intratracheally using a 100 μL Hamilton glass syringe terminated with a 1.5 in. polyethylene catheter mounted on a 30G needle. The catheter was introduced through the animal’s vocal cords into the trachea using an otoscope terminated with a 2 mm speculum. When indicated, mice were treated (qd) either intraperitoneally with dexamethasone (1 mg/kg) or perorally with compound <b>44</b> (40 mg/kg). All mice were euthanized by CO<sub>2</sub> asphyxiation on day 17 of the protocol to collect bronchoalveolar lavage (BAL) fluid and various tissue samples for analysis. BAL collection was performed as previously described.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Because systemic inflammation is minimal in this model, no blood samples were collected.</div></div><div id="sec5_10_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Statistical Analysis</h3><div class="NLM_p last">Results represent the mean ± SEM. Statistical significance for all results was determined using a Mann–Whitney U test. Results were considered significant for <i>P</i> values <0.05.</div></div><div id="sec5_10_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Guinea Pig Allergen Challenge Model</h3><div class="NLM_p last">Female Hartley guinea pigs between the weight range of 375 and 425 g (5–7 weeks) were obtained from Charles River . On days 1 and 5, guinea pigs were anesthetized with isoflurane inhalation prior to receiving a 1 mL intraperitoneal injection of 100 μg of OVA (Ovalbumin; grade V, minimum 98% agarose gel electrophoresis; batch no. 087K7004; A5503-50G; Sigma) with 100 mg of aluminum hydroxide (reagent grade; batch no. 09712JE; Sigma no. 239186-500G) in PBS. On day 15, animals were exposed to an aerosol of 0.01% OVA allergen in PBS for 60 min. Animals were dosed per os with test articles 1 h prior to and 6 h post OVA allergen challenge. To facilitate oral dosing, animals were anesthetized with isoflurane inhalation. An infant feeding tube was then placed into the stomach, and compounds were dosed in a 1 mL volume in 0.5% Tween made up in Cherry Blast FlavoRX syrup. All animals were euthanized by pentabarbitol overdose on day 16 of the protocol in order to collect bronchoalveolar lavage (BAL) fluid and various tissue samples for analysis. For BAL fluid collection lungs were lavaged with 2 × 10 mL of PBS. Recovered total cell numbers were pooled and counted using a hemocytometer. Evans Blue exclusion was used to assess cell viability. In terms of cell viability, there were no differences between vehicle treated and compound treated animals. Cell differentials were quantified from cells smears (prepared by spinning a 100 μL aliquot (106 cells/mL) in a Cytospin (Shandon) centrifuge) that were fixed using a solution of methanol for 10 s and stained with buffered eosin (10 s) and methylene blue/Azur (5 s). A total of 500 cells per smear were counted by light microscopy under oil immersion (×1000).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106"><a href="/doi/suppl/10.1021/jm401509e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Analytical data for intermediates. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401509e/suppl_file/jm401509e_si_001.pdf">jm401509e_si_001.pdf (78.54 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401509e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06016" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06016" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neelu Kaila</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#abc5cecec7de85c0cac2c7caebdbcdc2d1ced985c8c4c6"><span class="__cf_email__" data-cfemail="93fdf6f6ffe6bdf8f2fafff2d3e3f5fae9f6e1bdf0fcfe">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce Follows</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis Leung</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Thomason</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian Huang</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Moretto</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin Janz</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Lowe</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tarek S. Mansour</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cedric Hubeau</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Page</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Morgan</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Fish</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Xu</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cara Williams</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eddine Saiah</span> - <span class="hlFld-Affiliation affiliation">Pfizer Research and Development, Cambridge, Massachusetts 02140, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d4618e8050-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Seonghee Park, Aram Oganesian, Jianyao Wang, and Robert Espina for the in vitro and in vivo ADME studies and Professor William Abraham from the University of Miami for sheep studies. We would also like to thank the DAC group for analytical data.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i108" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i108"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i109" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i109"> Abbreviations Used</h2><tr><td class="NLM_term">CRTH2</td><td class="NLM_def"><p class="first last">chemoattractant receptor homologous molecule expressed on Th2 cells</p></td></tr><tr><td class="NLM_term">PGD2</td><td class="NLM_def"><p class="first last">prostaglandin D2</p></td></tr><tr><td class="NLM_term">cPLA2</td><td class="NLM_def"><p class="first last">cytosolic phospholipase A2</p></td></tr><tr><td class="NLM_term">TP</td><td class="NLM_def"><p class="first last">thromboxane type prostanoid receptor</p></td></tr><tr><td class="NLM_term">DP</td><td class="NLM_def"><p class="first last">the PGD2 receptor</p></td></tr><tr><td class="NLM_term">TXB2</td><td class="NLM_def"><p class="first last">11-dehydro-thromboxane B2</p></td></tr><tr><td class="NLM_term">FEV1</td><td class="NLM_def"><p class="first last">forced expiratory volume in 1 s</p></td></tr><tr><td class="NLM_term">AHR</td><td class="NLM_def"><p class="first last">airway hyperresponsiveness</p></td></tr><tr><td class="NLM_term">LAR</td><td class="NLM_def"><p class="first last">late airway response</p></td></tr><tr><td class="NLM_term">EAR</td><td class="NLM_def"><p class="first last">early airway response</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">benzotriazol-1-yloxytris(dimethylamino) phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability coefficient</p></td></tr><tr><td class="NLM_term">pH</td><td class="NLM_def"><p class="first last">potential hydrogen</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">HDM</td><td class="NLM_def"><p class="first last">house dust mite</p></td></tr><tr><td class="NLM_term">BAL</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage</p></td></tr><tr><td class="NLM_term">MgSO<sub>4</sub></td><td class="NLM_def"><p class="first last">magnesium sulfate</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein 1</p></td></tr><tr><td class="NLM_term">MRP</td><td class="NLM_def"><p class="first last">multidrug resistant protein</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophillic efficiency</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i110">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 19 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Haeggstrom, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinaldo-Matthis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelock, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterholm, A.</span><span> </span><span class="NLM_article-title">Advances in eicosanoid research, novel therapeutic implications</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=135-139&author=J.+Z.+Haeggstromauthor=A.+Rinaldo-Matthisauthor=C.+E.+Wheelockauthor=A.+Wetterholm&title=Advances+in+eicosanoid+research%2C+novel+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaeggstrom%26aufirst%3DJ.%2BZ.%26aulast%3DRinaldo-Matthis%26aufirst%3DA.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26aulast%3DWetterholm%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520eicosanoid%2520research%252C%2520novel%2520therapeutic%2520implications%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D21%26spage%3D135%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Castellani, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felaco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Amicis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecchiet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tete, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampoli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerulli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caraffa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antinolfi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccurullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felaco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempuraj, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boscolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, Y. B.</span><span> </span><span class="NLM_article-title">Mast cells and arachidonic acid cascade in inflammation</span> <span class="citation_source-journal">Eur. J. Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFynurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=131-137&author=M.+L.+Castellaniauthor=M.+Felacoauthor=F.+Pandolfiauthor=V.+Saliniauthor=D.+De+Amicisauthor=C.+Orsoauthor=J.+Vecchietauthor=S.+Teteauthor=C.+Ciampoliauthor=F.+Contiauthor=G.+Cerulliauthor=A.+Caraffaauthor=P.+Antinolfiauthor=C.+Cuccurulloauthor=P.+Felacoauthor=D.+Kempurajauthor=P.+Boscoloauthor=G.+Sabatinoauthor=Y.+B.+Shaik&title=Mast+cells+and+arachidonic+acid+cascade+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cells and arachidonic acid cascade in inflammation</span></div><div class="casAuthors">Castellani, M. L.; Felaco, M.; Pandolfi, F.; Salini, V.; De Amicis, D.; Orso, C.; Vecchiet, J.; Tete, S.; Ciampoli, C.; Conti, F.; Cerulli, G.; Caraffa, A.; Antinolfi, P.; Cuccurullo, C.; Felaco, P.; Kempuraj, D.; Boscolo, P.; Sabatino, G.; Shaik, Y. B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inflammation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-137</span>CODEN:
                <span class="NLM_cas:coden">EJIUA5</span>;
        ISSN:<span class="NLM_cas:issn">1721-727X</span>.
    
            (<span class="NLM_cas:orgname">Biolife, s.a.s.</span>)
        </div><div class="casAbstract">A review.  Prostaglandin D2 PGD2 is a major cyclooxygenase metabolite of arachidonic acid produced by mast cells and it is released following allergen challenge in diseases, such as allergic diseases.  PGD2 may act as a neuromodulator and as an allergic and inflammatory mediator.  In allergic diseases, activated mast cell synthesizes prostaglandin D2 (first cyclo-oxygenate mediator) which has bronchoconstrictive and vasodilating effects and attracts several leukocytes.  It has been found that activated mast cells, challenged with physiol. and non- physiol. secretagogues, release elevated histamine and tryptase and chymase, leukotrienes B4, C4 and D4,5-hydroxyeicosatetraenoic acid, PGD2, Platelet Activating Factor (PAF), heparin, and high-mol.-wt. neutrophil chemotactic factor and cytokines/chemokines.  PGD2 exerts its biol. activity through the DP and CRTH2 receptors and their cDNA cloning which were characterized 15 years ago.  In this report, we revisited the biol. effects of arachidonic acid compds. released by activated mast cells in allergic and inflammatory states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkqC5TikdJp7Vg90H21EOLACvtfcHk0ligyq2zJsswzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFynurzM&md5=07531ac3fe1d628a33dec19c3180131e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastellani%26aufirst%3DM.%2BL.%26aulast%3DFelaco%26aufirst%3DM.%26aulast%3DPandolfi%26aufirst%3DF.%26aulast%3DSalini%26aufirst%3DV.%26aulast%3DDe%2BAmicis%26aufirst%3DD.%26aulast%3DOrso%26aufirst%3DC.%26aulast%3DVecchiet%26aufirst%3DJ.%26aulast%3DTete%26aufirst%3DS.%26aulast%3DCiampoli%26aufirst%3DC.%26aulast%3DConti%26aufirst%3DF.%26aulast%3DCerulli%26aufirst%3DG.%26aulast%3DCaraffa%26aufirst%3DA.%26aulast%3DAntinolfi%26aufirst%3DP.%26aulast%3DCuccurullo%26aufirst%3DC.%26aulast%3DFelaco%26aufirst%3DP.%26aulast%3DKempuraj%26aufirst%3DD.%26aulast%3DBoscolo%26aufirst%3DP.%26aulast%3DSabatino%26aufirst%3DG.%26aulast%3DShaik%26aufirst%3DY.%2BB.%26atitle%3DMast%2520cells%2520and%2520arachidonic%2520acid%2520cascade%2520in%2520inflammation%26jtitle%3DEur.%2520J.%2520Inflammation%26date%3D2009%26volume%3D7%26spage%3D131%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aso, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span> </span><span class="NLM_article-title">CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s)</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=1999&pages=195-199&author=K.+Nagataauthor=H.+Hiraiauthor=K.+Tanakaauthor=K.+Ogawaauthor=T.+Asoauthor=K.+Sugamuraauthor=M.+Nakamuraauthor=S.+Takano&title=CRTH2%2C+an+orphan+receptor+of+T-helper-2-cells%2C+is+expressed+on+basophils+and+eosinophils+and+responds+to+mast+cell-derived+factor%28s%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DAso%26aufirst%3DT.%26aulast%3DSugamura%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DTakano%26aufirst%3DS.%26atitle%3DCRTH2%252C%2520an%2520orphan%2520receptor%2520of%2520T-helper-2-cells%252C%2520is%2520expressed%2520on%2520basophils%2520and%2520eosinophils%2520and%2520responds%2520to%2520mast%2520cell-derived%2520factor%2528s%2529%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D459%26spage%3D195%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span> </span><span class="NLM_article-title">The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes</span> <span class="citation_source-journal">Fatty Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1016%2FS0952-3278%2803%2900078-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=12895600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVKjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2003&pages=169-177&author=K.+Nagataauthor=H.+Hirai&title=The+second+PGD%282%29+receptor+CRTH2%3A+structure%2C+properties%2C+and+functions+in+leukocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The second PGD2 receptor CRTH2: structure, properties, and functions in leukocytes</span></div><div class="casAuthors">Nagata, Kinya; Hirai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins, Leukotrienes and Essential Fatty Acids</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">169-177</span>CODEN:
                <span class="NLM_cas:coden">PLEAEU</span>;
        ISSN:<span class="NLM_cas:issn">0952-3278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  PGD2 plays a broad range of physiol. and pathophysiol. functions.  Until just a few years ago, it was thought that most of the biol. actions of PGD2 are mediated via the classical PGD2 receptor DP.  Recently, we identified a 2nd PGD2 receptor, chemoattractant receptor-homologous mol. expressed on T helper (Th)2 cells (CRTH2), with different functions relative to DP.  Here, we review the recent findings on the structure, tissue distribution, ligand selectivity, signaling pathways, and functions in leukocytes of this receptor.  The data suggest that the PGD2/CRTH2 system play important roles in allergic inflammation through its stimulatory effects on Th2 cells, eosinophils, and basophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL7orwnSlzirVg90H21EOLACvtfcHk0ligyq2zJsswzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVKjsbk%253D&md5=e87fa1c7331a6891dada8d3d98272ed2</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS0952-3278%2803%2900078-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-3278%252803%252900078-4%26sid%3Dliteratum%253Aachs%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DH.%26atitle%3DThe%2520second%2520PGD%25282%2529%2520receptor%2520CRTH2%253A%2520structure%252C%2520properties%252C%2520and%2520functions%2520in%2520leukocytes%26jtitle%3DFatty%2520Acids%26date%3D2003%26volume%3D69%26spage%3D169%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Emerging roles of DP and CRTH2 in allergic inflammation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=148-158&author=E.+Kostenisauthor=T.+Ulven&title=Emerging+roles+of+DP+and+CRTH2+in+allergic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DEmerging%2520roles%2520of%2520DP%2520and%2520CRTH2%2520in%2520allergic%2520inflammation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D148%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Epub.</p></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cosmi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annunziato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnani, S.</span><span> </span><span class="NLM_article-title">CRTH2: marker for the detection of human Th2 and Tc2 cells</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">495</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=495&publication_year=2001&pages=25-29&author=L.+Cosmiauthor=F.+Annunziatoauthor=G.+Galliauthor=R.+Manettiauthor=E.+Maggiauthor=S.+Romagnani&title=CRTH2%3A+marker+for+the+detection+of+human+Th2+and+Tc2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCosmi%26aufirst%3DL.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DGalli%26aufirst%3DG.%26aulast%3DManetti%26aufirst%3DR.%26aulast%3DMaggi%26aufirst%3DE.%26aulast%3DRomagnani%26aufirst%3DS.%26atitle%3DCRTH2%253A%2520marker%2520for%2520the%2520detection%2520of%2520human%2520Th2%2520and%2520Tc2%2520cells%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2001%26volume%3D495%26spage%3D25%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenmotsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor CRTH2</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1084%2Fjem.193.2.255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=11208866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksl2msg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2001&pages=255-262&author=H.+Hiraiauthor=K.+Tanakaauthor=O.+Yoshieauthor=K.+Ogawaauthor=K.+Kenmotsuauthor=Y.+Takamoriauthor=M.+Ichimasaauthor=K.+Sugamuraauthor=M.+Nakamuraauthor=S.+Takano&title=Prostaglandin+D2+Selectively+Induces+Chemotaxis+in+T+Helper+Type+2+Cells%2C+Eosinophils%2C+and+Basophils+via+Seven-Transmembrane+Receptor+CRTH2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2</span></div><div class="casAuthors">Hirai, Hiroyuki; Tanaka, Kazuya; Yoshie, Osamu; Ogawa, Kazuyuki; Kenmotsu, Kazumi; Takamori, Yasushi; Ichimasa, Michiko; Sugamura, Kazuo; Nakamura, Masataka; Takano, Shoichi; Nagata, Kinya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Prostaglandin (PG)D2, which has long been implicated in allergic diseases, is currently considered to elicit its biol. actions through the DP receptor (DP).  Involvement of DP in the formation of allergic asthma was recently demonstrated with DP-deficient mice.  However, proinflammatory functions of PGD2 cannot be explained by DP alone.  The authors show here that a 7-transmembrane receptor, CRTH2, which is preferentially expressed in T helper type 2 (Th2) cells, eosinophils, and basophils in humans, serves as the novel receptor for PGD2.  In response to PGD2, CRTH2 induces intracellular Ca2+ mobilization and chemotaxis in Th2 cells in a Gαi-dependent manner.  In addn., CRTH2, but not DP, mediates PGD2-dependent cell migration of blood eosinophils and basophils.  Thus, PGD2 is likely involved in multiple aspects of allergic inflammation through its dual receptor systems, DP and CRTH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzrVzvfWtBArVg90H21EOLACvtfcHk0ljaXert0_htng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksl2msg%253D%253D&md5=be2c6671805c587029df75738463ccd3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1084%2Fjem.193.2.255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.193.2.255%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYoshie%26aufirst%3DO.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DKenmotsu%26aufirst%3DK.%26aulast%3DTakamori%26aufirst%3DY.%26aulast%3DIchimasa%26aufirst%3DM.%26aulast%3DSugamura%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DTakano%26aufirst%3DS.%26atitle%3DProstaglandin%2520D2%2520Selectively%2520Induces%2520Chemotaxis%2520in%2520T%2520Helper%2520Type%25202%2520Cells%252C%2520Eosinophils%252C%2520and%2520Basophils%2520via%2520Seven-Transmembrane%2520Receptor%2520CRTH2%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2001%26volume%3D193%26spage%3D255%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Huang, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunkett, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K. C.</span><span> </span><span class="NLM_article-title">Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2691</span><span class="NLM_x">–</span> <span class="NLM_lpage">2697</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1093%2Fhmg%2Fddh279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=15345705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=2691-2697&author=J.-L.+Huangauthor=P.-S.+Gaoauthor=R.+A.+Mathiasauthor=T.-C.+Yaoauthor=L.-C.+Chenauthor=M.-L.+Kuoauthor=S.-C.+Hsuauthor=B.+Plunkettauthor=A.+Togiasauthor=K.+C.+Barnes&title=Sequence+variants+of+the+gene+encoding+chemoattractant+receptor+expressed+on+Th2+cells+%28CRTH2%29+are+associated+with+asthma+and+differentially+influence+mRNA+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability</span></div><div class="casAuthors">Huang, Jing-Long; Gao, Pei-Song; Mathias, Rasika A.; Yao, Tsung-Chieh; Chen, Li-Chen; Kuo, Ming-Ling; Hsu, Shih-Chang; Plunkett, Beverly; Togias, Alkis; Barnes, Kathleen C.; Stellato, Cristiana; Beaty, Terri H.; Huang, Shau-Ku</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2691-2697</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The gene, CRTH2, encoding a receptor for prostaglandin D2 (PGD2), is located within the peak linkage region for asthma on chromosome (Chr.) 11q reported in African American families.  Family-based anal. of asthma and two common SNPs [G1544C and G1651A (rs545659)] in the 3'-untranslated region of CRTH2 showed significant evidence of linkage in the presence of disequil. for the 1651G allele (P=0.003) of SNP rs545659.  Haplotype anal. yielded addnl. evidence of linkage disequil. for the 1544G-1651G haplotype (P<0.001).  Population-based case-control analyses were conducted in two independent populations, and demonstrated significant assocn. of the 1544G-1651G haplotype with asthma in an African American population (P=0.004), and in a population of Chinese children (P<0.001).  Moreover, in the Chinese children the frequency of the 1651G allele in near-fatal asthmatics was significantly higher than mild-to-moderate asthmatics (P=0.001) and normal controls (P<0.001).  The 1651G allele of SNP re545659 was also assocd. with a higher degree of bronchial hyperresponsiveness (P<0.027).  Transcriptional pulsing expts. showed that the 1544G-1651G haplotype confers a significantly higher level of reporter mRNA stability, when compared with a non-transmitted haplotype (1544C-1651A), suggesting that the CRTH2 gene on Chr. 11q is a strong candidate gene for asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjOWRpXjZt0bVg90H21EOLACvtfcHk0ljaXert0_htng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVOis7Y%253D&md5=6588fe0d057772c7d639ed028dbe1c51</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddh279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddh279%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.-L.%26aulast%3DGao%26aufirst%3DP.-S.%26aulast%3DMathias%26aufirst%3DR.%2BA.%26aulast%3DYao%26aufirst%3DT.-C.%26aulast%3DChen%26aufirst%3DL.-C.%26aulast%3DKuo%26aufirst%3DM.-L.%26aulast%3DHsu%26aufirst%3DS.-C.%26aulast%3DPlunkett%26aufirst%3DB.%26aulast%3DTogias%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DK.%2BC.%26atitle%3DSequence%2520variants%2520of%2520the%2520gene%2520encoding%2520chemoattractant%2520receptor%2520expressed%2520on%2520Th2%2520cells%2520%2528CRTH2%2529%2520are%2520associated%2520with%2520asthma%2520and%2520differentially%2520influence%2520mRNA%2520stability%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2004%26volume%3D13%26spage%3D2691%26epage%3D2697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Follows, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiah, E.</span><span> </span><span class="NLM_article-title">Diazine Indole Acetic Acids as Potent, Selective, and Orally Bioavailable Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5088</span><span class="NLM_x">–</span> <span class="NLM_lpage">5109</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300007n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5088-5109&author=N.+Kailaauthor=A.+Huangauthor=A.+Morettoauthor=B.+Followsauthor=K.+Janzauthor=M.+Loweauthor=J.+Thomasonauthor=T.+S.+Mansourauthor=C.+Hubeauauthor=K.+Pageauthor=P.+Morganauthor=S.+Fishauthor=X.+Xuauthor=C.+Williamsauthor=E.+Saiah&title=Diazine+Indole+Acetic+Acids+as+Potent%2C+Selective%2C+and+Orally+Bioavailable+Antagonists+of+Chemoattractant+Receptor+Homologous+Molecule+Expressed+on+Th2+Cells+%28CRTH2%29+for+the+Treatment+of+Allergic+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm300007n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300007n%26sid%3Dliteratum%253Aachs%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DMoretto%26aufirst%3DA.%26aulast%3DFollows%26aufirst%3DB.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DLowe%26aufirst%3DM.%26aulast%3DThomason%26aufirst%3DJ.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DHubeau%26aufirst%3DC.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DFish%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DSaiah%26aufirst%3DE.%26atitle%3DDiazine%2520Indole%2520Acetic%2520Acids%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Antagonists%2520of%2520Chemoattractant%2520Receptor%2520Homologous%2520Molecule%2520Expressed%2520on%2520Th2%2520Cells%2520%2528CRTH2%2529%2520for%2520the%2520Treatment%2520of%2520Allergic%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5088%26epage%3D5109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Snell, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestbo, J.</span><span> </span><span class="NLM_article-title">Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD</span> <span class="citation_source-journal">Respir. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1722</span><span class="NLM_x">–</span> <span class="NLM_lpage">1730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1016%2Fj.rmed.2013.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=23827726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A280%3ADC%252BC3sjotFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2013&pages=1722-1730&author=N.+Snellauthor=M.+Fosterauthor=J.+Vestbo&title=Efficacy+and+safety+of+AZD1981%2C+a+CRTH2+receptor+antagonist%2C+in+patients+with+moderate+to+severe+COPD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD</span></div><div class="casAuthors">Snell Noel; Foster Martyn; Vestbo Jorgen</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1722-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the efficacy and tolerability of the selective CRTh2 (DP2) receptor antagonist AZD1981 compared with placebo in patients with moderate to severe COPD.  METHODS:  In this multicentre, randomised, double-blind, parallel-group, phase IIa study (ClinicalTrials.gov identifier: NCT00690482) patients with moderate to severe COPD received either AZD1981 1000 mg twice daily or matching placebo for 4 weeks.  Inhaled terbutaline was used as-needed as reliever medication throughout.  The co-primary endpoints were change from baseline to end of treatment in pre-bronchodilator forced expiratory volume in 1 s [FEV1] and the Clinical COPD Questionnaire (CCQ).  Additional endpoints included other lung function measures, 6-min walk test (6-MWT), COPD symptom score, reliever medication use and tolerability.  RESULTS:  118 patients were randomised to treatment (AZD1981 n = 61; placebo n = 57); 83% of patients were male and the mean age was 63 years (range 43-83).  There were no significant differences in the mean difference in change from baseline to end of treatment between AZD1981 and placebo for the co-primary endpoints of pre-bronchodilator FEV1 (AZD1981-placebo: -0.015, 95% CI: -0.10 to 0.070; p = 0.72) and CCQ total score (difference: 0.042, 95% CI: -0.21 to 0.30; p = 0.75).  Similarly, no differences were observed between treatments for the other outcomes of lung function, COPD symptom score, 6-MWT, BODE index, and use of reliever medication.  AZD1981 was well tolerated.  CONCLUSION:  There was no beneficial clinical effect of AZD1981, at a dose of 1000 mg twice daily for 4 weeks, in patients with moderate to severe COPD.  AZD1981 was well tolerated and no safety concerns were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPSqgbSDH0Dhcr74wzj5o5fW6udTcc2eYJIIpa2bePkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjotFKktg%253D%253D&md5=1cb066d5739b23480039c884b1950ccd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.rmed.2013.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.rmed.2013.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DSnell%26aufirst%3DN.%26aulast%3DFoster%26aufirst%3DM.%26aulast%3DVestbo%26aufirst%3DJ.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520AZD1981%252C%2520a%2520CRTH2%2520receptor%2520antagonist%252C%2520in%2520patients%2520with%2520moderate%2520to%2520severe%2520COPD%26jtitle%3DRespir.%2520Med.%26date%3D2013%26volume%3D107%26spage%3D1722%26epage%3D1730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Singh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettipher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B.</span><span> </span><span class="NLM_article-title">Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1183%2F09031936.00092111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=22496329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=46-52&author=D.+Singhauthor=P.+Caddenauthor=M.+Hunterauthor=L.+P.+Collinsauthor=M.+Perkinsauthor=R.+Pettipherauthor=E.+Townsendauthor=S.+Vinallauthor=B.+O%E2%80%99Connor&title=Inhibition+of+the+asthmatic+allergen+challenge+response+by+the+CRTH2+antagonist+OC000459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459</span></div><div class="casAuthors">Singh, Dave; Cadden, Paul; Hunter, Michael; Collins, Lisa Pearce; Perkins, Mike; Pettipher, Roy; Townsend, Elizabeth; Vinall, Shan; O'Connor, Brian</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">CRTH2 (chemoattractant receptor expressed on T-helper (Th) type 2 cells) is a G-protein-coupled receptor expressed by Th2 lymphocytes and eosinophils that mediates prostaglandin (PG)D2-driven chemotaxis.  We studied the efficacy of the oral CRTH2 antagonist OC000459 in steroid-naive asthmatic patients.  A randomized, double-blind, placebo-controlled, two-way crossover study of 16 days' treatment with OC000459 (200 mg twice daily) on the late (LAR) and early (EAR) asthmatic responses to bronchial allergen challenge was conducted, with 16 subjects completing the study.  There was a 25.4% (95% Cl 5.1-45.6%) redn. in the LAR area under the curve (AUC) for change in forced expiratory vol. in 1 s with OC000459 compared with placebo (p = 0.018) but no effect on the EAR.  Sputum eosinophil counts at 1 day post-allergen challenge were lower after OC000459 treatment (p = 0.002).  PGD2-induced blood eosinophil shape change ex vivo was assessed at day 7 (n = 7).  The AUC of eosinophil shift for OC000459 was lower than placebo; the mean difference was -33.6% (95% Cl -66.8-0.4%; p = 0.048).  OC000459 treatment inhibited LAR and post-allergen increase in sputum eosinophils.  This CRTH2 antagonist appears to inhibit allergic inflammation in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyWfR26wUk7rVg90H21EOLACvtfcHk0lg6OKN72Lkktg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrsbo%253D&md5=953eef3a067892fca95cd080e7bd180b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1183%2F09031936.00092111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00092111%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DD.%26aulast%3DCadden%26aufirst%3DP.%26aulast%3DHunter%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DL.%2BP.%26aulast%3DPerkins%26aufirst%3DM.%26aulast%3DPettipher%26aufirst%3DR.%26aulast%3DTownsend%26aufirst%3DE.%26aulast%3DVinall%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520the%2520asthmatic%2520allergen%2520challenge%2520response%2520by%2520the%2520CRTH2%2520antagonist%2520OC000459%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2013%26volume%3D41%26spage%3D46%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span>Arry-502/CRTH2 Antagonist. <a href="http://www.arraybiopharma.com/ProductPipeline/Inflamation/CRTh2.asp" class="extLink">http://www.arraybiopharma.com/ProductPipeline/Inflamation/CRTh2.asp</a> (accessed December 20, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Arry-502%2FCRTH2+Antagonist.+http%3A%2F%2Fwww.arraybiopharma.com%2FProductPipeline%2FInflamation%2FCRTh2.asp+%28accessed+December+20%2C+2013%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span> </span><span class="NLM_article-title">Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=981-985&author=H.+Hiraiauthor=K.+Tanakaauthor=S.+Takanoauthor=M.+Ichimasaauthor=M.+Nakamuraauthor=K.+Nagata&title=Cutting+edge%3A+agonistic+effect+of+indomethacin+on+a+prostaglandin+D2+receptor%2C+CRTH2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DS.%26aulast%3DIchimasa%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DK.%26atitle%3DCutting%2520edge%253A%2520agonistic%2520effect%2520of%2520indomethacin%2520on%2520a%2520prostaglandin%2520D2%2520receptor%252C%2520CRTH2%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D981%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fretz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdenaire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M. A.</span><span> </span><span class="NLM_article-title">Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4899</span><span class="NLM_x">–</span> <span class="NLM_lpage">4911</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400122f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4899-4911&author=H.+Fretzauthor=A.+Valdenaireauthor=J.+Pothierauthor=K.+Hilpertauthor=C.+Gnerreauthor=O.+Peterauthor=X.+Leroyauthor=M.+A.+Riederer&title=Identification+of+2-%282-%281-Naphthoyl%29-8-fluoro-3%2C4-dihydro-1H-pyrido%5B4%2C3-b%5Dindol-5%282H%29-yl%29acetic+Acid+%28Setipiprant%2FACT-129968%29%2C+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+Chemoattractant+Receptor-Homologous+Molecule+Expressed+on+Th2+Cells+%28CRTH2%29+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm400122f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400122f%26sid%3Dliteratum%253Aachs%26aulast%3DFretz%26aufirst%3DH.%26aulast%3DValdenaire%26aufirst%3DA.%26aulast%3DPothier%26aufirst%3DJ.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DPeter%26aufirst%3DO.%26aulast%3DLeroy%26aufirst%3DX.%26aulast%3DRiederer%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%25202-%25282-%25281-Naphthoyl%2529-8-fluoro-3%252C4-dihydro-1H-pyrido%255B4%252C3-b%255Dindol-5%25282H%2529-yl%2529acetic%2520Acid%2520%2528Setipiprant%252FACT-129968%2529%252C%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Chemoattractant%2520Receptor-Homologous%2520Molecule%2520Expressed%2520on%2520Th2%2520Cells%2520%2528CRTH2%2529%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4899%26epage%3D4911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tumey, L. N.</span><span> </span><span class="NLM_article-title">CRTH2 antagonists</span>. In  <span class="citation_source-book">Anti-Inflammatory Drug Discovery</span>; <span class="NLM_series">RSC Drug Discovery Series</span>, Vol.  <span class="NLM_volume">26</span>; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1039%2F9781849735346-00104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=104-134&author=L.+N.+Tumey&title=Anti-Inflammatory+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1039%2F9781849735346-00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849735346-00104%26sid%3Dliteratum%253Aachs%26aulast%3DTumey%26aufirst%3DL.%2BN.%26atitle%3DCRTH2%2520antagonists%26btitle%3DAnti-Inflammatory%2520Drug%2520Discovery%26volume%3D26%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2012%26spage%3D104%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Valdenaire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renneberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H.</span><span> </span><span class="NLM_article-title">Evolution of novel tricyclic CRTh2 receptor antagonists from a (<i>E</i>)-2-cyano-3-(1<i>H</i>-indol-3-yl)acrylamide scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">944</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=944-948&author=A.+Valdenaireauthor=J.+Pothierauthor=D.+Rennebergauthor=M.+A.+Riedererauthor=O.+Peterauthor=X.+Leroyauthor=C.+Gnerreauthor=H.+Fretz&title=Evolution+of+novel+tricyclic+CRTh2+receptor+antagonists+from+a+%28E%29-2-cyano-3-%281H-indol-3-yl%29acrylamide+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValdenaire%26aufirst%3DA.%26aulast%3DPothier%26aufirst%3DJ.%26aulast%3DRenneberg%26aufirst%3DD.%26aulast%3DRiederer%26aufirst%3DM.%2BA.%26aulast%3DPeter%26aufirst%3DO.%26aulast%3DLeroy%26aufirst%3DX.%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DFretz%26aufirst%3DH.%26atitle%3DEvolution%2520of%2520novel%2520tricyclic%2520CRTh2%2520receptor%2520antagonists%2520from%2520a%2520%2528E%2529-2-cyano-3-%25281H-indol-3-yl%2529acrylamide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D944%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Andres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buil, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calbet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenech, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehner, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevilla, S.</span><span> </span><span class="NLM_article-title">2-(1<i>H</i>-Pyrazol-4-yl)acetic acids as CRTh2 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3349</span><span class="NLM_x">–</span> <span class="NLM_lpage">3353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3349-3353&author=M.+Andresauthor=M.+Bravoauthor=M.+A.+Builauthor=M.+Calbetauthor=J.+Castroauthor=T.+Domenechauthor=P.+Eichhornauthor=M.+Ferrerauthor=E.+Gomezauthor=M.+D.+Lehnerauthor=I.+Morenoauthor=R.+S.+Robertsauthor=S.+Sevilla&title=2-%281H-Pyrazol-4-yl%29acetic+acids+as+CRTh2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndres%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DM.%26aulast%3DBuil%26aufirst%3DM.%2BA.%26aulast%3DCalbet%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DEichhorn%26aufirst%3DP.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DE.%26aulast%3DLehner%26aufirst%3DM.%2BD.%26aulast%3DMoreno%26aufirst%3DI.%26aulast%3DRoberts%26aufirst%3DR.%2BS.%26aulast%3DSevilla%26aufirst%3DS.%26atitle%3D2-%25281H-Pyrazol-4-yl%2529acetic%2520acids%2520as%2520CRTh2%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3349%26epage%3D3353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Lamers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flesch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merk, D.</span><span> </span><span class="NLM_article-title">Novel prostaglandin receptor modulators: a patent review (2002–2012), part I: Non-EP receptor modulators</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1517%2F13543776.2013.736495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCksr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=47-77&author=C.+Lamersauthor=D.+Fleschauthor=M.+Schubert-Zsilaveczauthor=D.+Merk&title=Novel+prostaglandin+receptor+modulators%3A+a+patent+review+%282002%E2%80%932012%29%2C+part+I%3A+Non-EP+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11eR"><div class="casContent"><span class="casTitleNuber">11e</span><div class="casTitle"><span class="NLM_cas:atitle">Novel prostaglandin receptor modulators: a patent review (2002 - 2012) - part I: non-EP receptor modulators</span></div><div class="casAuthors">Lamers, Christina; Flesch, Daniel; Schubert-Zsilavecz, Manfred; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-77</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Prostaglandins and their G-protein coupled receptors play numerous physiol. and pathophysiol. roles esp. in inflammation and its resoln.  The variety of physiol. effects mediated by prostanoids makes prostanoid receptors valuable drug targets and the research on prostaglandin receptor modulators is intensive.  Prostaglandin receptor targeting drugs might be beneficial for the treatment of inflammatory, allergic, respiratory and cardiovascular disorders as well as treatment of pain but several novel fields of use such as cancer and ophthalmic diseases have also been found apart from these classical indications.Areas covered: Evaluation of the patent activity over the last decade (2002 - 2012) illustrates many potent and selective modulators of the distinct prostanoid receptors and some novel methods for their use besides the classical indications.  By now, some prostaglandin receptor antagonists already have reached clin. development.Expert opinion: Though the structural diversity of compds. targeting prostanoid receptors is not really large, several highly potent agents with favorable properties have been developed.  The clin. potential of FP, IP, TP and DP modulators remains to be investigated, while first very promising clin. results are available as far as CRTH2 is concerned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw1AUIH0apC7Vg90H21EOLACvtfcHk0lhG1R2TksC4qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCksr3L&md5=99434046685e153cf2a350f342022b50</span></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.736495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.736495%26sid%3Dliteratum%253Aachs%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DFlesch%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DNovel%2520prostaglandin%2520receptor%2520modulators%253A%2520a%2520patent%2520review%2520%25282002%25E2%2580%25932012%2529%252C%2520part%2520I%253A%2520Non-EP%2520receptor%2520modulators%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D47%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Sandham, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschauer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Docx, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furegati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalthoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meingassner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Profit, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span> </span><span class="NLM_article-title">Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6582</span><span class="NLM_x">–</span> <span class="NLM_lpage">6591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6582-6591&author=D.+A.+Sandhamauthor=N.+Arnoldauthor=H.+Aschauerauthor=K.+Balaauthor=L.+Barkerauthor=L.+Brownauthor=Z.+Brownauthor=D.+Buddauthor=B.+Coxauthor=C.+Docxauthor=G.+Duboisauthor=N.+Dugganauthor=K.+Englandauthor=B.+Everattauthor=M.+Furegatiauthor=E.+Hallauthor=F.+Kalthoffauthor=A.+Kingauthor=C.+J.+Leblancauthor=J.+Maniniauthor=J.+Meingassnerauthor=R.+Profitauthor=A.+Schmidtauthor=J.+Simmonsauthor=B.+Sohalauthor=R.+Stringerauthor=M.+Thomasauthor=K.+L.+Turnerauthor=C.+Walkerauthor=S.+J.+Watsonauthor=J.+Westwickauthor=J.+Willisauthor=G.+Williamsauthor=C.+Wilson&title=Discovery+and+characterization+of+NVP-QAV680%2C+a+potent+and+selective+CRTh2+receptor+antagonist+suitable+for+clinical+testing+in+allergic+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandham%26aufirst%3DD.%2BA.%26aulast%3DArnold%26aufirst%3DN.%26aulast%3DAschauer%26aufirst%3DH.%26aulast%3DBala%26aufirst%3DK.%26aulast%3DBarker%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DZ.%26aulast%3DBudd%26aufirst%3DD.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DDocx%26aufirst%3DC.%26aulast%3DDubois%26aufirst%3DG.%26aulast%3DDuggan%26aufirst%3DN.%26aulast%3DEngland%26aufirst%3DK.%26aulast%3DEveratt%26aufirst%3DB.%26aulast%3DFuregati%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DE.%26aulast%3DKalthoff%26aufirst%3DF.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DLeblanc%26aufirst%3DC.%2BJ.%26aulast%3DManini%26aufirst%3DJ.%26aulast%3DMeingassner%26aufirst%3DJ.%26aulast%3DProfit%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DSimmons%26aufirst%3DJ.%26aulast%3DSohal%26aufirst%3DB.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DTurner%26aufirst%3DK.%2BL.%26aulast%3DWalker%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DS.%2BJ.%26aulast%3DWestwick%26aufirst%3DJ.%26aulast%3DWillis%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DWilson%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520NVP-QAV680%252C%2520a%2520potent%2520and%2520selective%2520CRTh2%2520receptor%2520antagonist%2520suitable%2520for%2520clinical%2520testing%2520in%2520allergic%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6582%26epage%3D6591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mahadevan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKew, J. C.</span><span> </span><span class="NLM_article-title">A general method for C3 reductive alkylation of indoles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4589</span><span class="NLM_x">–</span> <span class="NLM_lpage">4591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=4589-4591&author=A.+Mahadevanauthor=H.+Sardauthor=M.+Gonzalezauthor=J.+C.+McKew&title=A+general+method+for+C3+reductive+alkylation+of+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DA.%26aulast%3DSard%26aufirst%3DH.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DMcKew%26aufirst%3DJ.%2BC.%26atitle%3DA%2520general%2520method%2520for%2520C3%2520reductive%2520alkylation%2520of%2520indoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D4589%26epage%3D4591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bowman, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridge, C. F.</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">4051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1080%2F00397919908085926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Slurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bowman%2C+W.+R.%3B+Bridge%2C+C.+F.Synth.+Commun.+1999%2C+29+%2822%29+4051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of N-alkyl pyridones</span></div><div class="casAuthors">Bowman, W. Russell; Bridge, Colin F.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4051-4059</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The regioselective synthesis of N-alkyl pyridones can be facilitated by alkylation of 2-methoxypyridines with activated halides.  The syntheses are facile and high yielding with no traces of 2-alkoxypyridines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOQRTyum22LLVg90H21EOLACvtfcHk0ljj7VYa5Z4gYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Slurc%253D&md5=d71f06683cab10582394891489ee3bc9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F00397919908085926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919908085926%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DW.%2BR.%26aulast%3DBridge%26aufirst%3DC.%2BF.%26jtitle%3DSynth.%2520Commun.%26date%3D1999%26volume%3D29%26issue%3D22%26spage%3D4051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naughton, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parveen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threadgill, M. D.</span><span> </span><span class="NLM_article-title"><i>N</i>- and <i>O</i>-Alkylation of isoquinolin-1-ones in the Mitsunobu reaction: development of potential drug delivery systems</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=335-340&author=S.+Ferrerauthor=D.+P.+Naughtonauthor=I.+Parveenauthor=M.+D.+Threadgill&title=N-+and+O-Alkylation+of+isoquinolin-1-ones+in+the+Mitsunobu+reaction%3A+development+of+potential+drug+delivery+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DNaughton%26aufirst%3DD.%2BP.%26aulast%3DParveen%26aufirst%3DI.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DN-%2520and%2520O-Alkylation%2520of%2520isoquinolin-1-ones%2520in%2520the%2520Mitsunobu%2520reaction%253A%2520development%2520of%2520potential%2520drug%2520delivery%2520systems%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D2002%26spage%3D335%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Horning, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacasse, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, J. M.</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2796</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Horning%2C+D.+E.%3B+Lacasse%2C+G.%3B+Muchowski%2C+J.+M.Can.+J.+Chem.+1971%2C+49%2C+2785%E2%80%932796"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorning%26aufirst%3DD.%2BE.%26aulast%3DLacasse%26aufirst%3DG.%26aulast%3DMuchowski%26aufirst%3DJ.%2BM.%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1971%26volume%3D49%26spage%3D2785%26epage%3D2796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwahn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güssregen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreuder, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmeister, A.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors based on a tetrahydro-1(2<i>H</i>)-isoquinolinone scaffold: synthesis, biological evaluation and X-ray crystal structure</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">1550</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1055%2Fs-2005-865324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFOktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=1550-1554&author=S.+Peukertauthor=U.+Schwahnauthor=S.+G%C3%BCssregenauthor=H.+Schreuderauthor=A.+Hofmeister&title=Poly%28ADP-ribose%29+polymerase-1+%28PARP-1%29+inhibitors+based+on+a+tetrahydro-1%282H%29-isoquinolinone+scaffold%3A+synthesis%2C+biological+evaluation+and+X-ray+crystal+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors based on a tetrahydro-1(2H)-isoquinolinone scaffold: Synthesis, biological evaluation and X-ray crystal structure</span></div><div class="casAuthors">Peukert, Stefan; Schwahn, Uwe; Guessregen, Stefan; Schreuder, Herman; Hofmeister, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1550-1554</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The synthesis, activity and phys. properties of two series of novel potent tetrahydro-1(2H)-isoquinolinone based PARP-1 inhibitors I (R1 = H, Me; R2 = MeCO, HOCH2, MeSO2, F3C, Me2NHCO, etc.) and II [R3 = n-Bu, Me2NCH2CH2, 3-pyridylmethyl, nicotinoyl, etc., R4 = H; R3R4 = (CH2)4; R3 = PhCH2, R4 = 1-methylimidazol-2-ylmethyl] are described.  The new structural classes with a non-planar ring system interact specifically with the PARP-1 protein at the nicotinamide-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfwetqoHTtDrVg90H21EOLACvtfcHk0ljj7VYa5Z4gYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFOktb0%253D&md5=f5168800db2546316a2f8bfd942df808</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1055%2Fs-2005-865324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2005-865324%26sid%3Dliteratum%253Aachs%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DSchwahn%26aufirst%3DU.%26aulast%3DG%25C3%25BCssregen%26aufirst%3DS.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DHofmeister%26aufirst%3DA.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase-1%2520%2528PARP-1%2529%2520inhibitors%2520based%2520on%2520a%2520tetrahydro-1%25282H%2529-isoquinolinone%2520scaffold%253A%2520synthesis%252C%2520biological%2520evaluation%2520and%2520X-ray%2520crystal%2520structure%26jtitle%3DSynthesis%26date%3D2005%26spage%3D1550%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Long, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sypek, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, S. J.</span><span> </span><span class="NLM_article-title">Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1165%2Frcmb.2005-0451OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=16645179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVCqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2006&pages=357-365&author=A.+J.+Longauthor=J.+P.+Sypekauthor=R.+Askewauthor=S.+C.+Fishauthor=L.+E.+Masonauthor=C.+M.+Williamsauthor=S.+J.+Goldman&title=Gob-5+contributes+to+goblet+cell+hyperplasia+and+modulates+pulmonary+tissue+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation</span></div><div class="casAuthors">Long, Andrew J.; Sypek, Joseph P.; Askew, Roger; Fish, Susan C.; Mason, Lawrence E.; Williams, Cara M. M.; Goldman, Samuel J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Gob-5 is a member of the calcium-activated chloride channel family and has been assocd. with allergic response in mouse models of pulmonary inflammation.  Gene expression of Gob-5 has been shown to be induced in allergic airways and has been strongly assocd. with mucin gene regulation and goblet cell hyperplasia.  The authors investigated the physiol. role of Gob-5 in murine models of pulmonary inflammation using mice deficient in Gob-5.  After sensitization and aerosol challenge with ovalbumin (OVA), Gob-5 knockout mice exhibit significantly increased bronchoalveolar lavage (BAL) inflammation as compared with wild-type controls.  The augmented inflammation in BAL consisted predominantly of neutrophils.  Examn. of perivascular inflammation revealed that tissue inflammation was decreased in OVA-challenged Gob-5-/- mice.  OVA-challenged Gob-5 knockout mice also had decreased goblet cell hyperplasia as well as decreased mucus prodn.  These mice also had decreased airway hypersensitivity after cholinergic provocation with methacholine.  Gob-5 knockout mice were also challenged via intranasal LPS, a TLR-4 agonist.  Gob-5-/- mice responded with increased neutrophilic BAL inflammation and decreased perivascular tissue inflammation as compared with wild-type controls.  There was little effect on goblet cell hyperplasia and mucus prodn. after LPS challenge.  These observations reinforce findings that assoc. Gob-5 with goblet cell hyperplasia and mucus prodn. in the allergic immune response, but also implicate Gob-5 in the regulation of tissue inflammation in the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqplVl3cGYKXLVg90H21EOLACvtfcHk0lg3LTQ7cY_WyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVCqtrY%253D&md5=9f3db4194a906caec345e736f4d53ae7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2005-0451OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2005-0451OC%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DA.%2BJ.%26aulast%3DSypek%26aufirst%3DJ.%2BP.%26aulast%3DAskew%26aufirst%3DR.%26aulast%3DFish%26aufirst%3DS.%2BC.%26aulast%3DMason%26aufirst%3DL.%2BE.%26aulast%3DWilliams%26aufirst%3DC.%2BM.%26aulast%3DGoldman%26aufirst%3DS.%2BJ.%26atitle%3DGob-5%2520contributes%2520to%2520goblet%2520cell%2520hyperplasia%2520and%2520modulates%2520pulmonary%2520tissue%2520inflammation%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2006%26volume%3D35%26spage%3D357%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abraham, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabater, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauredo, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botvinnikova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjercke, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revelle, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, I. L.</span><span> </span><span class="NLM_article-title">Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1164%2Fajrccm.159.4.9806002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=10194167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A280%3ADyaK1M3htVeltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=1999&pages=1205-1214&author=W.+M.+Abrahamauthor=A.+Ahmedauthor=J.+R.+Sabaterauthor=I.+T.+Lauredoauthor=Y.+Botvinnikovaauthor=R.+J.+Bjerckeauthor=X.+Huauthor=B.+M.+Revelleauthor=T.+P.+Koganauthor=I.+L.+Scott&title=Selectin+blockade+prevents+antigen-induced+late+bronchial+responses+and+airway+hyperresponsiveness+in+allergic+sheep"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep</span></div><div class="casAuthors">Abraham W M; Ahmed A; Sabater J R; Lauredo I T; Botvinnikova Y; Bjercke R J; Hu X; Revelle B M; Kogan T P; Scott I L; Dixon R A; Yeh E T; Beck P J</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4 Pt 1</span>),
    <span class="NLM_cas:pages">1205-14</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Antigen challenge can elicit an allergic inflammatory response in the airways that involves eosinophils, basophils, and neutrophils and that is expressed physiologically as a late airway response (LAR) and airway hyperresponsiveness (AHR).  Although previous studies have suggested that E-selectin participates in these allergic airway responses, there is little information concerning the role of L-selectin.  To address this question, we examined the effects of administering an L-selectin-specific monoclonal antibody, DU1-29, as well as three small molecule selectin binding inhibitors, on the development of early airway responses (EAR), LAR and AHR in allergic sheep undergoing airway challenge with Ascaris suum antigen.  Sheep treated with aerosol DU1-29 before antigen challenge had a significantly reduced LAR and did not develop postchallenge AHR.  No protective effect was seen when sheep were treated with a nonspecific control monoclonal antibody.  Treatment with DU1-29 also reduced the severity of the EAR to antigen.  Similar results were obtained with each of the three small molecule selectin inhibitors at doses that depended on their L-, but not necessarily E-selectin inhibitory capacity.  The inhibition of the EAR with one of the inhibitors, TBC-1269, was associated with a reduction in histamine release.  Likewise, treatment with TBC-1269 reduced the number of neutrophils recovered in bronchoalveolar lavage (BAL) during the time of LAR and AHR.  TBC-1269, given 90 min after antigen challenge also blocked the LAR and the AHR, but this protection was lost if the treatment was withheld until 4 h after challenge, a result consistent with the proposed time course of L-selectin involvement in leukocyte trafficking.  These are the first data indicating that L-selectin may have a unique cellular function that modulates allergen-induced pulmonary responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTv12xzCsvkk8RAV4D_Ins_fW6udTcc2eZ_g5q2C-pIC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3htVeltg%253D%253D&md5=ec9baba5fe245699940d9b62a7044b14</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.159.4.9806002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.159.4.9806002%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DW.%2BM.%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DSabater%26aufirst%3DJ.%2BR.%26aulast%3DLauredo%26aufirst%3DI.%2BT.%26aulast%3DBotvinnikova%26aufirst%3DY.%26aulast%3DBjercke%26aufirst%3DR.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DRevelle%26aufirst%3DB.%2BM.%26aulast%3DKogan%26aufirst%3DT.%2BP.%26aulast%3DScott%26aufirst%3DI.%2BL.%26atitle%3DSelectin%2520blockade%2520prevents%2520antigen-induced%2520late%2520bronchial%2520responses%2520and%2520airway%2520hyperresponsiveness%2520in%2520allergic%2520sheep%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1999%26volume%3D159%26spage%3D1205%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Abraham, W. M.</span><span> </span><span class="NLM_article-title">Modeling of asthma, COPD and cystic fibrosis in sheep</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1016%2Fj.pupt.2008.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=18339565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2jtLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=743-754&author=W.+M.+Abraham&title=Modeling+of+asthma%2C+COPD+and+cystic+fibrosis+in+sheep"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling of asthma, COPD and cystic fibrosis in sheep</span></div><div class="casAuthors">Abraham, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">743-754</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sheep naturally allergic to Ascaris suum antigen have been used to study the pathophysiol. of asthma and more recently allergic rhinitis, chronic obstructive pulmonary disease (COPD) and cystic fibrosis.  The utility of the model as it relates to the study of these diseases is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXZ8N7v4f_-LVg90H21EOLACvtfcHk0lg3LTQ7cY_WyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2jtLfJ&md5=47182ec714f412eb27b14be7d7a2a643</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2008.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2008.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DW.%2BM.%26atitle%3DModeling%2520of%2520asthma%252C%2520COPD%2520and%2520cystic%2520fibrosis%2520in%2520sheep%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D21%26spage%3D743%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mellor, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, E. J.</span><span> </span><span class="NLM_article-title">Aspects of the Chemistry of Dioxolanes: Synthesis of C-Nucleoside Analogues</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=243-256&author=B.+J.+Mellorauthor=P.+E.+Murrayauthor=E.+J.+Thomas&title=Aspects+of+the+Chemistry+of+Dioxolanes%3A+Synthesis+of+C-Nucleoside+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DB.%2BJ.%26aulast%3DMurray%26aufirst%3DP.%2BE.%26aulast%3DThomas%26aufirst%3DE.%2BJ.%26atitle%3DAspects%2520of%2520the%2520Chemistry%2520of%2520Dioxolanes%253A%2520Synthesis%2520of%2520C-Nucleoside%2520Analogues%26jtitle%3DTetrahedron%26date%3D1998%26volume%3D54%26spage%3D243%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11e','cit11f'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Qian Wang, Kumchok C. Mgimpatsang, Xin Li, <span class="NLM_string-name hlFld-ContribAuthor">Alexander Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">Isoquinolone-4-Carboxylic Acids by Ammonia-Ugi-4CR and Copper-Catalyzed Domino Reaction. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (14)
                                     , 9771-9780. <a href="https://doi.org/10.1021/acs.joc.1c01170" title="DOI URL">https://doi.org/10.1021/acs.joc.1c01170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c01170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c01170%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIsoquinolone-4-Carboxylic%252BAcids%252Bby%252BAmmonia-Ugi-4CR%252Band%252BCopper-Catalyzed%252BDomino%252BReaction%26aulast%3DWang%26aufirst%3DQian%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19052021%26date%3D29062021%26volume%3D86%26issue%3D14%26spage%3D9771%26epage%3D9780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaoyi Zhu, Ruibo Li, Hequan Yao, <span class="NLM_string-name hlFld-ContribAuthor">Aijun Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Allenamide Carbopalladation/Allylation with Active Methine Compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (12)
                                     , 4630-4634. <a href="https://doi.org/10.1021/acs.orglett.1c01369" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01369%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BAllenamide%252BCarbopalladation%25252FAllylation%252Bwith%252BActive%252BMethine%252BCompounds%26aulast%3DZhu%26aufirst%3DXiaoyi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D20042021%26date%3D28052021%26volume%3D23%26issue%3D12%26spage%3D4630%26epage%3D4634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sen Zhou, Xiaoya Hou, Kai Yang, Minjie Guo, Wentao Zhao, Xiangyang Tang, <span class="NLM_string-name hlFld-ContribAuthor">Guangwei Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Synthesis of N-Difluoromethyl-2-pyridones from Pyridines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (9)
                                     , 6879-6887. <a href="https://doi.org/10.1021/acs.joc.1c00228" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00228%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BSynthesis%252Bof%252BN-Difluoromethyl-2-pyridones%252Bfrom%252BPyridines%26aulast%3DZhou%26aufirst%3DSen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D29012021%26date%3D27042021%26volume%3D86%26issue%3D9%26spage%3D6879%26epage%3D6887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Juan Tang, Xue Chen, Chao-qun Zhao, Wen-jing Li, Shun Li, Xue-li Zheng, Mao-lin Yuan, Hai-yan Fu, Rui-xiang Li, <span class="NLM_string-name hlFld-ContribAuthor">Hua Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Iodination/Amidation of the N-Alkyl (Iso)quinolinium Salts. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (1)
                                     , 716-730. <a href="https://doi.org/10.1021/acs.joc.0c02321" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02321</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02321%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIodination%25252FAmidation%252Bof%252Bthe%252BN-Alkyl%252B%252528Iso%252529quinolinium%252BSalts%26aulast%3DTang%26aufirst%3DJuan%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D30092020%26date%3D02122020%26volume%3D86%26issue%3D1%26spage%3D716%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Adrien Dumas, Jean-Baptiste Garsi, Guillaume Poissonnet, <span class="NLM_string-name hlFld-ContribAuthor">Stephen Hanessian</span>. </span><span class="cited-content_cbyCitation_article-title">Ni-Catalyzed Reductive and Merged Photocatalytic Cross-Coupling Reactions toward sp3/sp2-Functionalized Isoquinolones: Creating Diversity at C-6 and C-7 to Address Bioactive Analogues. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (42)
                                     , 27591-27606. <a href="https://doi.org/10.1021/acsomega.0c04181" title="DOI URL">https://doi.org/10.1021/acsomega.0c04181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c04181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c04181%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DNi-Catalyzed%252BReductive%252Band%252BMerged%252BPhotocatalytic%252BCross-Coupling%252BReactions%252Btoward%252Bsp3%25252Fsp2-Functionalized%252BIsoquinolones%25253A%252BCreating%252BDiversity%252Bat%252BC-6%252Band%252BC-7%252Bto%252BAddress%252BBioactive%252BAnalogues%26aulast%3DDumas%26aufirst%3DAdrien%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28082020%26date%3D22092020%26date%3D16102020%26volume%3D5%26issue%3D42%26spage%3D27591%26epage%3D27606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anand Kumar Pandey, Shiv Chand, Rahul Singh, Saurabh Kumar, <span class="NLM_string-name hlFld-ContribAuthor">Krishna Nand Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-Catalyzed Synthesis of 3-Arylthioindoles Employing a 1-Aryltriazene/CS2 Combination as a New Sulfenylation Source. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (13)
                                     , 7627-7635. <a href="https://doi.org/10.1021/acsomega.0c00472" title="DOI URL">https://doi.org/10.1021/acsomega.0c00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c00472%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DIodine-Catalyzed%252BSynthesis%252Bof%252B3-Arylthioindoles%252BEmploying%252Ba%252B1-Aryltriazene%25252FCS2%252BCombination%252Bas%252Ba%252BNew%252BSulfenylation%252BSource%26aulast%3DPandey%26aufirst%3DAnand%2BKumar%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03022020%26date%3D13032020%26date%3D24032020%26volume%3D5%26issue%3D13%26spage%3D7627%26epage%3D7635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zaixiang Fang, Yi Wang, <span class="NLM_string-name hlFld-ContribAuthor">Yuanhua Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-Iodoisoquinolin-1(2H)-ones by a Dirhodium(II)-Catalyzed 1,4-Bisfunctionalization of Isoquinolinium Iodide Salts. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (2)
                                     , 434-438. <a href="https://doi.org/10.1021/acs.orglett.8b03614" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b03614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b03614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b03614%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252B4-Iodoisoquinolin-1%2525282H%252529-ones%252Bby%252Ba%252BDirhodium%252528II%252529-Catalyzed%252B1%25252C4-Bisfunctionalization%252Bof%252BIsoquinolinium%252BIodide%252BSalts%26aulast%3DFang%26aufirst%3DZaixiang%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13112018%26date%3D07012019%26volume%3D21%26issue%3D2%26spage%3D434%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">You-Quan Zhu, Jing-Li He, Yun-Xia Niu, Hui-Ying Kang, Ting-Feng Han, <span class="NLM_string-name hlFld-ContribAuthor">Hao-Yu Li</span>. </span><span class="cited-content_cbyCitation_article-title">AgSbF6-Mediated Selective Thiolation and Selenylation at C-4 Position of Isoquinolin-1(2H)-ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (17)
                                     , 9958-9967. <a href="https://doi.org/10.1021/acs.joc.8b01361" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01361%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAgSbF6-Mediated%252BSelective%252BThiolation%252Band%252BSelenylation%252Bat%252BC-4%252BPosition%252Bof%252BIsoquinolin-1%2525282H%252529-ones%26aulast%3DZhu%26aufirst%3DYou-Quan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30052018%26date%3D20072018%26date%3D11072018%26volume%3D83%26issue%3D17%26spage%3D9958%26epage%3D9967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linjun  Qi</span>, <span class="hlFld-ContribAuthor ">Kun  Hu</span>, <span class="hlFld-ContribAuthor ">Shuling  Yu</span>, <span class="hlFld-ContribAuthor ">Jianghe  Zhu</span>, <span class="hlFld-ContribAuthor ">Tianxing  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Jiuxi  Chen</span>, and <span class="hlFld-ContribAuthor ">Huayue  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Tandem Addition/Cyclization for Access to Isoquinolines and Isoquinolones via Catalytic Carbopalladation of Nitriles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (1)
                                     , 218-221. <a href="https://doi.org/10.1021/acs.orglett.6b03499" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03499%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTandem%252BAddition%25252FCyclization%252Bfor%252BAccess%252Bto%252BIsoquinolines%252Band%252BIsoquinolones%252Bvia%252BCatalytic%252BCarbopalladation%252Bof%252BNitriles%26aulast%3DQi%26aufirst%3DLinjun%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D23112016%26date%3D27122016%26date%3D06012017%26volume%3D19%26issue%3D1%26spage%3D218%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Shinmee  Mah</span>, and <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>  . </span><span class="cited-content_cbyCitation_article-title">Catalyst Controlled Divergent C4/C8 Site-Selective C–H Arylation of Isoquinolones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (15)
                                     , 3864-3867. <a href="https://doi.org/10.1021/acs.orglett.5b01840" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b01840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b01840%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalyst%252BControlled%252BDivergent%252BC4%25252FC8%252BSite-Selective%252BC%2525E2%252580%252593H%252BArylation%252Bof%252BIsoquinolones%26aulast%3DLee%26aufirst%3DSoyoung%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D26062015%26date%3D28072015%26date%3D07082015%26volume%3D17%26issue%3D15%26spage%3D3864%26epage%3D3867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentine G.  Nenajdenko</span>, <span class="hlFld-ContribAuthor ">Vasiliy M.  Muzalevskiy</span>, and <span class="hlFld-ContribAuthor ">Aleksey V.  Shastin</span>  . </span><span class="cited-content_cbyCitation_article-title">Polyfluorinated Ethanes as Versatile Fluorinated C2-Building Blocks for Organic Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2015,</strong> <em>115 </em>
                                    (2)
                                     , 973-1050. <a href="https://doi.org/10.1021/cr500465n" title="DOI URL">https://doi.org/10.1021/cr500465n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500465n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500465n%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPolyfluorinated%252BEthanes%252Bas%252BVersatile%252BFluorinated%252BC2-Building%252BBlocks%252Bfor%252BOrganic%252BSynthesis%26aulast%3DNenajdenko%26aufirst%3DValentine%2BG.%26date%3D2015%26date%3D2015%26date%3D2013%26date%3D15102013%26date%3D16012015%26date%3D28012015%26volume%3D115%26issue%3D2%26spage%3D973%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yangxiu  Mu</span>, <span class="hlFld-ContribAuthor ">Minghua  Yang</span>, <span class="hlFld-ContribAuthor ">Fengxia  Li</span>, <span class="hlFld-ContribAuthor ">Zafar  Iqbal</span>, <span class="hlFld-ContribAuthor ">Rui  Jiang</span>, <span class="hlFld-ContribAuthor ">Jing  Hou</span>, <span class="hlFld-ContribAuthor ">Xin  Guo</span>, <span class="hlFld-ContribAuthor ">Zhixiang  Yang</span>, <span class="hlFld-ContribAuthor ">Dong  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-catalyzed sulfuration of isoquinolin-1(2
              H
              )-ones applying ethyl sulfinates. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (11)
                                     , 4934-4937. <a href="https://doi.org/10.1039/D1NJ00390A" title="DOI URL">https://doi.org/10.1039/D1NJ00390A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1NJ00390A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1NJ00390A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DIodine-catalyzed%252Bsulfuration%252Bof%252Bisoquinolin-1%2525282%252BH%252B%252529-ones%252Bapplying%252Bethyl%252Bsulfinates%26aulast%3DMu%26aufirst%3DYangxiu%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D11%26spage%3D4934%26epage%3D4937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cai‐Yun  Yang</span>, <span class="hlFld-ContribAuthor ">Xia  Li</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Guo‐Li  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">I
              2
              ‐Promoted Direct C−H Sulfenylation of Isoquinolin‐1(2
              H
              )‐ones with Sulfonyl Chlorides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (1)
                                     , 117-124. <a href="https://doi.org/10.1002/ejoc.202001371" title="DOI URL">https://doi.org/10.1002/ejoc.202001371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001371%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DI%252B2%252B%2525E2%252580%252590Promoted%252BDirect%252BC%2525E2%252588%252592H%252BSulfenylation%252Bof%252BIsoquinolin%2525E2%252580%2525901%2525282%252BH%252B%252529%2525E2%252580%252590ones%252Bwith%252BSulfonyl%252BChlorides%26aulast%3DYang%26aufirst%3DCai%25E2%2580%2590Yun%26date%3D2021%26date%3D2020%26volume%3D2021%26issue%3D1%26spage%3D117%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanglong  Pan</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>, <span class="hlFld-ContribAuthor ">Wentao  Wang</span>, <span class="hlFld-ContribAuthor ">Yurong  Tang</span>, <span class="hlFld-ContribAuthor ">Yunfei  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Heterogeneous photocatalytic cyanomethylarylation of alkenes with acetonitrile: synthesis of diverse nitrogenous heterocyclic compounds. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>17 </em>, 1171-1180. <a href="https://doi.org/10.3762/bjoc.17.89" title="DOI URL">https://doi.org/10.3762/bjoc.17.89</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.17.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.17.89%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DHeterogeneous%252Bphotocatalytic%252Bcyanomethylarylation%252Bof%252Balkenes%252Bwith%252Bacetonitrile%25253A%252Bsynthesis%252Bof%252Bdiverse%252Bnitrogenous%252Bheterocyclic%252Bcompounds%26aulast%3DPan%26aufirst%3DGuanglong%26date%3D2021%26date%3D2021%26volume%3D17%26spage%3D1171%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Liu</span>, <span class="hlFld-ContribAuthor ">Yajun  Wang</span>, <span class="hlFld-ContribAuthor ">Dan  Song</span>, <span class="hlFld-ContribAuthor ">Yuhan  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical regioselective selenylation/oxidation of
              N
              -alkylisoquinolinium salts
              via
              double C(sp
              2
              )–H bond functionalization. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (97)
                                     , 15325-15328. <a href="https://doi.org/10.1039/D0CC06778D" title="DOI URL">https://doi.org/10.1039/D0CC06778D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC06778D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC06778D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DElectrochemical%252Bregioselective%252Bselenylation%25252Foxidation%252Bof%252BN%252B-alkylisoquinolinium%252Bsalts%252Bvia%252Bdouble%252BC%252528sp%252B2%252B%252529%2525E2%252580%252593H%252Bbond%252Bfunctionalization%26aulast%3DLiu%26aufirst%3DXiang%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D97%26spage%3D15325%26epage%3D15328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youkang  Zhou</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Zhiming  Xing</span>, <span class="hlFld-ContribAuthor ">Jiali  Guan</span>, <span class="hlFld-ContribAuthor ">Zhibin  Song</span>, <span class="hlFld-ContribAuthor ">Yiyuan  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">External-photocatalyst-free visible-light-mediated aerobic oxidation and 1,4-bisfunctionalization of
              N
              -alkyl isoquinolinium salts. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (17)
                                     , 2405-2413. <a href="https://doi.org/10.1039/D0QO00663G" title="DOI URL">https://doi.org/10.1039/D0QO00663G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00663G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00663G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DExternal-photocatalyst-free%252Bvisible-light-mediated%252Baerobic%252Boxidation%252Band%252B1%25252C4-bisfunctionalization%252Bof%252BN%252B-alkyl%252Bisoquinolinium%252Bsalts%26aulast%3DZhou%26aufirst%3DYoukang%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D17%26spage%3D2405%26epage%3D2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuxuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Fanghui  Ma</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of spiro[imidazolidine-4,3′-indolin]-2′-imines
              via
              copper(
              i
              )-catalyzed formal [2 + 2 + 1] cycloaddition of 3-diazoindolin-2-imines and triazines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (39)
                                     , 8849-8852. <a href="https://doi.org/10.1039/C9OB01767D" title="DOI URL">https://doi.org/10.1039/C9OB01767D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01767D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01767D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPreparation%252Bof%252Bspiro%25255Bimidazolidine-4%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-imines%252Bvia%252Bcopper%252528%252Bi%252B%252529-catalyzed%252Bformal%252B%25255B2%252B%25252B%252B2%252B%25252B%252B1%25255D%252Bcycloaddition%252Bof%252B3-diazoindolin-2-imines%252Band%252Btriazines%26aulast%3DZhou%26aufirst%3DYuxuan%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D39%26spage%3D8849%26epage%3D8852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristina Søborg  Pedersen</span>, <span class="hlFld-ContribAuthor ">Karin Michaelsen  Nielsen</span>, <span class="hlFld-ContribAuthor ">Jesper  Fonslet</span>, <span class="hlFld-ContribAuthor ">Mikael  Jensen</span>, <span class="hlFld-ContribAuthor ">Fedor  Zhuravlev</span>. </span><span class="cited-content_cbyCitation_article-title">Separation of Radiogallium from Zinc Using Membrane-Based Liquid-Liquid Extraction in Flow: Experimental and COSMO-RS Studies. </span><span class="cited-content_cbyCitation_journal-name">Solvent Extraction and Ion Exchange</span><span> <strong>2019,</strong> <em>37 </em>
                                    (5)
                                     , 376-391. <a href="https://doi.org/10.1080/07366299.2019.1646982" title="DOI URL">https://doi.org/10.1080/07366299.2019.1646982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07366299.2019.1646982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07366299.2019.1646982%26sid%3Dliteratum%253Aachs%26jtitle%3DSolvent%2520Extraction%2520and%2520Ion%2520Exchange%26atitle%3DSeparation%252Bof%252BRadiogallium%252Bfrom%252BZinc%252BUsing%252BMembrane-Based%252BLiquid-Liquid%252BExtraction%252Bin%252BFlow%25253A%252BExperimental%252Band%252BCOSMO-RS%252BStudies%26aulast%3DPedersen%26aufirst%3DKristina%2BS%25C3%25B8borg%26date%3D2019%26date%3D2019%26volume%3D37%26issue%3D5%26spage%3D376%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You‐Quan  Zhu</span>, <span class="hlFld-ContribAuthor ">Yun‐Xia  Niu</span>, <span class="hlFld-ContribAuthor ">Li‐Wen  Hui</span>, <span class="hlFld-ContribAuthor ">Jing‐Li  He</span>, <span class="hlFld-ContribAuthor ">Kun  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Reaction of Isoquinolin‐1(2
              H
              )‐Ones with Methylenecyclopropanes via Rhodium(III)‐Catalyzed C−H Activation. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (12)
                                     , 2897-2903. <a href="https://doi.org/10.1002/adsc.201900176" title="DOI URL">https://doi.org/10.1002/adsc.201900176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201900176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201900176%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DReaction%252Bof%252BIsoquinolin%2525E2%252580%2525901%2525282%252BH%252B%252529%2525E2%252580%252590Ones%252Bwith%252BMethylenecyclopropanes%252Bvia%252BRhodium%252528III%252529%2525E2%252580%252590Catalyzed%252BC%2525E2%252588%252592H%252BActivation%26aulast%3DZhu%26aufirst%3DYou%25E2%2580%2590Quan%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D12%26spage%3D2897%26epage%3D2903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emiliya V.  Nosova</span>, <span class="hlFld-ContribAuthor ">Galina N.  Lipunova</span>, <span class="hlFld-ContribAuthor ">Valery N.  Charushin</span>, <span class="hlFld-ContribAuthor ">Oleg N.  Chupakhin</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine-containing indoles: Synthesis and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2018,</strong> <em>212 </em>, 51-106. <a href="https://doi.org/10.1016/j.jfluchem.2018.05.012" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2018.05.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2018.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2018.05.012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DFluorine-containing%252Bindoles%25253A%252BSynthesis%252Band%252Bbiological%252Bactivity%26aulast%3DNosova%26aufirst%3DEmiliya%2BV.%26date%3D2018%26volume%3D212%26spage%3D51%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fanghui  Ma</span>, <span class="hlFld-ContribAuthor ">Jing  Qian</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient synthesis of 2-amino-3-(arylthio)indoles
              via
              the Rh-catalyzed reaction of 3-diazoindol-2-imines with thioesters. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (3)
                                     , 439-443. <a href="https://doi.org/10.1039/C7OB02597A" title="DOI URL">https://doi.org/10.1039/C7OB02597A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02597A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02597A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DConvenient%252Bsynthesis%252Bof%252B2-amino-3-%252528arylthio%252529indoles%252Bvia%252Bthe%252BRh-catalyzed%252Breaction%252Bof%252B3-diazoindol-2-imines%252Bwith%252Bthioesters%26aulast%3DMa%26aufirst%3DFanghui%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D3%26spage%3D439%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amrita  Mondal</span>, <span class="hlFld-ContribAuthor ">Priyanka  Kundu</span>, <span class="hlFld-ContribAuthor ">Moumita  Jash</span>, <span class="hlFld-ContribAuthor ">Chinmay  Chowdhury</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalysed stereoselective synthesis of 4-(diarylmethylidene)-3,4-dihydroisoquinolin-1(2
              H
              )-ones: expedient access to 4-substituted isoquinolin-1(2
              H
              )-ones and isoquinolines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (6)
                                     , 963-980. <a href="https://doi.org/10.1039/C7OB02788E" title="DOI URL">https://doi.org/10.1039/C7OB02788E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02788E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02788E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPalladium-catalysed%252Bstereoselective%252Bsynthesis%252Bof%252B4-%252528diarylmethylidene%252529-3%25252C4-dihydroisoquinolin-1%2525282%252BH%252B%252529-ones%25253A%252Bexpedient%252Baccess%252Bto%252B4-substituted%252Bisoquinolin-1%2525282%252BH%252B%252529-ones%252Band%252Bisoquinolines%26aulast%3DMondal%26aufirst%3DAmrita%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D6%26spage%3D963%26epage%3D980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erwann  Grenet</span>, <span class="hlFld-ContribAuthor ">Ashis  Das</span>, <span class="hlFld-ContribAuthor ">Paola  Caramenti</span>, <span class="hlFld-ContribAuthor ">Jérôme  Waser</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium-catalyzed C–H functionalization of heteroarenes using indoleBX hypervalent iodine reagents. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>14 </em>, 1208-1214. <a href="https://doi.org/10.3762/bjoc.14.102" title="DOI URL">https://doi.org/10.3762/bjoc.14.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.14.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.14.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRhodium-catalyzed%252BC%2525E2%252580%252593H%252Bfunctionalization%252Bof%252Bheteroarenes%252Busing%252BindoleBX%252Bhypervalent%252Biodine%252Breagents%26aulast%3DGrenet%26aufirst%3DErwann%26date%3D2018%26date%3D2018%26volume%3D14%26spage%3D1208%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Anil Kumar</span>, <span class="hlFld-ContribAuthor ">Prakash  Kannaboina</span>, <span class="hlFld-ContribAuthor ">Parthasarathi  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium-catalyzed site-selective C–H arylation of 2-pyridones and 1-isoquinolinones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (26)
                                     , 5457-5461. <a href="https://doi.org/10.1039/C7OB01277B" title="DOI URL">https://doi.org/10.1039/C7OB01277B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB01277B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB01277B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRuthenium-catalyzed%252Bsite-selective%252BC%2525E2%252580%252593H%252Barylation%252Bof%252B2-pyridones%252Band%252B1-isoquinolinones%26aulast%3DAnil%2BKumar%26aufirst%3DK.%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D26%26spage%3D5457%26epage%3D5461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jatinder  Singh</span>, <span class="hlFld-ContribAuthor ">Ramanpreet  Shah</span>, <span class="hlFld-ContribAuthor ">Dhandeep  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases. </span><span class="cited-content_cbyCitation_journal-name">International Immunopharmacology</span><span> <strong>2016,</strong> <em>40 </em>, 362-384. <a href="https://doi.org/10.1016/j.intimp.2016.09.019" title="DOI URL">https://doi.org/10.1016/j.intimp.2016.09.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.intimp.2016.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.intimp.2016.09.019%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Immunopharmacology%26atitle%3DTargeting%252Bmast%252Bcells%25253A%252BUncovering%252Bprolific%252Btherapeutic%252Brole%252Bin%252Bmyriad%252Bdiseases%26aulast%3DSingh%26aufirst%3DJatinder%26date%3D2016%26volume%3D40%26spage%3D362%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Cuperlovic-Culf</span>, <span class="hlFld-ContribAuthor ">A. S.  Culf</span>. </span><span class="cited-content_cbyCitation_article-title">Applied metabolomics in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (8)
                                     , 759-770. <a href="https://doi.org/10.1080/17460441.2016.1195365" title="DOI URL">https://doi.org/10.1080/17460441.2016.1195365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1195365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1195365%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DApplied%252Bmetabolomics%252Bin%252Bdrug%252Bdiscovery%26aulast%3DCuperlovic-Culf%26aufirst%3DM.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D8%26spage%3D759%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stéphanie  Eustache</span>, <span class="hlFld-ContribAuthor ">Jérôme  Leprince</span>, <span class="hlFld-ContribAuthor ">Pierre  Tufféry</span>. </span><span class="cited-content_cbyCitation_article-title">Progress with peptide scanning to study structure-activity relationships: the implications for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (8)
                                     , 771-784. <a href="https://doi.org/10.1080/17460441.2016.1201058" title="DOI URL">https://doi.org/10.1080/17460441.2016.1201058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1201058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1201058%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DProgress%252Bwith%252Bpeptide%252Bscanning%252Bto%252Bstudy%252Bstructure-activity%252Brelationships%25253A%252Bthe%252Bimplications%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DEustache%26aufirst%3DSt%25C3%25A9phanie%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D8%26spage%3D771%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alastair L.  Parkes</span>, <span class="hlFld-ContribAuthor ">Ian A.  Yule</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid antibiotics – clinical progress and novel designs. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (7)
                                     , 665-680. <a href="https://doi.org/10.1080/17460441.2016.1187597" title="DOI URL">https://doi.org/10.1080/17460441.2016.1187597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1187597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1187597%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DHybrid%252Bantibiotics%252B%2525E2%252580%252593%252Bclinical%252Bprogress%252Band%252Bnovel%252Bdesigns%26aulast%3DParkes%26aufirst%3DAlastair%2BL.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D7%26spage%3D665%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno Junior  Neves</span>, <span class="hlFld-ContribAuthor ">Eugene  Muratov</span>, <span class="hlFld-ContribAuthor ">Renato Beilner  Machado</span>, <span class="hlFld-ContribAuthor ">Carolina Horta  Andrade</span>, <span class="hlFld-ContribAuthor ">Pedro Vitor Lemos  Cravo</span>. </span><span class="cited-content_cbyCitation_article-title">Modern approaches to accelerate discovery of new antischistosomal drugs. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , 557-567. <a href="https://doi.org/10.1080/17460441.2016.1178230" title="DOI URL">https://doi.org/10.1080/17460441.2016.1178230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1178230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1178230%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DModern%252Bapproaches%252Bto%252Baccelerate%252Bdiscovery%252Bof%252Bnew%252Bantischistosomal%252Bdrugs%26aulast%3DNeves%26aufirst%3DBruno%2BJunior%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3D557%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sathya  Babu</span>, <span class="hlFld-ContribAuthor ">Santhosh Kumar  Nagarajan</span>, <span class="hlFld-ContribAuthor ">Sung Haeng  Lee</span>, <span class="hlFld-ContribAuthor ">Thirumurthy  Madhavan</span>. </span><span class="cited-content_cbyCitation_article-title">Structural characterization of human CRTh2: a combined homology modeling, molecular docking and 3D-QSAR-based in silico approach. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2016,</strong> <em>25 </em>
                                    (4)
                                     , 653-671. <a href="https://doi.org/10.1007/s00044-016-1516-z" title="DOI URL">https://doi.org/10.1007/s00044-016-1516-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-016-1516-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-016-1516-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DStructural%252Bcharacterization%252Bof%252Bhuman%252BCRTh2%25253A%252Ba%252Bcombined%252Bhomology%252Bmodeling%25252C%252Bmolecular%252Bdocking%252Band%252B3D-QSAR-based%252Bin%252Bsilico%252Bapproach%26aulast%3DBabu%26aufirst%3DSathya%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D4%26spage%3D653%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Yang</span>, <span class="hlFld-ContribAuthor ">Wanmei  Li</span>, <span class="hlFld-ContribAuthor ">Chengcai  Xia</span>, <span class="hlFld-ContribAuthor ">Beibei  Ying</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Controlled Selectivity in C−S Bond Formation: Highly Efficient Synthesis of C2- and C3-Sulfonylindoles. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2016,</strong> <em>8 </em>
                                    (2)
                                     , 304-307. <a href="https://doi.org/10.1002/cctc.201500917" title="DOI URL">https://doi.org/10.1002/cctc.201500917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.201500917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.201500917%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DCatalyst-Controlled%252BSelectivity%252Bin%252BC%2525E2%252588%252592S%252BBond%252BFormation%25253A%252BHighly%252BEfficient%252BSynthesis%252Bof%252BC2-%252Band%252BC3-Sulfonylindoles%26aulast%3DYang%26aufirst%3DYong%26date%3D2016%26date%3D2015%26volume%3D8%26issue%3D2%26spage%3D304%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daoquan  Tu</span>, <span class="hlFld-ContribAuthor ">Xiuzhi  Cheng</span>, <span class="hlFld-ContribAuthor ">Yadong  Gao</span>, <span class="hlFld-ContribAuthor ">Panpan  Yang</span>, <span class="hlFld-ContribAuthor ">Yousong  Ding</span>, <span class="hlFld-ContribAuthor ">Chao  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalysed direct C-2 methylation of indoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (31)
                                     , 7443-7446. <a href="https://doi.org/10.1039/C6OB01281G" title="DOI URL">https://doi.org/10.1039/C6OB01281G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB01281G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB01281G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPalladium-catalysed%252Bdirect%252BC-2%252Bmethylation%252Bof%252Bindoles%26aulast%3DTu%26aufirst%3DDaoquan%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D31%26spage%3D7443%26epage%3D7446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sathya  Babu</span>, <span class="hlFld-ContribAuthor ">Seema A.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Honglae  Sohn</span>, <span class="hlFld-ContribAuthor ">Thirumurthy  Madhavan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of leads through in silico approaches utilizing benzylthio-1H-benzo[d]imidazol-1-yl acetic acid derivatives: A potent CRTh2 antagonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2015,</strong> <em>1102 </em>, 25-41. <a href="https://doi.org/10.1016/j.molstruc.2015.08.031" title="DOI URL">https://doi.org/10.1016/j.molstruc.2015.08.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2015.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2015.08.031%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DIdentification%252Bof%252Bleads%252Bthrough%252Bin%252Bsilico%252Bapproaches%252Butilizing%252Bbenzylthio-1H-benzo%25255Bd%25255Dimidazol-1-yl%252Bacetic%252Bacid%252Bderivatives%25253A%252BA%252Bpotent%252BCRTh2%252Bantagonist%26aulast%3DBabu%26aufirst%3DSathya%26date%3D2015%26volume%3D1102%26spage%3D25%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sathya  Babu</span>, <span class="hlFld-ContribAuthor ">Thirumurthy  Madhavan</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand Based HQSAR Analysis of CRTh2 Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Chosun Natural Science</span><span> <strong>2015,</strong> <em>8 </em>
                                    (1)
                                     , 1-12. <a href="https://doi.org/10.13160/ricns.2015.8.1.1" title="DOI URL">https://doi.org/10.13160/ricns.2015.8.1.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.13160/ricns.2015.8.1.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.13160%2Fricns.2015.8.1.1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Chosun%2520Natural%2520Science%26atitle%3DLigand%252BBased%252BHQSAR%252BAnalysis%252Bof%252BCRTh2%252BAntagonists%26aulast%3DBabu%26aufirst%3DSathya%26date%3D2015%26volume%3D8%26issue%3D1%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacek G.  Sośnicki</span>, <span class="hlFld-ContribAuthor ">Łukasz  Struk</span>, <span class="hlFld-ContribAuthor ">Tomasz  Idzik</span>, <span class="hlFld-ContribAuthor ">Gabriela  Maciejewska</span>. </span><span class="cited-content_cbyCitation_article-title">Scope and limitations of the synthesis of functionalized quinolizidinones and related compounds by a simple precursor approach via addition of lithium allylmagnesates to 2-pyridones and RCM as key steps. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (45)
                                     , 8624-8635. <a href="https://doi.org/10.1016/j.tet.2014.09.043" title="DOI URL">https://doi.org/10.1016/j.tet.2014.09.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.09.043%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DScope%252Band%252Blimitations%252Bof%252Bthe%252Bsynthesis%252Bof%252Bfunctionalized%252Bquinolizidinones%252Band%252Brelated%252Bcompounds%252Bby%252Ba%252Bsimple%252Bprecursor%252Bapproach%252Bvia%252Baddition%252Bof%252Blithium%252Ballylmagnesates%252Bto%252B2-pyridones%252Band%2525C2%2525A0RCM%252Bas%252Bkey%252Bsteps%26aulast%3DSo%25C5%259Bnicki%26aufirst%3DJacek%2BG.%26date%3D2014%26volume%3D70%26issue%3D45%26spage%3D8624%26epage%3D8635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyridazine Linker Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of {3-[(1-Benzyl-6-oxo-1,6-dihydropyridin-3-yl)methyl]-5-fluoro-2-methyl-1<i>H</i>-indol- 1-yl}acetic Acid</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Substituted <i>N</i>-Benzyl Pyridone Linker Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>N</i>-Alkyl Pyridone Linker Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Substituted <i>N</i>-Benzyl Pyridone Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <i>N</i>-Alkyl Pyridone Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0016.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <i>N</i>-Benzyl 5-Chloro- and 5-<i>H</i> Pyridones</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0017.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of 2-Methyl Propionoc Acid Pyridone Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0018.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of <i>N</i>-Benzyl Isoquinolinone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch10A" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0019.jpeg" id="rightTab-GRAPHIC-d4618e876-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. (A) Synthesis of <i>N</i>-Benzyl Isoquinolinone, (B) Synthesis of <i>N</i>-Benzyl Isoquinolinone, (C) Synthesis of <i>N</i>-Alkyl Isoquinolinone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch10A"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0020.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Saturated Isoquinolinone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0002.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Uptake of <b>1</b> into Sf9 cells expressing Mrp2/MRP2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2A" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0003.jpeg" id="rightTab-GRAPHIC-d4618e1240-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Plot of log IC<sub>50</sub> in the FRET and basophil chemotaxis assay. (B) Plot of log IC<sub>50</sub> in the FRET and binding assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig2A"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0004.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of log IC<sub>50</sub> in the FRET and hEOS (free) assay. *Calculated human plasma protein binding used to determine hEOS (free) values</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0005.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of cLogP versus FRET IC<sub>50</sub> (nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0006.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo efficacy in CHS model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0007.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Modulation of HDM-induced allergic airway disease in BALB/c mice with <b>44</b> and dexamethasone (Dex). Total cellularity and eosinophil, macrophage, lymphocyte, and neutrophil cell numbers in BAL samples collected 72 h post-HDM challenge.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0008.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Modulation of OVA-induced allergic lung inflammation in the guinea pig: total cellularity and eosinophils, in BAL samples collected 24 h post-OVA challenge. Solid bars are OVA sensitized, PBS challenged animals; hatched bars are OVA sensitized OVA challenged animals that received vehicle orally 1 h prior to challenge and 6 h post challenge (1 mL of 0.5 Tween 80 in FlavoRX Cherry blast syrup) <i>N</i> = 15 animals; gray bars are animals that have been treated with dexamethasone orally at 30 mg/kg 1 h prior to challenge. <i>N</i> = 9 animals; open bars are animals that have been treated with compound <b>44</b> orally at 20 mg/kg 1 h prior to challenge and 6 h post challenge. <i>N</i> = 14 animals. <i>P</i> values as determined by student’s unpaired <i>t</i> test compared with vehicle treated animals are provided above the relevant bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8A" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/medium/jm-2013-01509e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0009.jpeg" id="rightTab-GRAPHIC-d4618e2612-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Administration of compound <b>44</b> at 3 mg/kg iv in a sheep model of allergic airway bronchoconstriction and AHR. (i) While compound <b>44</b> (pink line) did not attenuate EAR as determined by increases in airway resistance above baseline, it completely ablated the <i>Ascaris suum</i> allergen induced LAR compared to untreated historical control values observed after allergen challenge in the same animals. (ii) Compound <b>44</b> blocks AHR to aerosolized carbachol (pink bar) as determined by an increase in PC400 values (the cumulative carbachol breath units that increased specific lung resistance by 400% (PC400) following allergen challenge compared to historical untreated control values in the same animals (blue bar). (B) Compound <b>44</b> attenuates <i>Ascaris</i> induced BAL fluid inflammation at 1 mg/kg iv qd for 7 days in sheep. (C) Reduction in mucocilliary clearance in sheep with <b>44</b> at 3 mpk iv.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401509e/production/images/large/jm-2013-01509e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401509e&amp;id=fig8A"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i110">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 19 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Haeggstrom, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinaldo-Matthis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelock, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterholm, A.</span><span> </span><span class="NLM_article-title">Advances in eicosanoid research, novel therapeutic implications</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=135-139&author=J.+Z.+Haeggstromauthor=A.+Rinaldo-Matthisauthor=C.+E.+Wheelockauthor=A.+Wetterholm&title=Advances+in+eicosanoid+research%2C+novel+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaeggstrom%26aufirst%3DJ.%2BZ.%26aulast%3DRinaldo-Matthis%26aufirst%3DA.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26aulast%3DWetterholm%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520eicosanoid%2520research%252C%2520novel%2520therapeutic%2520implications%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D21%26spage%3D135%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Castellani, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felaco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Amicis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecchiet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tete, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampoli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerulli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caraffa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antinolfi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuccurullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felaco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempuraj, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boscolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, Y. B.</span><span> </span><span class="NLM_article-title">Mast cells and arachidonic acid cascade in inflammation</span> <span class="citation_source-journal">Eur. J. Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFynurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=131-137&author=M.+L.+Castellaniauthor=M.+Felacoauthor=F.+Pandolfiauthor=V.+Saliniauthor=D.+De+Amicisauthor=C.+Orsoauthor=J.+Vecchietauthor=S.+Teteauthor=C.+Ciampoliauthor=F.+Contiauthor=G.+Cerulliauthor=A.+Caraffaauthor=P.+Antinolfiauthor=C.+Cuccurulloauthor=P.+Felacoauthor=D.+Kempurajauthor=P.+Boscoloauthor=G.+Sabatinoauthor=Y.+B.+Shaik&title=Mast+cells+and+arachidonic+acid+cascade+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cells and arachidonic acid cascade in inflammation</span></div><div class="casAuthors">Castellani, M. L.; Felaco, M.; Pandolfi, F.; Salini, V.; De Amicis, D.; Orso, C.; Vecchiet, J.; Tete, S.; Ciampoli, C.; Conti, F.; Cerulli, G.; Caraffa, A.; Antinolfi, P.; Cuccurullo, C.; Felaco, P.; Kempuraj, D.; Boscolo, P.; Sabatino, G.; Shaik, Y. B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inflammation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-137</span>CODEN:
                <span class="NLM_cas:coden">EJIUA5</span>;
        ISSN:<span class="NLM_cas:issn">1721-727X</span>.
    
            (<span class="NLM_cas:orgname">Biolife, s.a.s.</span>)
        </div><div class="casAbstract">A review.  Prostaglandin D2 PGD2 is a major cyclooxygenase metabolite of arachidonic acid produced by mast cells and it is released following allergen challenge in diseases, such as allergic diseases.  PGD2 may act as a neuromodulator and as an allergic and inflammatory mediator.  In allergic diseases, activated mast cell synthesizes prostaglandin D2 (first cyclo-oxygenate mediator) which has bronchoconstrictive and vasodilating effects and attracts several leukocytes.  It has been found that activated mast cells, challenged with physiol. and non- physiol. secretagogues, release elevated histamine and tryptase and chymase, leukotrienes B4, C4 and D4,5-hydroxyeicosatetraenoic acid, PGD2, Platelet Activating Factor (PAF), heparin, and high-mol.-wt. neutrophil chemotactic factor and cytokines/chemokines.  PGD2 exerts its biol. activity through the DP and CRTH2 receptors and their cDNA cloning which were characterized 15 years ago.  In this report, we revisited the biol. effects of arachidonic acid compds. released by activated mast cells in allergic and inflammatory states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkqC5TikdJp7Vg90H21EOLACvtfcHk0ljnUOgnlYmR5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFynurzM&md5=07531ac3fe1d628a33dec19c3180131e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastellani%26aufirst%3DM.%2BL.%26aulast%3DFelaco%26aufirst%3DM.%26aulast%3DPandolfi%26aufirst%3DF.%26aulast%3DSalini%26aufirst%3DV.%26aulast%3DDe%2BAmicis%26aufirst%3DD.%26aulast%3DOrso%26aufirst%3DC.%26aulast%3DVecchiet%26aufirst%3DJ.%26aulast%3DTete%26aufirst%3DS.%26aulast%3DCiampoli%26aufirst%3DC.%26aulast%3DConti%26aufirst%3DF.%26aulast%3DCerulli%26aufirst%3DG.%26aulast%3DCaraffa%26aufirst%3DA.%26aulast%3DAntinolfi%26aufirst%3DP.%26aulast%3DCuccurullo%26aufirst%3DC.%26aulast%3DFelaco%26aufirst%3DP.%26aulast%3DKempuraj%26aufirst%3DD.%26aulast%3DBoscolo%26aufirst%3DP.%26aulast%3DSabatino%26aufirst%3DG.%26aulast%3DShaik%26aufirst%3DY.%2BB.%26atitle%3DMast%2520cells%2520and%2520arachidonic%2520acid%2520cascade%2520in%2520inflammation%26jtitle%3DEur.%2520J.%2520Inflammation%26date%3D2009%26volume%3D7%26spage%3D131%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aso, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span> </span><span class="NLM_article-title">CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s)</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=1999&pages=195-199&author=K.+Nagataauthor=H.+Hiraiauthor=K.+Tanakaauthor=K.+Ogawaauthor=T.+Asoauthor=K.+Sugamuraauthor=M.+Nakamuraauthor=S.+Takano&title=CRTH2%2C+an+orphan+receptor+of+T-helper-2-cells%2C+is+expressed+on+basophils+and+eosinophils+and+responds+to+mast+cell-derived+factor%28s%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DAso%26aufirst%3DT.%26aulast%3DSugamura%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DTakano%26aufirst%3DS.%26atitle%3DCRTH2%252C%2520an%2520orphan%2520receptor%2520of%2520T-helper-2-cells%252C%2520is%2520expressed%2520on%2520basophils%2520and%2520eosinophils%2520and%2520responds%2520to%2520mast%2520cell-derived%2520factor%2528s%2529%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D459%26spage%3D195%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span> </span><span class="NLM_article-title">The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes</span> <span class="citation_source-journal">Fatty Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1016%2FS0952-3278%2803%2900078-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=12895600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVKjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2003&pages=169-177&author=K.+Nagataauthor=H.+Hirai&title=The+second+PGD%282%29+receptor+CRTH2%3A+structure%2C+properties%2C+and+functions+in+leukocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The second PGD2 receptor CRTH2: structure, properties, and functions in leukocytes</span></div><div class="casAuthors">Nagata, Kinya; Hirai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins, Leukotrienes and Essential Fatty Acids</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">169-177</span>CODEN:
                <span class="NLM_cas:coden">PLEAEU</span>;
        ISSN:<span class="NLM_cas:issn">0952-3278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  PGD2 plays a broad range of physiol. and pathophysiol. functions.  Until just a few years ago, it was thought that most of the biol. actions of PGD2 are mediated via the classical PGD2 receptor DP.  Recently, we identified a 2nd PGD2 receptor, chemoattractant receptor-homologous mol. expressed on T helper (Th)2 cells (CRTH2), with different functions relative to DP.  Here, we review the recent findings on the structure, tissue distribution, ligand selectivity, signaling pathways, and functions in leukocytes of this receptor.  The data suggest that the PGD2/CRTH2 system play important roles in allergic inflammation through its stimulatory effects on Th2 cells, eosinophils, and basophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL7orwnSlzirVg90H21EOLACvtfcHk0ljnUOgnlYmR5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVKjsbk%253D&md5=e87fa1c7331a6891dada8d3d98272ed2</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS0952-3278%2803%2900078-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-3278%252803%252900078-4%26sid%3Dliteratum%253Aachs%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DH.%26atitle%3DThe%2520second%2520PGD%25282%2529%2520receptor%2520CRTH2%253A%2520structure%252C%2520properties%252C%2520and%2520functions%2520in%2520leukocytes%26jtitle%3DFatty%2520Acids%26date%3D2003%26volume%3D69%26spage%3D169%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Emerging roles of DP and CRTH2 in allergic inflammation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=148-158&author=E.+Kostenisauthor=T.+Ulven&title=Emerging+roles+of+DP+and+CRTH2+in+allergic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DEmerging%2520roles%2520of%2520DP%2520and%2520CRTH2%2520in%2520allergic%2520inflammation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D148%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Epub.</p></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cosmi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annunziato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnani, S.</span><span> </span><span class="NLM_article-title">CRTH2: marker for the detection of human Th2 and Tc2 cells</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">495</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=495&publication_year=2001&pages=25-29&author=L.+Cosmiauthor=F.+Annunziatoauthor=G.+Galliauthor=R.+Manettiauthor=E.+Maggiauthor=S.+Romagnani&title=CRTH2%3A+marker+for+the+detection+of+human+Th2+and+Tc2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCosmi%26aufirst%3DL.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DGalli%26aufirst%3DG.%26aulast%3DManetti%26aufirst%3DR.%26aulast%3DMaggi%26aufirst%3DE.%26aulast%3DRomagnani%26aufirst%3DS.%26atitle%3DCRTH2%253A%2520marker%2520for%2520the%2520detection%2520of%2520human%2520Th2%2520and%2520Tc2%2520cells%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2001%26volume%3D495%26spage%3D25%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenmotsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor CRTH2</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1084%2Fjem.193.2.255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=11208866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksl2msg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2001&pages=255-262&author=H.+Hiraiauthor=K.+Tanakaauthor=O.+Yoshieauthor=K.+Ogawaauthor=K.+Kenmotsuauthor=Y.+Takamoriauthor=M.+Ichimasaauthor=K.+Sugamuraauthor=M.+Nakamuraauthor=S.+Takano&title=Prostaglandin+D2+Selectively+Induces+Chemotaxis+in+T+Helper+Type+2+Cells%2C+Eosinophils%2C+and+Basophils+via+Seven-Transmembrane+Receptor+CRTH2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2</span></div><div class="casAuthors">Hirai, Hiroyuki; Tanaka, Kazuya; Yoshie, Osamu; Ogawa, Kazuyuki; Kenmotsu, Kazumi; Takamori, Yasushi; Ichimasa, Michiko; Sugamura, Kazuo; Nakamura, Masataka; Takano, Shoichi; Nagata, Kinya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Prostaglandin (PG)D2, which has long been implicated in allergic diseases, is currently considered to elicit its biol. actions through the DP receptor (DP).  Involvement of DP in the formation of allergic asthma was recently demonstrated with DP-deficient mice.  However, proinflammatory functions of PGD2 cannot be explained by DP alone.  The authors show here that a 7-transmembrane receptor, CRTH2, which is preferentially expressed in T helper type 2 (Th2) cells, eosinophils, and basophils in humans, serves as the novel receptor for PGD2.  In response to PGD2, CRTH2 induces intracellular Ca2+ mobilization and chemotaxis in Th2 cells in a Gαi-dependent manner.  In addn., CRTH2, but not DP, mediates PGD2-dependent cell migration of blood eosinophils and basophils.  Thus, PGD2 is likely involved in multiple aspects of allergic inflammation through its dual receptor systems, DP and CRTH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzrVzvfWtBArVg90H21EOLACvtfcHk0lhxOUD_t8M0vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksl2msg%253D%253D&md5=be2c6671805c587029df75738463ccd3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1084%2Fjem.193.2.255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.193.2.255%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYoshie%26aufirst%3DO.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DKenmotsu%26aufirst%3DK.%26aulast%3DTakamori%26aufirst%3DY.%26aulast%3DIchimasa%26aufirst%3DM.%26aulast%3DSugamura%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DTakano%26aufirst%3DS.%26atitle%3DProstaglandin%2520D2%2520Selectively%2520Induces%2520Chemotaxis%2520in%2520T%2520Helper%2520Type%25202%2520Cells%252C%2520Eosinophils%252C%2520and%2520Basophils%2520via%2520Seven-Transmembrane%2520Receptor%2520CRTH2%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2001%26volume%3D193%26spage%3D255%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Huang, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, P.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunkett, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K. C.</span><span> </span><span class="NLM_article-title">Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2691</span><span class="NLM_x">–</span> <span class="NLM_lpage">2697</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1093%2Fhmg%2Fddh279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=15345705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=2691-2697&author=J.-L.+Huangauthor=P.-S.+Gaoauthor=R.+A.+Mathiasauthor=T.-C.+Yaoauthor=L.-C.+Chenauthor=M.-L.+Kuoauthor=S.-C.+Hsuauthor=B.+Plunkettauthor=A.+Togiasauthor=K.+C.+Barnes&title=Sequence+variants+of+the+gene+encoding+chemoattractant+receptor+expressed+on+Th2+cells+%28CRTH2%29+are+associated+with+asthma+and+differentially+influence+mRNA+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability</span></div><div class="casAuthors">Huang, Jing-Long; Gao, Pei-Song; Mathias, Rasika A.; Yao, Tsung-Chieh; Chen, Li-Chen; Kuo, Ming-Ling; Hsu, Shih-Chang; Plunkett, Beverly; Togias, Alkis; Barnes, Kathleen C.; Stellato, Cristiana; Beaty, Terri H.; Huang, Shau-Ku</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2691-2697</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The gene, CRTH2, encoding a receptor for prostaglandin D2 (PGD2), is located within the peak linkage region for asthma on chromosome (Chr.) 11q reported in African American families.  Family-based anal. of asthma and two common SNPs [G1544C and G1651A (rs545659)] in the 3'-untranslated region of CRTH2 showed significant evidence of linkage in the presence of disequil. for the 1651G allele (P=0.003) of SNP rs545659.  Haplotype anal. yielded addnl. evidence of linkage disequil. for the 1544G-1651G haplotype (P<0.001).  Population-based case-control analyses were conducted in two independent populations, and demonstrated significant assocn. of the 1544G-1651G haplotype with asthma in an African American population (P=0.004), and in a population of Chinese children (P<0.001).  Moreover, in the Chinese children the frequency of the 1651G allele in near-fatal asthmatics was significantly higher than mild-to-moderate asthmatics (P=0.001) and normal controls (P<0.001).  The 1651G allele of SNP re545659 was also assocd. with a higher degree of bronchial hyperresponsiveness (P<0.027).  Transcriptional pulsing expts. showed that the 1544G-1651G haplotype confers a significantly higher level of reporter mRNA stability, when compared with a non-transmitted haplotype (1544C-1651A), suggesting that the CRTH2 gene on Chr. 11q is a strong candidate gene for asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjOWRpXjZt0bVg90H21EOLACvtfcHk0lhxOUD_t8M0vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVOis7Y%253D&md5=6588fe0d057772c7d639ed028dbe1c51</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddh279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddh279%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.-L.%26aulast%3DGao%26aufirst%3DP.-S.%26aulast%3DMathias%26aufirst%3DR.%2BA.%26aulast%3DYao%26aufirst%3DT.-C.%26aulast%3DChen%26aufirst%3DL.-C.%26aulast%3DKuo%26aufirst%3DM.-L.%26aulast%3DHsu%26aufirst%3DS.-C.%26aulast%3DPlunkett%26aufirst%3DB.%26aulast%3DTogias%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DK.%2BC.%26atitle%3DSequence%2520variants%2520of%2520the%2520gene%2520encoding%2520chemoattractant%2520receptor%2520expressed%2520on%2520Th2%2520cells%2520%2528CRTH2%2529%2520are%2520associated%2520with%2520asthma%2520and%2520differentially%2520influence%2520mRNA%2520stability%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2004%26volume%3D13%26spage%3D2691%26epage%3D2697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Follows, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiah, E.</span><span> </span><span class="NLM_article-title">Diazine Indole Acetic Acids as Potent, Selective, and Orally Bioavailable Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5088</span><span class="NLM_x">–</span> <span class="NLM_lpage">5109</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300007n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5088-5109&author=N.+Kailaauthor=A.+Huangauthor=A.+Morettoauthor=B.+Followsauthor=K.+Janzauthor=M.+Loweauthor=J.+Thomasonauthor=T.+S.+Mansourauthor=C.+Hubeauauthor=K.+Pageauthor=P.+Morganauthor=S.+Fishauthor=X.+Xuauthor=C.+Williamsauthor=E.+Saiah&title=Diazine+Indole+Acetic+Acids+as+Potent%2C+Selective%2C+and+Orally+Bioavailable+Antagonists+of+Chemoattractant+Receptor+Homologous+Molecule+Expressed+on+Th2+Cells+%28CRTH2%29+for+the+Treatment+of+Allergic+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm300007n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300007n%26sid%3Dliteratum%253Aachs%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DMoretto%26aufirst%3DA.%26aulast%3DFollows%26aufirst%3DB.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DLowe%26aufirst%3DM.%26aulast%3DThomason%26aufirst%3DJ.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DHubeau%26aufirst%3DC.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DFish%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DSaiah%26aufirst%3DE.%26atitle%3DDiazine%2520Indole%2520Acetic%2520Acids%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Antagonists%2520of%2520Chemoattractant%2520Receptor%2520Homologous%2520Molecule%2520Expressed%2520on%2520Th2%2520Cells%2520%2528CRTH2%2529%2520for%2520the%2520Treatment%2520of%2520Allergic%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5088%26epage%3D5109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Snell, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestbo, J.</span><span> </span><span class="NLM_article-title">Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD</span> <span class="citation_source-journal">Respir. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1722</span><span class="NLM_x">–</span> <span class="NLM_lpage">1730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1016%2Fj.rmed.2013.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=23827726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A280%3ADC%252BC3sjotFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2013&pages=1722-1730&author=N.+Snellauthor=M.+Fosterauthor=J.+Vestbo&title=Efficacy+and+safety+of+AZD1981%2C+a+CRTH2+receptor+antagonist%2C+in+patients+with+moderate+to+severe+COPD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD</span></div><div class="casAuthors">Snell Noel; Foster Martyn; Vestbo Jorgen</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1722-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the efficacy and tolerability of the selective CRTh2 (DP2) receptor antagonist AZD1981 compared with placebo in patients with moderate to severe COPD.  METHODS:  In this multicentre, randomised, double-blind, parallel-group, phase IIa study (ClinicalTrials.gov identifier: NCT00690482) patients with moderate to severe COPD received either AZD1981 1000 mg twice daily or matching placebo for 4 weeks.  Inhaled terbutaline was used as-needed as reliever medication throughout.  The co-primary endpoints were change from baseline to end of treatment in pre-bronchodilator forced expiratory volume in 1 s [FEV1] and the Clinical COPD Questionnaire (CCQ).  Additional endpoints included other lung function measures, 6-min walk test (6-MWT), COPD symptom score, reliever medication use and tolerability.  RESULTS:  118 patients were randomised to treatment (AZD1981 n = 61; placebo n = 57); 83% of patients were male and the mean age was 63 years (range 43-83).  There were no significant differences in the mean difference in change from baseline to end of treatment between AZD1981 and placebo for the co-primary endpoints of pre-bronchodilator FEV1 (AZD1981-placebo: -0.015, 95% CI: -0.10 to 0.070; p = 0.72) and CCQ total score (difference: 0.042, 95% CI: -0.21 to 0.30; p = 0.75).  Similarly, no differences were observed between treatments for the other outcomes of lung function, COPD symptom score, 6-MWT, BODE index, and use of reliever medication.  AZD1981 was well tolerated.  CONCLUSION:  There was no beneficial clinical effect of AZD1981, at a dose of 1000 mg twice daily for 4 weeks, in patients with moderate to severe COPD.  AZD1981 was well tolerated and no safety concerns were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPSqgbSDH0Dhcr74wzj5o5fW6udTcc2eYW8AZ8dDPViLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjotFKktg%253D%253D&md5=1cb066d5739b23480039c884b1950ccd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.rmed.2013.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.rmed.2013.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DSnell%26aufirst%3DN.%26aulast%3DFoster%26aufirst%3DM.%26aulast%3DVestbo%26aufirst%3DJ.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520AZD1981%252C%2520a%2520CRTH2%2520receptor%2520antagonist%252C%2520in%2520patients%2520with%2520moderate%2520to%2520severe%2520COPD%26jtitle%3DRespir.%2520Med.%26date%3D2013%26volume%3D107%26spage%3D1722%26epage%3D1730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Singh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettipher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B.</span><span> </span><span class="NLM_article-title">Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1183%2F09031936.00092111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=22496329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=46-52&author=D.+Singhauthor=P.+Caddenauthor=M.+Hunterauthor=L.+P.+Collinsauthor=M.+Perkinsauthor=R.+Pettipherauthor=E.+Townsendauthor=S.+Vinallauthor=B.+O%E2%80%99Connor&title=Inhibition+of+the+asthmatic+allergen+challenge+response+by+the+CRTH2+antagonist+OC000459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459</span></div><div class="casAuthors">Singh, Dave; Cadden, Paul; Hunter, Michael; Collins, Lisa Pearce; Perkins, Mike; Pettipher, Roy; Townsend, Elizabeth; Vinall, Shan; O'Connor, Brian</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">CRTH2 (chemoattractant receptor expressed on T-helper (Th) type 2 cells) is a G-protein-coupled receptor expressed by Th2 lymphocytes and eosinophils that mediates prostaglandin (PG)D2-driven chemotaxis.  We studied the efficacy of the oral CRTH2 antagonist OC000459 in steroid-naive asthmatic patients.  A randomized, double-blind, placebo-controlled, two-way crossover study of 16 days' treatment with OC000459 (200 mg twice daily) on the late (LAR) and early (EAR) asthmatic responses to bronchial allergen challenge was conducted, with 16 subjects completing the study.  There was a 25.4% (95% Cl 5.1-45.6%) redn. in the LAR area under the curve (AUC) for change in forced expiratory vol. in 1 s with OC000459 compared with placebo (p = 0.018) but no effect on the EAR.  Sputum eosinophil counts at 1 day post-allergen challenge were lower after OC000459 treatment (p = 0.002).  PGD2-induced blood eosinophil shape change ex vivo was assessed at day 7 (n = 7).  The AUC of eosinophil shift for OC000459 was lower than placebo; the mean difference was -33.6% (95% Cl -66.8-0.4%; p = 0.048).  OC000459 treatment inhibited LAR and post-allergen increase in sputum eosinophils.  This CRTH2 antagonist appears to inhibit allergic inflammation in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyWfR26wUk7rVg90H21EOLACvtfcHk0linqEJKcLgVog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrsbo%253D&md5=953eef3a067892fca95cd080e7bd180b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1183%2F09031936.00092111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00092111%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DD.%26aulast%3DCadden%26aufirst%3DP.%26aulast%3DHunter%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DL.%2BP.%26aulast%3DPerkins%26aufirst%3DM.%26aulast%3DPettipher%26aufirst%3DR.%26aulast%3DTownsend%26aufirst%3DE.%26aulast%3DVinall%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520the%2520asthmatic%2520allergen%2520challenge%2520response%2520by%2520the%2520CRTH2%2520antagonist%2520OC000459%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2013%26volume%3D41%26spage%3D46%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span>Arry-502/CRTH2 Antagonist. <a href="http://www.arraybiopharma.com/ProductPipeline/Inflamation/CRTh2.asp" class="extLink">http://www.arraybiopharma.com/ProductPipeline/Inflamation/CRTh2.asp</a> (accessed December 20, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Arry-502%2FCRTH2+Antagonist.+http%3A%2F%2Fwww.arraybiopharma.com%2FProductPipeline%2FInflamation%2FCRTh2.asp+%28accessed+December+20%2C+2013%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span> </span><span class="NLM_article-title">Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=981-985&author=H.+Hiraiauthor=K.+Tanakaauthor=S.+Takanoauthor=M.+Ichimasaauthor=M.+Nakamuraauthor=K.+Nagata&title=Cutting+edge%3A+agonistic+effect+of+indomethacin+on+a+prostaglandin+D2+receptor%2C+CRTH2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DS.%26aulast%3DIchimasa%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DK.%26atitle%3DCutting%2520edge%253A%2520agonistic%2520effect%2520of%2520indomethacin%2520on%2520a%2520prostaglandin%2520D2%2520receptor%252C%2520CRTH2%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D981%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fretz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdenaire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M. A.</span><span> </span><span class="NLM_article-title">Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4899</span><span class="NLM_x">–</span> <span class="NLM_lpage">4911</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400122f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4899-4911&author=H.+Fretzauthor=A.+Valdenaireauthor=J.+Pothierauthor=K.+Hilpertauthor=C.+Gnerreauthor=O.+Peterauthor=X.+Leroyauthor=M.+A.+Riederer&title=Identification+of+2-%282-%281-Naphthoyl%29-8-fluoro-3%2C4-dihydro-1H-pyrido%5B4%2C3-b%5Dindol-5%282H%29-yl%29acetic+Acid+%28Setipiprant%2FACT-129968%29%2C+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+Chemoattractant+Receptor-Homologous+Molecule+Expressed+on+Th2+Cells+%28CRTH2%29+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm400122f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400122f%26sid%3Dliteratum%253Aachs%26aulast%3DFretz%26aufirst%3DH.%26aulast%3DValdenaire%26aufirst%3DA.%26aulast%3DPothier%26aufirst%3DJ.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DPeter%26aufirst%3DO.%26aulast%3DLeroy%26aufirst%3DX.%26aulast%3DRiederer%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%25202-%25282-%25281-Naphthoyl%2529-8-fluoro-3%252C4-dihydro-1H-pyrido%255B4%252C3-b%255Dindol-5%25282H%2529-yl%2529acetic%2520Acid%2520%2528Setipiprant%252FACT-129968%2529%252C%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Chemoattractant%2520Receptor-Homologous%2520Molecule%2520Expressed%2520on%2520Th2%2520Cells%2520%2528CRTH2%2529%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4899%26epage%3D4911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tumey, L. N.</span><span> </span><span class="NLM_article-title">CRTH2 antagonists</span>. In  <span class="citation_source-book">Anti-Inflammatory Drug Discovery</span>; <span class="NLM_series">RSC Drug Discovery Series</span>, Vol.  <span class="NLM_volume">26</span>; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1039%2F9781849735346-00104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=104-134&author=L.+N.+Tumey&title=Anti-Inflammatory+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1039%2F9781849735346-00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849735346-00104%26sid%3Dliteratum%253Aachs%26aulast%3DTumey%26aufirst%3DL.%2BN.%26atitle%3DCRTH2%2520antagonists%26btitle%3DAnti-Inflammatory%2520Drug%2520Discovery%26volume%3D26%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2012%26spage%3D104%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Valdenaire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renneberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H.</span><span> </span><span class="NLM_article-title">Evolution of novel tricyclic CRTh2 receptor antagonists from a (<i>E</i>)-2-cyano-3-(1<i>H</i>-indol-3-yl)acrylamide scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">944</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=944-948&author=A.+Valdenaireauthor=J.+Pothierauthor=D.+Rennebergauthor=M.+A.+Riedererauthor=O.+Peterauthor=X.+Leroyauthor=C.+Gnerreauthor=H.+Fretz&title=Evolution+of+novel+tricyclic+CRTh2+receptor+antagonists+from+a+%28E%29-2-cyano-3-%281H-indol-3-yl%29acrylamide+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValdenaire%26aufirst%3DA.%26aulast%3DPothier%26aufirst%3DJ.%26aulast%3DRenneberg%26aufirst%3DD.%26aulast%3DRiederer%26aufirst%3DM.%2BA.%26aulast%3DPeter%26aufirst%3DO.%26aulast%3DLeroy%26aufirst%3DX.%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DFretz%26aufirst%3DH.%26atitle%3DEvolution%2520of%2520novel%2520tricyclic%2520CRTh2%2520receptor%2520antagonists%2520from%2520a%2520%2528E%2529-2-cyano-3-%25281H-indol-3-yl%2529acrylamide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D944%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Andres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buil, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calbet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenech, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehner, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevilla, S.</span><span> </span><span class="NLM_article-title">2-(1<i>H</i>-Pyrazol-4-yl)acetic acids as CRTh2 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3349</span><span class="NLM_x">–</span> <span class="NLM_lpage">3353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3349-3353&author=M.+Andresauthor=M.+Bravoauthor=M.+A.+Builauthor=M.+Calbetauthor=J.+Castroauthor=T.+Domenechauthor=P.+Eichhornauthor=M.+Ferrerauthor=E.+Gomezauthor=M.+D.+Lehnerauthor=I.+Morenoauthor=R.+S.+Robertsauthor=S.+Sevilla&title=2-%281H-Pyrazol-4-yl%29acetic+acids+as+CRTh2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndres%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DM.%26aulast%3DBuil%26aufirst%3DM.%2BA.%26aulast%3DCalbet%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DEichhorn%26aufirst%3DP.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DE.%26aulast%3DLehner%26aufirst%3DM.%2BD.%26aulast%3DMoreno%26aufirst%3DI.%26aulast%3DRoberts%26aufirst%3DR.%2BS.%26aulast%3DSevilla%26aufirst%3DS.%26atitle%3D2-%25281H-Pyrazol-4-yl%2529acetic%2520acids%2520as%2520CRTh2%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3349%26epage%3D3353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Lamers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flesch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merk, D.</span><span> </span><span class="NLM_article-title">Novel prostaglandin receptor modulators: a patent review (2002–2012), part I: Non-EP receptor modulators</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1517%2F13543776.2013.736495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCksr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=47-77&author=C.+Lamersauthor=D.+Fleschauthor=M.+Schubert-Zsilaveczauthor=D.+Merk&title=Novel+prostaglandin+receptor+modulators%3A+a+patent+review+%282002%E2%80%932012%29%2C+part+I%3A+Non-EP+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11eR"><div class="casContent"><span class="casTitleNuber">11e</span><div class="casTitle"><span class="NLM_cas:atitle">Novel prostaglandin receptor modulators: a patent review (2002 - 2012) - part I: non-EP receptor modulators</span></div><div class="casAuthors">Lamers, Christina; Flesch, Daniel; Schubert-Zsilavecz, Manfred; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-77</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Prostaglandins and their G-protein coupled receptors play numerous physiol. and pathophysiol. roles esp. in inflammation and its resoln.  The variety of physiol. effects mediated by prostanoids makes prostanoid receptors valuable drug targets and the research on prostaglandin receptor modulators is intensive.  Prostaglandin receptor targeting drugs might be beneficial for the treatment of inflammatory, allergic, respiratory and cardiovascular disorders as well as treatment of pain but several novel fields of use such as cancer and ophthalmic diseases have also been found apart from these classical indications.Areas covered: Evaluation of the patent activity over the last decade (2002 - 2012) illustrates many potent and selective modulators of the distinct prostanoid receptors and some novel methods for their use besides the classical indications.  By now, some prostaglandin receptor antagonists already have reached clin. development.Expert opinion: Though the structural diversity of compds. targeting prostanoid receptors is not really large, several highly potent agents with favorable properties have been developed.  The clin. potential of FP, IP, TP and DP modulators remains to be investigated, while first very promising clin. results are available as far as CRTH2 is concerned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw1AUIH0apC7Vg90H21EOLACvtfcHk0lgHnMRJmgaS_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCksr3L&md5=99434046685e153cf2a350f342022b50</span></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.736495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.736495%26sid%3Dliteratum%253Aachs%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DFlesch%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DNovel%2520prostaglandin%2520receptor%2520modulators%253A%2520a%2520patent%2520review%2520%25282002%25E2%2580%25932012%2529%252C%2520part%2520I%253A%2520Non-EP%2520receptor%2520modulators%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D47%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Sandham, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschauer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Docx, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furegati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalthoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meingassner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Profit, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span> </span><span class="NLM_article-title">Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6582</span><span class="NLM_x">–</span> <span class="NLM_lpage">6591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6582-6591&author=D.+A.+Sandhamauthor=N.+Arnoldauthor=H.+Aschauerauthor=K.+Balaauthor=L.+Barkerauthor=L.+Brownauthor=Z.+Brownauthor=D.+Buddauthor=B.+Coxauthor=C.+Docxauthor=G.+Duboisauthor=N.+Dugganauthor=K.+Englandauthor=B.+Everattauthor=M.+Furegatiauthor=E.+Hallauthor=F.+Kalthoffauthor=A.+Kingauthor=C.+J.+Leblancauthor=J.+Maniniauthor=J.+Meingassnerauthor=R.+Profitauthor=A.+Schmidtauthor=J.+Simmonsauthor=B.+Sohalauthor=R.+Stringerauthor=M.+Thomasauthor=K.+L.+Turnerauthor=C.+Walkerauthor=S.+J.+Watsonauthor=J.+Westwickauthor=J.+Willisauthor=G.+Williamsauthor=C.+Wilson&title=Discovery+and+characterization+of+NVP-QAV680%2C+a+potent+and+selective+CRTh2+receptor+antagonist+suitable+for+clinical+testing+in+allergic+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandham%26aufirst%3DD.%2BA.%26aulast%3DArnold%26aufirst%3DN.%26aulast%3DAschauer%26aufirst%3DH.%26aulast%3DBala%26aufirst%3DK.%26aulast%3DBarker%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DZ.%26aulast%3DBudd%26aufirst%3DD.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DDocx%26aufirst%3DC.%26aulast%3DDubois%26aufirst%3DG.%26aulast%3DDuggan%26aufirst%3DN.%26aulast%3DEngland%26aufirst%3DK.%26aulast%3DEveratt%26aufirst%3DB.%26aulast%3DFuregati%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DE.%26aulast%3DKalthoff%26aufirst%3DF.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DLeblanc%26aufirst%3DC.%2BJ.%26aulast%3DManini%26aufirst%3DJ.%26aulast%3DMeingassner%26aufirst%3DJ.%26aulast%3DProfit%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DSimmons%26aufirst%3DJ.%26aulast%3DSohal%26aufirst%3DB.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DTurner%26aufirst%3DK.%2BL.%26aulast%3DWalker%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DS.%2BJ.%26aulast%3DWestwick%26aufirst%3DJ.%26aulast%3DWillis%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DWilson%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520NVP-QAV680%252C%2520a%2520potent%2520and%2520selective%2520CRTh2%2520receptor%2520antagonist%2520suitable%2520for%2520clinical%2520testing%2520in%2520allergic%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6582%26epage%3D6591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mahadevan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKew, J. C.</span><span> </span><span class="NLM_article-title">A general method for C3 reductive alkylation of indoles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4589</span><span class="NLM_x">–</span> <span class="NLM_lpage">4591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=4589-4591&author=A.+Mahadevanauthor=H.+Sardauthor=M.+Gonzalezauthor=J.+C.+McKew&title=A+general+method+for+C3+reductive+alkylation+of+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DA.%26aulast%3DSard%26aufirst%3DH.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DMcKew%26aufirst%3DJ.%2BC.%26atitle%3DA%2520general%2520method%2520for%2520C3%2520reductive%2520alkylation%2520of%2520indoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D4589%26epage%3D4591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bowman, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridge, C. F.</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">4051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1080%2F00397919908085926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Slurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bowman%2C+W.+R.%3B+Bridge%2C+C.+F.Synth.+Commun.+1999%2C+29+%2822%29+4051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of N-alkyl pyridones</span></div><div class="casAuthors">Bowman, W. Russell; Bridge, Colin F.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4051-4059</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The regioselective synthesis of N-alkyl pyridones can be facilitated by alkylation of 2-methoxypyridines with activated halides.  The syntheses are facile and high yielding with no traces of 2-alkoxypyridines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOQRTyum22LLVg90H21EOLACvtfcHk0ljhxgrFYbokrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Slurc%253D&md5=d71f06683cab10582394891489ee3bc9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F00397919908085926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919908085926%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DW.%2BR.%26aulast%3DBridge%26aufirst%3DC.%2BF.%26jtitle%3DSynth.%2520Commun.%26date%3D1999%26volume%3D29%26issue%3D22%26spage%3D4051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naughton, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parveen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threadgill, M. D.</span><span> </span><span class="NLM_article-title"><i>N</i>- and <i>O</i>-Alkylation of isoquinolin-1-ones in the Mitsunobu reaction: development of potential drug delivery systems</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=335-340&author=S.+Ferrerauthor=D.+P.+Naughtonauthor=I.+Parveenauthor=M.+D.+Threadgill&title=N-+and+O-Alkylation+of+isoquinolin-1-ones+in+the+Mitsunobu+reaction%3A+development+of+potential+drug+delivery+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DNaughton%26aufirst%3DD.%2BP.%26aulast%3DParveen%26aufirst%3DI.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DN-%2520and%2520O-Alkylation%2520of%2520isoquinolin-1-ones%2520in%2520the%2520Mitsunobu%2520reaction%253A%2520development%2520of%2520potential%2520drug%2520delivery%2520systems%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D2002%26spage%3D335%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Horning, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacasse, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, J. M.</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2796</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Horning%2C+D.+E.%3B+Lacasse%2C+G.%3B+Muchowski%2C+J.+M.Can.+J.+Chem.+1971%2C+49%2C+2785%E2%80%932796"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorning%26aufirst%3DD.%2BE.%26aulast%3DLacasse%26aufirst%3DG.%26aulast%3DMuchowski%26aufirst%3DJ.%2BM.%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1971%26volume%3D49%26spage%3D2785%26epage%3D2796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwahn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güssregen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreuder, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmeister, A.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors based on a tetrahydro-1(2<i>H</i>)-isoquinolinone scaffold: synthesis, biological evaluation and X-ray crystal structure</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">1550</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1055%2Fs-2005-865324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFOktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=1550-1554&author=S.+Peukertauthor=U.+Schwahnauthor=S.+G%C3%BCssregenauthor=H.+Schreuderauthor=A.+Hofmeister&title=Poly%28ADP-ribose%29+polymerase-1+%28PARP-1%29+inhibitors+based+on+a+tetrahydro-1%282H%29-isoquinolinone+scaffold%3A+synthesis%2C+biological+evaluation+and+X-ray+crystal+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors based on a tetrahydro-1(2H)-isoquinolinone scaffold: Synthesis, biological evaluation and X-ray crystal structure</span></div><div class="casAuthors">Peukert, Stefan; Schwahn, Uwe; Guessregen, Stefan; Schreuder, Herman; Hofmeister, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1550-1554</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The synthesis, activity and phys. properties of two series of novel potent tetrahydro-1(2H)-isoquinolinone based PARP-1 inhibitors I (R1 = H, Me; R2 = MeCO, HOCH2, MeSO2, F3C, Me2NHCO, etc.) and II [R3 = n-Bu, Me2NCH2CH2, 3-pyridylmethyl, nicotinoyl, etc., R4 = H; R3R4 = (CH2)4; R3 = PhCH2, R4 = 1-methylimidazol-2-ylmethyl] are described.  The new structural classes with a non-planar ring system interact specifically with the PARP-1 protein at the nicotinamide-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfwetqoHTtDrVg90H21EOLACvtfcHk0ljhxgrFYbokrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFOktb0%253D&md5=f5168800db2546316a2f8bfd942df808</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1055%2Fs-2005-865324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2005-865324%26sid%3Dliteratum%253Aachs%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DSchwahn%26aufirst%3DU.%26aulast%3DG%25C3%25BCssregen%26aufirst%3DS.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DHofmeister%26aufirst%3DA.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase-1%2520%2528PARP-1%2529%2520inhibitors%2520based%2520on%2520a%2520tetrahydro-1%25282H%2529-isoquinolinone%2520scaffold%253A%2520synthesis%252C%2520biological%2520evaluation%2520and%2520X-ray%2520crystal%2520structure%26jtitle%3DSynthesis%26date%3D2005%26spage%3D1550%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Long, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sypek, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, S. J.</span><span> </span><span class="NLM_article-title">Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1165%2Frcmb.2005-0451OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=16645179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVCqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2006&pages=357-365&author=A.+J.+Longauthor=J.+P.+Sypekauthor=R.+Askewauthor=S.+C.+Fishauthor=L.+E.+Masonauthor=C.+M.+Williamsauthor=S.+J.+Goldman&title=Gob-5+contributes+to+goblet+cell+hyperplasia+and+modulates+pulmonary+tissue+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation</span></div><div class="casAuthors">Long, Andrew J.; Sypek, Joseph P.; Askew, Roger; Fish, Susan C.; Mason, Lawrence E.; Williams, Cara M. M.; Goldman, Samuel J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Gob-5 is a member of the calcium-activated chloride channel family and has been assocd. with allergic response in mouse models of pulmonary inflammation.  Gene expression of Gob-5 has been shown to be induced in allergic airways and has been strongly assocd. with mucin gene regulation and goblet cell hyperplasia.  The authors investigated the physiol. role of Gob-5 in murine models of pulmonary inflammation using mice deficient in Gob-5.  After sensitization and aerosol challenge with ovalbumin (OVA), Gob-5 knockout mice exhibit significantly increased bronchoalveolar lavage (BAL) inflammation as compared with wild-type controls.  The augmented inflammation in BAL consisted predominantly of neutrophils.  Examn. of perivascular inflammation revealed that tissue inflammation was decreased in OVA-challenged Gob-5-/- mice.  OVA-challenged Gob-5 knockout mice also had decreased goblet cell hyperplasia as well as decreased mucus prodn.  These mice also had decreased airway hypersensitivity after cholinergic provocation with methacholine.  Gob-5 knockout mice were also challenged via intranasal LPS, a TLR-4 agonist.  Gob-5-/- mice responded with increased neutrophilic BAL inflammation and decreased perivascular tissue inflammation as compared with wild-type controls.  There was little effect on goblet cell hyperplasia and mucus prodn. after LPS challenge.  These observations reinforce findings that assoc. Gob-5 with goblet cell hyperplasia and mucus prodn. in the allergic immune response, but also implicate Gob-5 in the regulation of tissue inflammation in the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqplVl3cGYKXLVg90H21EOLACvtfcHk0ljze7EtZNrRoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVCqtrY%253D&md5=9f3db4194a906caec345e736f4d53ae7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2005-0451OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2005-0451OC%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DA.%2BJ.%26aulast%3DSypek%26aufirst%3DJ.%2BP.%26aulast%3DAskew%26aufirst%3DR.%26aulast%3DFish%26aufirst%3DS.%2BC.%26aulast%3DMason%26aufirst%3DL.%2BE.%26aulast%3DWilliams%26aufirst%3DC.%2BM.%26aulast%3DGoldman%26aufirst%3DS.%2BJ.%26atitle%3DGob-5%2520contributes%2520to%2520goblet%2520cell%2520hyperplasia%2520and%2520modulates%2520pulmonary%2520tissue%2520inflammation%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2006%26volume%3D35%26spage%3D357%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abraham, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabater, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauredo, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botvinnikova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjercke, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revelle, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, I. L.</span><span> </span><span class="NLM_article-title">Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1164%2Fajrccm.159.4.9806002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=10194167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A280%3ADyaK1M3htVeltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=1999&pages=1205-1214&author=W.+M.+Abrahamauthor=A.+Ahmedauthor=J.+R.+Sabaterauthor=I.+T.+Lauredoauthor=Y.+Botvinnikovaauthor=R.+J.+Bjerckeauthor=X.+Huauthor=B.+M.+Revelleauthor=T.+P.+Koganauthor=I.+L.+Scott&title=Selectin+blockade+prevents+antigen-induced+late+bronchial+responses+and+airway+hyperresponsiveness+in+allergic+sheep"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep</span></div><div class="casAuthors">Abraham W M; Ahmed A; Sabater J R; Lauredo I T; Botvinnikova Y; Bjercke R J; Hu X; Revelle B M; Kogan T P; Scott I L; Dixon R A; Yeh E T; Beck P J</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4 Pt 1</span>),
    <span class="NLM_cas:pages">1205-14</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Antigen challenge can elicit an allergic inflammatory response in the airways that involves eosinophils, basophils, and neutrophils and that is expressed physiologically as a late airway response (LAR) and airway hyperresponsiveness (AHR).  Although previous studies have suggested that E-selectin participates in these allergic airway responses, there is little information concerning the role of L-selectin.  To address this question, we examined the effects of administering an L-selectin-specific monoclonal antibody, DU1-29, as well as three small molecule selectin binding inhibitors, on the development of early airway responses (EAR), LAR and AHR in allergic sheep undergoing airway challenge with Ascaris suum antigen.  Sheep treated with aerosol DU1-29 before antigen challenge had a significantly reduced LAR and did not develop postchallenge AHR.  No protective effect was seen when sheep were treated with a nonspecific control monoclonal antibody.  Treatment with DU1-29 also reduced the severity of the EAR to antigen.  Similar results were obtained with each of the three small molecule selectin inhibitors at doses that depended on their L-, but not necessarily E-selectin inhibitory capacity.  The inhibition of the EAR with one of the inhibitors, TBC-1269, was associated with a reduction in histamine release.  Likewise, treatment with TBC-1269 reduced the number of neutrophils recovered in bronchoalveolar lavage (BAL) during the time of LAR and AHR.  TBC-1269, given 90 min after antigen challenge also blocked the LAR and the AHR, but this protection was lost if the treatment was withheld until 4 h after challenge, a result consistent with the proposed time course of L-selectin involvement in leukocyte trafficking.  These are the first data indicating that L-selectin may have a unique cellular function that modulates allergen-induced pulmonary responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTv12xzCsvkk8RAV4D_Ins_fW6udTcc2eZPGwqTZvFBAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3htVeltg%253D%253D&md5=ec9baba5fe245699940d9b62a7044b14</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.159.4.9806002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.159.4.9806002%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DW.%2BM.%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DSabater%26aufirst%3DJ.%2BR.%26aulast%3DLauredo%26aufirst%3DI.%2BT.%26aulast%3DBotvinnikova%26aufirst%3DY.%26aulast%3DBjercke%26aufirst%3DR.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DRevelle%26aufirst%3DB.%2BM.%26aulast%3DKogan%26aufirst%3DT.%2BP.%26aulast%3DScott%26aufirst%3DI.%2BL.%26atitle%3DSelectin%2520blockade%2520prevents%2520antigen-induced%2520late%2520bronchial%2520responses%2520and%2520airway%2520hyperresponsiveness%2520in%2520allergic%2520sheep%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1999%26volume%3D159%26spage%3D1205%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Abraham, W. M.</span><span> </span><span class="NLM_article-title">Modeling of asthma, COPD and cystic fibrosis in sheep</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm401509e&amp;key=10.1016%2Fj.pupt.2008.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm401509e&amp;key=18339565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm401509e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2jtLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=743-754&author=W.+M.+Abraham&title=Modeling+of+asthma%2C+COPD+and+cystic+fibrosis+in+sheep"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling of asthma, COPD and cystic fibrosis in sheep</span></div><div class="casAuthors">Abraham, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">743-754</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sheep naturally allergic to Ascaris suum antigen have been used to study the pathophysiol. of asthma and more recently allergic rhinitis, chronic obstructive pulmonary disease (COPD) and cystic fibrosis.  The utility of the model as it relates to the study of these diseases is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXZ8N7v4f_-LVg90H21EOLACvtfcHk0ljze7EtZNrRoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2jtLfJ&md5=47182ec714f412eb27b14be7d7a2a643</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2008.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2008.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DW.%2BM.%26atitle%3DModeling%2520of%2520asthma%252C%2520COPD%2520and%2520cystic%2520fibrosis%2520in%2520sheep%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D21%26spage%3D743%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mellor, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, E. J.</span><span> </span><span class="NLM_article-title">Aspects of the Chemistry of Dioxolanes: Synthesis of C-Nucleoside Analogues</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=243-256&author=B.+J.+Mellorauthor=P.+E.+Murrayauthor=E.+J.+Thomas&title=Aspects+of+the+Chemistry+of+Dioxolanes%3A+Synthesis+of+C-Nucleoside+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DB.%2BJ.%26aulast%3DMurray%26aufirst%3DP.%2BE.%26aulast%3DThomas%26aufirst%3DE.%2BJ.%26atitle%3DAspects%2520of%2520the%2520Chemistry%2520of%2520Dioxolanes%253A%2520Synthesis%2520of%2520C-Nucleoside%2520Analogues%26jtitle%3DTetrahedron%26date%3D1998%26volume%3D54%26spage%3D243%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i106"><a href="/doi/suppl/10.1021/jm401509e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48812"></div></div></div></div></div><hr /></hr><p class="last">Analytical data for intermediates. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401509e/suppl_file/jm401509e_si_001.pdf">jm401509e_si_001.pdf (78.54 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401509e&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-4%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm401509e%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401509e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799649a8e6d3ce8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
